CD000004 v. 8.0 Abdominal decompression for suspected fetal compromisepre-eclampsia.rm5
CD000006 v. 8.0 Absorbable suture materials for primary repair of episiotomy and second degree tears.rm5
CD000008 v. 8.2 Acupuncture for chronic asthma.rm5
CD000009 v. 12.2 Acupuncture and related interventions for smoking cessation.rm5
CD000011 v. 10.0 Interventions for enhancing medication adherence.rm5
CD000012 v. 10.0 Alternative versus conventional institutional settings for birth.rm5
CD000013 v. 8.0 Amnioinfusion for potential or suspected umbilical cord compression in labour.rm5
CD000014 v. 11.0 Amnioinfusion for meconium-stained liquor in labour.rm5
CD000016 v. 10.0 Amodiaquine for treating malaria.rm5
CD000019 v. 11.0 Thyrotropin-releasing hormone added to corticosteroids for women at risk of preterm birth for preven.rm5
CD000020 v. 9.0 Anti-D administration in pregnancy for preventing Rhesus alloimmunisation.rm5
CD000021 v. 6.0 Anti-D administration after childbirth for preventing Rhesus alloimmunisation.rm5
CD000022 v. 11.0 Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving inte.rm5
CD000023 v. 23.0 Antibiotics for sore throat.rm5
CD000024 v. 8.0 Anticoagulants for acute ischaemic stroke.rm5
CD000025 v. 10.0 Magnesium sulphate and other anticonvulsants for women with pre-eclampsia.rm5
CD000026 v. 16.0 Routine versus selective antifungal administration for control of fungal infections in patients with.rm5
CD000028 v. 14.0 Pharmacotherapy for hypertension in the elderly.rm5
CD000029 v. 8.2 Oral antiplatelet therapy for acute ischaemic stroke.rm5
CD000030 v. 11.0 Antipsychotic medication versus placebo for people with both schizophrenia and learning disability.rm5
CD000031 v. 19.0 Antidepressants for smoking cessation.rm5
CD000032 v. 9.0 Antenatal dietary education and supplementation to increase energy and protein intake.rm5
CD000033 v. 9.12 Barbiturates for acute traumatic brain injury.rm5
CD000034 v. 10.0 Bed rest in hospital for suspected impaired fetal growth.rm5
CD000035 v. 6.0 Tocolytics for suspected intrapartum fetal distress.rm5
CD000036 v. 11.0 Betamimetics for suspected impaired fetal growth.rm5
CD000037 v. 8.0 Tocolysis for preventing fetal distress in second stage of labour.rm5
CD000038 v. 8.0 Biophysical profile for fetal assessment in high risk pregnancies.rm5
CD000039 v. 8.0 Interventions for deliberately altering blood pressure in acute stroke.rm5
CD000048 v. 9.0 Prophylactic caffeine to prevent postoperative apnoea following general anaesthesia in preterm infan.rm5
CD000049 v. 8.0 Calcium channel blockers for potential impaired fetal growth.rm5
CD000051 v. 10.0 Cephalic version by postural management for breech presentation.rm5
CD000052 v. 16.0 Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma.rm5
CD000053 v. 7.0 Drugs for treating urinary schistosomiasis.rm5
CD000054 v. 10.0 Interventions for treating genital chlamydia trachomatis infection in pregnancy.rm5
CD000057 v. 7.0 Clomiphene citrate for unexplained subfertility in women.rm5
CD000058 v. 10.0 Clonidine for smoking cessation.rm5
CD000059 v. 12.0 Clozapine versus typical neuroleptic medication for schizophrenia.rm5
CD000060 v. 7.0 Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute ast.rm5
CD000064 v. 8.0 Corticosteroids for acute ischaemic stroke.rm5
CD000066 v. 10.2 Topical preparations for preventing stretch marks in pregnancy.rm5
CD000067 v. 9.0 Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.rm5
CD000068 v. 8.8 Danazol for pelvic pain associated with endometriosis.rm5
CD000069 v. 5.0 Danazol for unexplained subfertility.rm5
CD000071 v. 5.0 Patches of different types for carotid patch angioplasty.rm5
CD000072 v. 6.0 Interprofessional collaboration to improve professional practice and healthcare outcomes.rm5
CD000074 v. 12.3 Doxapram treatment for apnea in preterm infants.rm5
CD000075 v. 10.0 Doxapram versus methylxanthine for apnea in preterm infants.rm5
CD000076 v. 11.0 Electroconvulsive therapy for schizophrenia.rm5
CD000078 v. 12.0 Caesarean section versus vaginal delivery for preterm birth in singletons.rm5
CD000079 v. 8.0 Transcutaneous electrostimulation for suspected placental insufficiency (diagnosed by Doppler studie.rm5
CD000081 v. 9.0 Selective versus routine use of episiotomy for vaginal birth.rm5
CD000082 v. 9.0 Expedited versus conservative approaches for vaginal delivery in breech presentation.rm5
CD000083 v. 14.0 External cephalic version for breech presentation at term.rm5
CD000084 v. 8.0 External cephalic version for breech presentation before term.rm5
CD000085 v. 5.0 Extra-abdominal versus intra-abdominal repair of the uterine incision at caesarean section.rm5
CD000086 v. 7.0 Replacement arthroplasty versus internal fixation for extracapsular hip fractures in adults.rm5
CD000088 v. 14.0 Family intervention for schizophrenia.rm5
CD000089 v. 11.0 Family therapy for asthma in children.rm5
CD000091 v. 6.0 Fibrinogen depleting agents for acute ischaemic stroke.rm5
CD000093 v. 9.0 Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsula.rm5
CD000094 v. 6.0 Gangliosides for acute ischaemic stroke.rm5
CD000095 v. 11.0 Garlic for peripheral arterial occlusive disease.rm5
CD000096 v. 7.0 Glycerol for acute stroke.rm5
CD000098 v. 13.0 Antibiotics for gonorrhoea in pregnancy.rm5
CD000099 v. 7.0 Growth hormone for in vitro fertilization.rm5
CD000100 v. 6.0 Vaccines for preventing hepatitis B in health-care workers.rm5
CD000102 v. 12.0 Interventions for reducing the risk of mother-to-child transmission of HIV infection.rm5
CD000103 v. 5.0 Haemodilution for acute ischaemic stroke.rm5
CD000104 v. 14.0 Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary .rm5
CD000108 v. 7.0 Biochemical tests of placental function for assessment in pregnancy.rm5
CD000109 v. 8.0 Hormones for suspected impaired fetal growth.rm5
CD000110 v. 7.0 Hospitalisation and bed rest for multiple pregnancy.rm5
CD000111 v. 10.0 Immersion in water in labour and birth.rm5
CD000112 v. 7.0 Immunotherapy for recurrent miscarriage.rm5
CD000114 v. 7.0 Instruments for chorionic villus sampling for prenatal diagnosis.rm5
CD000116 v. 11.0 Fetal electrocardiogram (ECG) for fetal monitoring during labour.rm5
CD000119 v. 12.0 Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischae.rm5
CD000121 v. 12.0 Interventions for leg cramps in pregnancy.rm5
CD000122 v. 9.0 Early light reduction for preventing retinopathy of prematurity in very low birth weight infants.rm5
CD000123 v. 8.0 Lipid-lowering for peripheral arterial disease of the lower limb.rm5
CD000124 v. 9.0 Lobeline for smoking cessation.rm5
CD000125 v. 12.8 Local opinion leaders effects on professional practice and health care outcomes.rm5
CD000126 v. 6.0 Local versus general anaesthesia for carotid endarterectomy.rm5
CD000127 v. 8.0 Magnesium sulphate versus diazepam for eclampsia.rm5
CD000128 v. 9.0 Magnesium sulphate versus phenytoin for eclampsia.rm5
CD000133 v. 7.0 Maternal dietary antigen avoidance during pregnancy or lactation or both for preventing or treatin.rm5
CD000134 v. 9.0 Maternal hydration for increasing amniotic fluid volume in oligohydramnios and normal amniotic fluid.rm5
CD000136 v. 8.7 Maternal oxygen administration for fetal distress.rm5
CD000137 v. 10.0 Maternal oxygen administration for suspected impaired fetal growth.rm5
CD000139 v. 11.0 Prophylactic methylxanthines for endotracheal extubation in preterm infants.rm5
CD000140 v. 12.0 Methylxanthine treatment for apnoea in preterm infants.rm5
CD000141 v. 5.0 Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal res.rm5
CD000143 v. 10.0 Nasal continuous positive airway pressure immediately after extubation for preventing morbidity in p.rm5
CD000144 v. 8.1 Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and tr.rm5
CD000146 v. 19.3 Nicotine replacement therapy for smoking cessation.rm5
CD000147 v. 10.0 Nimodipine for primary degenerative mixed and vascular dementia.rm5
CD000148 v. 8.0 Maternal nutrient supplementation for suspected impaired fetal growth.rm5
CD000154 v. 6.0 Oral contraceptive pill for heavy menstrual bleeding.rm5
CD000155 v. 9.0 Ovulation suppression for endometriosis for women with subfertility.rm5
CD000160 v. 5.0 Patch angioplasty versus primary closure for carotid endarterectomy.rm5
CD000161 v. 8.0 Pelvimetry for fetal cephalic presentations at or near term for deciding on mode of delivery.rm5
CD000162 v. 6.0 Pentoxifylline propentofylline and pentifylline for acute ischaemic stroke.rm5
CD000163 v. 10.0 Closure versus non-closure of the peritoneum at caesarean section short- and long-term outcomes.rm5
CD000164 v. 11.0 Phenobarbital prior to preterm birth for preventing neonatal periventricular haemorrhage.rm5
CD000165 v. 14.0 Physician advice for smoking cessation.rm5
CD000166 v. 15.0 Planned caesarean section for term breech delivery.rm5
CD000167 v. 9.0 Plasma volume expansion for suspected impaired fetal growth.rm5
CD000168 v. 10.0 Pre-operative traction for hip fractures in adults.rm5
CD000169 v. 19.2 Drugs for preventing malaria in pregnant women in endemic areas any drug regimen versus placebo or .rm5
CD000171 v. 12.0 Treatment of latent tuberculosis infection in HIV infected persons.rm5
CD000174 v. 7.0 Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants.rm5
CD000175 v. 8.0 Prophylactic intravenous preloading for regional analgesia in labour.rm5
CD000176 v. 9.0 Prophylactic versus therapeutic amnioinfusion for oligohydramnios in labour.rm5
CD000177 v. 7.0 Prostacyclin and analogues for acute ischaemic stroke.rm5
CD000179 v. 9.0 Pyridoxine (vitamin B6) supplementation during pregnancy or labour for maternal and neonatal outcome.rm5
CD000180 v. 7.1 Aerobic exercise for women during pregnancy.rm5
CD000184 v. 11.0 Interventions for helping to turn term breech babies to head first presentation when using external .rm5
CD000185 v. 6.0 Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history.rm5
CD000187 v. 5.0 Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atria.rm5
CD000188 v. 14.0 Steroid sex hormones for lower limb atherosclerosis.rm5
CD000189 v. 12.0 Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid.rm5
CD000190 v. 7.0 Routine or selective carotid artery shunting for carotid endarterectomy (and different methods of mo.rm5
CD000191 v. 8.2 Silver acetate for smoking cessation.rm5
CD000193 v. 13.0 Somatostatin analogues for acute bleeding oesophageal varices.rm5
CD000194 v. 9.0 Spironolactone versus placebo or in combination with steroids for hirsutism andor acne.rm5
CD000195 v. 8.0 Corticosteroids for preventing relapse following acute exacerbations of asthma.rm5
CD000196 v. 10.0 Corticosteroids for acute traumatic brain injury.rm5
CD000197 v. 12.0 Organised inpatient (stroke unit) care for stroke.rm5
CD000198 v. 12.0 Support during pregnancy for women at increased risk of low birthweight babies.rm5
CD000200 v. 6.0 Surgery for primary supratentorial intracerebral haemorrhage.rm5
CD000201 v. 7.0 Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour.rm5
CD000203 v. 14.0 Gamma-aminobutyric acid agonists for antipsychotic-induced tardive dyskinesia.rm5
CD000204 v. 8.0 Anticholinergic medication for antipsychotic-induced tardive dyskinesia.rm5
CD000205 v. 11.0 Benzodiazepines for antipsychotic-induced tardive dyskinesia.rm5
CD000206 v. 13.3 Calcium channel blockers for antipsychotic-induced tardive dyskinesia.rm5
CD000207 v. 10.5 Cholinergic medication for antipsychotic-induced tardive dyskinesia.rm5
CD000208 v. 12.0 Miscellaneous treatments for antipsychotic-induced tardive dyskinesia.rm5
CD000209 v. 15.0 Vitamin E for antipsychotic-induced tardive dyskinesia.rm5
CD000211 v. 6.0 Theophylline aminophylline caffeine and analogues for acute ischaemic stroke.rm5
CD000212 v. 7.0 Interventions for treating psoriatic arthritis.rm5
CD000213 v. 10.0 Thrombolysis for acute ischaemic stroke.rm5
CD000214 v. 11.0 Training health professionals in smoking cessation.rm5
CD000215 v. 9.0 Anthelmintics for people with neurocysticercosis.rm5
CD000216 v. 8.0 Repeated lumbar or ventricular punctures in newborns with intraventricular haemorrhage.rm5
CD000218 v. 8.0 Interventions for treating trichomoniasis in women.rm5
CD000219 v. 17.0 Antibiotics for acute otitis media in children.rm5
CD000220 v. 10.7 Interventions for trichomoniasis in pregnancy.rm5
CD000221 v. 9.0 Techniques for pelvic surgery in subfertility.rm5
CD000222 v. 19.0 Ursodeoxycholic acid for cystic fibrosis-related liver disease.rm5
CD000223 v. 7.0 Doxapram for ventilatory failure due to exacerbations of chronic obstructive pulmonary disease.rm5
CD000225 v. 9.0 Topical treatment for vaginal candidiasis (thrush) in pregnancy.rm5
CD000227 v. 11.0 Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men.rm5
CD000229 v. 8.0 Vitamin K prior to preterm birth for preventing neonatal periventricular haemorrhage.rm5
CD000230 v. 9.0 Zinc supplementation for improving pregnancy and infant outcome.rm5
CD000234 v. 11.0 Beta-blocker supplementation of standard drug treatment for schizophrenia.rm5
CD000235 v. 5.0 Pergolide for levodopa-induced complications in Parkinson's disease.rm5
CD000236 v. 3.0 Pergolide versus bromocriptine for levodopa-induced complications in Parkinson's disease.rm5
CD000238 v. 9.0 Ambulatory oxygen for people with chronic obstructive pulmonary disease who are not hypoxaemic at re.rm5
CD000239 v. 14.0 Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients.rm5
CD000244 v. 7.0 Antibiotic prophylaxis for surgery for proximal femoral and other closed long bone fractures.rm5
CD000245 v. 20.0 Antibiotics for acute bronchitis.rm5
CD000246 v. 9.0 Prophylactic antibiotics for inhibiting preterm labour with intact membranes.rm5
CD000247 v. 11.0 Antibiotics for the common cold and acute purulent rhinitis.rm5
CD000248 v. 6.0 Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or tr.rm5
CD000249 v. 10.0 Antifibrinolytics for heavy menstrual bleeding.rm5
CD000253 v. 19.0 Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration.rm5
CD000254 v. 16.0 Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degen.rm5
CD000255 v. 8.0 Antithrombotic drugs for carotid artery dissection.rm5
CD000256 v. 10.0 Artemisinin derivatives for treating uncomplicated malaria.rm5
CD000259 v. 11.2 Audit and feedback effects on professional practice and healthcare outcomes.rm5
CD000261 v. 11.0 Back schools for non-specific low-back pain..rm5
CD000262 v. 11.0 Antibiotics for treating bacterial vaginosis in pregnancy.rm5
CD000265 v. 15.0 Compression for venous leg ulcers.rm5
CD000269 v. 9.0 Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with ch.rm5
CD000270 v. 9.0 Community mental health teams (CMHTs) for people with severe mental illnesses and disordered persona.rm5
CD000273 v. 8.0 Caffeine versus theophylline for apnea in preterm infants.rm5
CD000277 v. 7.0 Calcium antagonists for aneurysmal subarachnoid haemorrhage.rm5
CD000279 v. 9.0 Strategies for detecting colon cancer in patients with inflammatory bowel disease.rm5
CD000280 v. 5.2 Carbohydrate supplementation of human milk to promote growth in preterm infants.rm5
CD000283 v. 10.2 Chest physiotherapy for preventing morbidity in babies being extubated from mechanical ventilation.rm5
CD000284 v. 16.0 Chlorpromazine versus placebo for schizophrenia.rm5
CD000296 v. 7.0 Budesonide for induction of remission in Crohn's disease.rm5
CD000297 v. 5.0 Cyclosporine for induction of remission in Crohn's disease.rm5
CD000299 v. 6.0 Anti-tuberculous therapy for maintenance of remission in Crohn's disease.rm5
CD000301 v. 7.0 Corticosteroids for maintenance of remission in Crohn's disease.rm5
CD000305 v. 8.0 Heparin low molecular weight heparin and physical methods for preventing deep vein thrombosis and p.rm5
CD000307 v. 10.0 Fluphenazine decanoate (depot) and enanthate for schizophrenia.rm5
CD000308 v. 8.0 Intravenous dexamethasone for extubation of newborn infants.rm5
CD000313 v. 8.2 Discharge planning from hospital.rm5
CD000314 v. 12.0 Conservative interventions for treating distal radial fractures in adults.rm5
CD000317 v. 10.0 Intrauterine insemination versus intracervical insemination in donor sperm treatment.rm5
CD000320 v. 14.0 Interventions for treating scabies.rm5
CD000323 v. 8.1 Interventions for dysphagia and nutritional support in acute and subacute stroke.rm5
CD000324 v. 6.0 Interventions for tubal ectopic pregnancy.rm5
CD000326 v. 6.0 Educational interventions for asthma in children.rm5
CD000328 v. 6.0 Elective high frequency jet ventilation versus conventional ventilation for respiratory distress syn.rm5
CD000329 v. 8.0 Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding.rm5
CD000330 v. 13.2 Enemas during labour.rm5
CD000331 v. 10.2 Epidural versus non-epidural or no analgesia in labour.rm5
CD000332 v. 10.0 Erythropoiesis-stimulating agents for anemia in rheumatoid arthritis.rm5
CD000333 v. 9.0 Exercise for preventing and treating osteoporosis in postmenopausal women.rm5
CD000335 v. 14.0 Exercise therapy for treatment of non-specific low back pain.rm5
CD000336 v. 7.0 Effect of outpatient pharmacists'non-dispensing roleson patient outcomes and prescribing patterns.rm5
CD000337 v. 8.0 Conservative versus operative treatment for hip fractures in adults.rm5
CD000338 v. 8.0 Condylocephalic nails versus extramedullary implants for extracapsular hip fractures.rm5
CD000339 v. 11.0 Extramedullary fixation implants and external fixators for extracapsular hip fractures in adults.rm5
CD000341 v. 8.0 Fat supplementation of human milk for promoting growth in preterm infants.rm5
CD000343 v. 6.0 Multi-nutrient fortification of human milk for preterm infants.rm5
CD000345 v. 7.0 Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for .rm5
CD000349 v. 4.2 Guidelines in professions allied to medicine.rm5
CD000352 v. 12.0 Planned hospital birth versus planned home birth.rm5
CD000353 v. 9.0 Homeopathy for chronic asthma.rm5
CD000356 v. 9.0 Early discharge hospital at home.rm5
CD000359 v. 8.0 Hydergine for dementia.rm5
CD000360 v. 10.0 Assisted reproductive technologies for male subfertility.rm5
CD000361 v. 10.0 Intravenous immunoglobulin for preventing infection in preterm andor low birth weight infants.rm5
CD000363 v. 5.0 Insecticide-treated bed nets and curtains for preventing malaria.rm5
CD000364 v. 9.0 Vaccines for preventing influenza in people with asthma.rm5
CD000366 v. 9.0 Inositol in preterm infants at risk for or having respiratory distress syndrome.rm5
CD000368 v. 13.0 Intercessory prayer for the alleviation of ill health.rm5
CD000369 v. 6.0 Interferon for acute hepatitis C.rm5
CD000370 v. 5.0 Interferon for interferon naive patients with chronic hepatitis C.rm5
CD000371 v. 18.0 Deworming drugs for soil-transmitted intestinal worms in children effects on nutritional indicators.rm5
CD000373 v. 7.2 Kinesthetic stimulation for preventing apnea in preterm infants.rm5
CD000375 v. 9.0 Longchain polyunsaturated fatty acid supplementation in preterm infants.rm5
CD000376 v. 9.0 Long chain polyunsaturated fatty acid supplementation in infants born at term.rm5
CD000377 v. 6.6 Antipsychotic medication for challenging behaviour in people with learning disability.rm5
CD000380 v. 9.0 Surgical versus conservative treatment for acute injuries of the lateral ligament complex of the ank.rm5
CD000381 v. 10.0 Life skills programmes for chronic mental illnesses.rm5
CD000384 v. 8.2 Length of hospitalisation for people with severe mental illness.rm5
CD000386 v. 9.0 Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for treating uncomplicated malari.rm5
CD000389 v. 7.0 Mass media interventions effects on health services utilisation.rm5
CD000390 v. 7.0 Massage for promoting growth and development of preterm andor low birth-weight infants.rm5
CD000391 v. 8.0 Methotrexate as a steroid sparing agent for asthma in adults.rm5
CD000396 v. 11.0 Non-steroidal anti-inflammatory drugs for low back pain.rm5
CD000398 v. 8.0 Nitric oxide donors (nitrates) L-arginine or nitric oxide synthase inhibitors for acute stroke.rm5
CD000399 v. 13.0 Nitric oxide for respiratory failure in infants born at or near term.rm5
CD000400 v. 8.0 Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding.rm5
CD000402 v. 9.0 Hormone therapy in postmenopausal women and risk of endometrial hyperplasia.rm5
CD000405 v. 10.0 Enteral antibiotics for preventing necrotizing enterocolitis in low birthweight or preterm infants.rm5
CD000406 v. 18.0 Oral calorie supplements for cystic fibrosis.rm5
CD000407 v. 21.0 Oral steroids for long-term use in cystic fibrosis.rm5
CD000409 v. 7.0 Educational outreach visits effects on professional practice and health care outcomes.rm5
CD000412 v. 6.0 Pulsatile gonadotrophin releasing hormone for ovulation induction in subfertility associated with po.rm5
CD000419 v. 9.0 Piracetam for acute ischaemic stroke.rm5
CD000422 v. 8.0 Vaccines for preventing pneumococcal infection in adults.rm5
CD000424 v. 6.0 Pharmacological treatment for aphasia following stroke.rm5
CD000425 v. 9.0 Speech and language therapy for aphasia following stroke.rm5
CD000427 v. 9.0 Preoxygenation for tracheal suctioning in intubated ventilated newborn infants.rm5
CD000432 v. 11.0 Prophylactic methylxanthine for prevention of apnoea in preterm infants.rm5
CD000433 v. 5.0 Protein supplementation of human milk for promoting growth in preterm infants.rm5
CD000434 v. 12.0 Interventions for treating proximal humeral fractures in adults.rm5
CD000435 v. 7.0 Radiant warmers versus incubators for regulating body temperature in newborn infants.rm5
CD000436 v. 8.0 Dietary sodium manipulation and asthma.rm5
CD000437 v. 3.4 Rescue high-frequency jet ventilation versus conventional ventilation for severe pulmonary dysfuncti.rm5
CD000438 v. 7.0 Rescue high frequency oscillatory ventilation versus conventional ventilation for pulmonary dysfunct.rm5
CD000440 v. 12.0 Risperidone versus typical antipsychotic medication for schizophrenia.rm5
CD000442 v. 13.1 Selegiline for Alzheimer's disease.rm5
CD000443 v. 8.0 Early supported discharge services for people with acute stroke.rm5
CD000448 v. 10.0 St John's wort for major depression.rm5
CD000450 v. 6.0 Interventions for preventing and treating stress fractures and stress reactions of bone of the lower.rm5
CD000451 v. 10.0 Membrane sweeping for induction of labour.rm5
CD000452 v. 11.0 Support for mothers fathers and families after perinatal death.rm5
CD000453 v. 13.0 Supported housing for people with severe mental disorders.rm5
CD000456 v. 9.0 Synchronized mechanical ventilation for respiratory support in newborn infants.rm5
CD000458 v. 13.0 Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia.rm5
CD000459 v. 8.0 Antipsychotic reduction andor cessation and antipsychotics as specific treatments for tardive dyski.rm5
CD000460 v. 10.0 Tartrazine exclusion for allergic asthma.rm5
CD000464 v. 12.0 Thioridazine for dementia.rm5
CD000467 v. 5.0 Calcium channel blockers for primary and secondary Raynaud's phenomenon.rm5
CD000475 v. 10.0 Barrier agents for adhesion prevention after gynaecological surgery.rm5
CD000478 v. 7.0 Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.rm5
CD000479 v. 7.2 Surgery or embolization for varicoceles in subfertile men.rm5
CD000480 v. 7.0 Vinpocetine for acute ischaemic stroke.rm5
CD000483 v. 5.0 Circulatory volume expansion therapy for aneurysmal subarachnoid haemorrhage.rm5
CD000490 v. 7.0 Antibiotics for asymptomatic bacteriuria in pregnancy.rm5
CD000491 v. 8.0 Duration of treatment for asymptomatic bacteriuria during pregnancy.rm5
CD000493 v. 10.0 Interventions for treating cholestasis in pregnancy.rm5
CD000494 v. 11.0 Prostaglandins for preventing postpartum haemorrhage.rm5
CD000495 v. 10.0 Therapeutic ultrasound for postpartum perineal pain and dyspareunia.rm5
CD000498 v. 6.2 Intraventricular streptokinase after intraventricular hemorrhage in newborn infants.rm5
CD000499 v. 6.0 Kinesthetic stimulation for treating apnea in preterm infants.rm5
CD000500 v. 6.0 Endotracheal intubation at birth for preventing morbidity and mortality in vigorous meconium-staine.rm5
CD000501 v. 11.0 Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birth .rm5
CD000502 v. 6.0 Kinesthetic stimulation versus methylxanthine for apnea in preterm infants.rm5
CD000503 v. 8.0 Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants.rm5
CD000504 v. 6.0 Early trophic feeding versus enteral fasting for very preterm or very low birth weight infants.rm5
CD000505 v. 5.0 Umbilical artery catheters in the newborn effects of position of the catheter tip.rm5
CD000506 v. 8.0 Nebulized racemic epinephrine for extubation of newborn infants.rm5
CD000507 v. 5.0 Umbilical artery catheters in the newborn effects of heparin.rm5
CD000508 v. 5.0 Umbilical artery catheters in the newborn effects of catheter design (end vs. side hole).rm5
CD000509 v. 12.0 Inhaled nitric oxide for respiratory failure in preterm infants.rm5
CD000510 v. 7.0 Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm inf.rm5
CD000511 v. 5.4 Prophylactic animal derived surfactant extract for preventing morbidity and mortality in preterm inf.rm5
CD000512 v. 4.0 Low versus high haemoglobin concentration threshold for blood transfusion for preventing morbidity a.rm5
CD000514 v. 6.0 Thrombolysis (different doses routes of administration and agents) for acute ischaemic stroke.rm5
CD000515 v. 6.2 Percutaneous transluminal balloon angioplasty and stenting for carotid artery stenosis.rm5
CD000516 v. 4.0 Percutaneous transluminal angioplasty and stenting for vertebral artery stenosis.rm5
CD000518 v. 10.0 Balneotherapy (or spa therapy) for rheumatoid arthritis.rm5
CD000520 v. 7.0 Injectable gold for rheumatoid arthritis.rm5
CD000521 v. 10.0 Anaesthesia for hip fracture surgery in adults.rm5
CD000522 v. 7.8 Osteotomy compression and other modifications of surgical techniques for internal fixation of extra.rm5
CD000523 v. 13.0 Interventions for treating isolated diaphyseal fractures of the ulna in adults.rm5
CD000525 v. 7.0 Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses.rm5
CD000526 v. 8.2 Interventions for treating tuberculous pericarditis.rm5
CD000527 v. 10.0 Artemisinin derivatives for treating severe malaria.rm5
CD000528 v. 8.4 Drugs for treating Schistosoma mansoni infection.rm5
CD000530 v. 11.0 Echinacea for preventing and treating the common cold.rm5
CD000531 v. 4.5 Target payments in primary care effects on professional practice and health care outcomes.rm5
CD000532 v. 5.0 On-site mental health workers delivering psychological therapy and psychosocial interventions to pat.rm5
CD000535 v. 8.0 Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery.rm5
CD000536 v. 9.0 Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery.rm5
CD000542 v. 9.3 Enteral nutritional therapy for induction of remission in Crohn's disease.rm5
CD000543 v. 13.0 Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.rm5
CD000544 v. 13.0 Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.rm5
CD000545 v. 11.0 Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.rm5
CD000546 v. 12.0 Aversive smoking for smoking cessation.rm5
CD000547 v. 7.0 Preoperative medical therapy before surgery for uterine fibroids.rm5
CD000551 v. 9.2 Ursodeoxycholic acid for primary biliary cirrhosis.rm5
CD000553 v. 6.0 Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis.rm5
CD000560 v. 11.0 Psychological debriefing for preventing post traumatic stress disorder (PTSD).rm5
CD000561 v. 13.0 Antidepressants versus placebo for the depressed elderly.rm5
CD000562 v. 15.0 Psychological treatments for bulimia nervosa and binging.rm5
CD000563 v. 14.0 Post-operative radiotherapy for ductal carcinoma in situ of the breast.rm5
CD000565 v. 8.3 Calcium channel blockers for acute traumatic brain injury.rm5
CD000566 v. 9.0 Hyperventilation therapy for acute traumatic brain injury.rm5
CD000567 v. 15.0 Colloids versus crystalloids for fluid resuscitation in critically ill patients.rm5
CD000934 v. 9.0 Alternative versus standard packages of antenatal care for low-risk pregnancy.rm5
CD000935 v. 11.0 Antenatal education for self-diagnosis of the onset of active labour at term.rm5
CD000936 v. 8.0 Labour assessment programs to delay admission to labour wards.rm5
CD000937 v. 11.0 Magnesium supplementation in pregnancy.rm5
CD000938 v. 10.0 Induction of labour at or near term for suspected fetal macrosomia.rm5
CD000940 v. 7.2 Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour.rm5
CD000941 v. 13.0 Vaginal misoprostol for cervical ripening and induction of labour.rm5
CD000942 v. 8.0 Amnioinfusion for third trimester preterm premature rupture of membranes.rm5
CD000944 v. 8.0 Symphysis-fundal height measurement in pregnancy.rm5
CD000947 v. 8.0 Continuous and interrupted suturing techniques for repair of episiotomy or second-degree tears.rm5
CD000948 v. 7.0 Nasal versus oral intubation for mechanical ventilation of newborn infants.rm5
CD000949 v. 5.0 Umbilical artery catheters in the newborn effects of catheter materials.rm5
CD000950 v. 6.0 Carnitine supplementation of parenterally fed neonates.rm5
CD000951 v. 10.0 Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumat.rm5
CD000952 v. 8.0 Calcium and vitamin D for corticosteroid-induced osteoporosis.rm5
CD000953 v. 7.0 Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis.rm5
CD000954 v. 6.0 Ketanserin for Raynaud's phenomenon in progressive systemic sclerosis.rm5
CD000955 v. 6.0 Cyclofenil for Raynaud's phenomenon in progressive systemic sclerosis.rm5
CD000956 v. 6.0 Prazosin for Raynaud's phenomenon in progressive systemic sclerosis.rm5
CD000957 v. 8.0 Methotrexate for treating rheumatoid arthritis.rm5
CD000958 v. 7.0 Sulfasalazine for treating rheumatoid arthritis.rm5
CD000959 v. 9.0 Antimalarials for treating rheumatoid arthritis.rm5
CD000963 v. 9.3 Multidisciplinary biopsychosocial rehabilitation for chronic low back pain.rm5
CD000966 v. 9.0 Newer atypical antipsychotic medication versus clozapine for schizophrenia.rm5
CD000967 v. 13.0 Quetiapine for schizophrenia.rm5
CD000968 v. 4.0 Cognitive rehabilitation for people with schizophrenia and related conditions.rm5
CD000969 v. 15.0 Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia.rm5
CD000970 v. 8.0 Fully intermittent dosing with drugs for treating tuberculosis in adults.rm5
CD000972 v. 7.2 Steroids for treating cerebral malaria.rm5
CD000974 v. 14.1 Vaccines for preventing cholera killed whole cell or other subunit vaccines (injected).rm5
CD000976 v. 7.2 Vaccines for preventing plague.rm5
CD000977 v. 4.0 Vaccines for preventing tick-borne encephalitis.rm5
CD000978 v. 13.0 Interventions for preventing oral mucositis for patients with cancer receiving treatment.rm5
CD000979 v. 6.2 Orthodontic treatment for posterior crossbites.rm5
CD000980 v. 16.0 Vitamin C for preventing and treating the common cold.rm5
CD000984 v. 11.0 Interventions to change the behaviour of health professionals and the organisation of care to promot.rm5
CD000985 v. 8.1 Infusion techniques for peripheral arterial thrombolysis.rm5
CD000986 v. 6.0 Prostanoids for intermittent claudication.rm5
CD000987 v. 4.0 Vitamin E for intermittent claudication.rm5
CD000988 v. 12.0 Buflomedil for intermittent claudication.rm5
CD000990 v. 10.0 Exercise for intermittent claudication.rm5
CD000991 v. 5.0 Intravenous fluids for abdominal aortic surgery.rm5
CD000994 v. 9.4 Home care by outreach nursing for chronic obstructive pulmonary disease.rm5
CD000995 v. 11.0 Alexander technique for chronic asthma.rm5
CD000996 v. 6.0 Inhaled steroids for bronchiectasis.rm5
CD000998 v. 11.0 Nutritional supplementation for stable chronic obstructive pulmonary disease.rm5
CD001000 v. 13.0 Corticosteroids for the prevention and treatment of post-extubation stridor in neonates children an.rm5
CD001001 v. 9.0 Lung volume reduction surgery for diffuse emphysema.rm5
CD001002 v. 9.0 Manual therapy for asthma.rm5
CD001004 v. 9.0 Surgery for obstructive sleep apnoea in adults.rm5
CD001005 v. 3.0 Limited (information only) patient education programs for adults with asthma.rm5
CD001006 v. 13.0 Mass media interventions for preventing smoking in young people.rm5
CD001007 v. 9.68 Group behaviour therapy programmes for smoking cessation.rm5
CD001008 v. 10.0 Hypnotherapy for smoking cessation.rm5
CD001009 v. 13.0 Mecamylamine (a nicotine antagonist) for smoking cessation.rm5
CD001011 v. 12.0 Piracetam for dementia or cognitive impairment.rm5
CD001015 v. 10.0 Lecithin for dementia and cognitive impairment.rm5
CD001016 v. 5.0 Cyclical progestogens for heavy menstrual bleeding.rm5
CD001017 v. 5.2 Danazol for heavy menstrual bleeding.rm5
CD001018 v. 10.0 Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women.rm5
CD001019 v. 6.4 Oral contraceptives for pain associated with endometriosis.rm5
CD001021 v. 13.1 Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.rm5
CD001024 v. 8.0 Tamoxifen for hepatocellular carcinoma.rm5
CD001025 v. 14.0 Counselling for mental health and psychosocial problems in primary care.rm5
CD001026 v. 12.0 Antidepressants plus benzodiazepines for major depression.rm5
CD001027 v. 14.0 Cognitive behaviour therapy for chronic fatigue syndrome in adults.rm5
CD001030 v. 11.2 Carbamazepine versus valproate monotherapy for epilepsy.rm5
CD001031 v. 13.0 Lamotrigine versus carbamazepine monotherapy for epilepsy an individual participant data review.rm5
CD001034 v. 12.0 Tamoxifen for relapse of ovarian cancer.rm5
CD001035 v. 9.0 Interventions for encouraging sexual behaviours intended to prevent cervical cancer.rm5
CD001036 v. 11.0 Collection devices for obtaining cervical cytology samples.rm5
CD001040 v. 10.0 Adjuvant progestagens for endometrial cancer.rm5
CD001041 v. 8.0 Allopurinol for chronic prostatitis.rm5
CD001043 v. 7.0 Beta-sitosterols for benign prostatic hyperplasia.rm5
CD001044 v. 5.0 Pygeum africanum for benign prostatic hyperplasia.rm5
CD001046 v. 14.5 Steroids for acute spinal cord injury.rm5
CD001047 v. 9.0 Pool fencing for preventing drowning of children.rm5
CD001048 v. 13.0 Hypothermia for traumatic brain injury.rm5
CD001049 v. 12.0 Mannitol for acute traumatic brain injury.rm5
CD001054 v. 11.2 Community screening for visual impairment in older people.rm5
CD001055 v. 9.0 Psychosocial interventions for supporting women to stop smoking in pregnancy.rm5
CD001057 v. 7.0 Topical umbilical cord care at birth.rm5
CD001058 v. 12.0 Antibiotics for preterm rupture of membranes.rm5
CD001059 v. 13.0 Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems.rm5
CD001060 v. 7.0 Magnesium sulphate for preventing preterm birth in threatened preterm labour.rm5
CD001062 v. 10.0 Abdominal decompression in normal pregnancy.rm5
CD001063 v. 5.0 Hands and knees posture in late pregnancy or labour for fetal malposition (lateral or posterior).rm5
CD001064 v. 9.0 Piracetam for fetal distress in labour.rm5
CD001065 v. 10.0 Operative versus conservative management for 'fetal distress' in labour.rm5
CD001066 v. 9.0 Interventions for varicose veins and leg oedema in pregnancy.rm5
CD001067 v. 11.0 Antibiotic regimens for postpartum endometritis.rm5
CD001069 v. 9.0 Sucrose for analgesia in newborn infants undergoing painful procedures.rm5
CD001070 v. 8.0 Thyroid hormones for preventing neurodevelopmental impairment in preterm infants.rm5
CD001071 v. 12.0 Non-nutritive sucking for increasing physiologic stability and nutrition in preterm infants.rm5
CD001072 v. 6.0 Continuous positive airway pressure versus theophylline for apnea in preterm infants.rm5
CD001073 v. 6.0 D-Penicillamine for preventing retinopathy of prematurity in preterm infants.rm5
CD001074 v. 5.0 Servo-control for maintaining abdominal skin temperature at 36C in low birth weight infants.rm5
CD001075 v. 6.0 Gradual versus abrupt discontinuation of oxygen in preterm or low birth weight infants.rm5
CD001076 v. 9.4 Early versus late discontinuation of oxygen in preterm or low birth weight infants.rm5
CD001077 v. 7.0 Restricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low b.rm5
CD001078 v. 8.0 Extubation from low-rate intermittent positive airway pressure versus extubation after a trial of en.rm5
CD001079 v. 5.0 Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm inf.rm5
CD001080 v. 6.2 Digoxin for preventing or treating neonatal respiratory distress syndrome.rm5
CD001081 v. 7.0 Carotid endarterectomy for symptomatic carotid stenosis.rm5
CD001083 v. 7.0 Cyclosporine for treating rheumatoid arthritis.rm5
CD001084 v. 6.0 Pharmacotherapy for Behcet's syndrome.rm5
CD001087 v. 14.0 Crisis intervention for people with severe mental illnesses.rm5
CD001088 v. 10.2 Psychosocial interventions for people with both severe mental illness and substance misuse.rm5
CD001090 v. 11.0 Intravenous immunoglobulin for treating sepsis severe sepsis and septic shock.rm5
CD001093 v. 7.3 Polysaccharide vaccines for preventing serogroup A meningococcal meningitis.rm5
CD001095 v. 14.0 Short-course antibiotics for acute otitis media.rm5
CD001096 v. 6.0 The effects of on-screen point of care computer reminders on processes and outcomes of care.rm5
CD001097 v. 6.0 Surgery for deep venous incompetence.rm5
CD001099 v. 5.0 Fibrinolytic agents for peripheral arterial occlusion.rm5
CD001100 v. 9.0 Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin fo.rm5
CD001104 v. 7.0 Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease.rm5
CD001106 v. 7.0 Continuous positive airways pressure for obstructive sleep apnoea in adults.rm5
CD001107 v. 3.0 Inhaled steroids for episodic viral wheeze of childhood.rm5
CD001108 v. 11.0 Azoles for allergic bronchopulmonary aspergillosis associated with asthma.rm5
CD001112 v. 8.3 Caffeine for asthma.rm5
CD001114 v. 10.0 Corticosteroids for pulmonary sarcoidosis.rm5
CD001115 v. 9.0 Continuous versus intermittent beta-agonists for acute asthma.rm5
CD001116 v. 10.0 Physical training for asthma.rm5
CD001117 v. 7.0 Self-management education and regular practitioner review for adults with asthma.rm5
CD001118 v. 11.0 Print-based self-help interventions for smoking cessation.rm5
CD001120 v. 8.0 Reminiscence therapy for dementia.rm5
CD001122 v. 13.0 Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary .rm5
CD001125 v. 5.0 Cyproterone acetate for hirsutism.rm5
CD001127 v. 15.0 Dornase alfa for cystic fibrosis.rm5
CD001131 v. 8.6 Pharmacological interventions for spasticity following spinal cord injury.rm5
CD001132 v. 10.14 5-Fluorouracil for glaucoma surgery.rm5
CD001134 v. 9.0 Psychosocial and psychological interventions for preventing postpartum depression.rm5
CD001139 v. 7.0 Interventions for preventing and treating low-back and pelvic pain during pregnancy.rm5
CD001141 v. 10.3 Support for healthy breastfeeding mothers with healthy term babies.rm5
CD001142 v. 6.0 Interventions for treating constipation in pregnancy.rm5
CD001143 v. 9.0 Antibiotics for syphilis diagnosed during pregnancy.rm5
CD001144 v. 7.0 Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preter.rm5
CD001145 v. 9.0 Late ( 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in p.rm5
CD001146 v. 11.2 Early ( 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in .rm5
CD001148 v. 10.0 Furosemide for prevention of morbidity in indomethacin-treated infants with patent ductus arteriosus.rm5
CD001149 v. 3.0 Synthetic surfactant for respiratory distress syndrome in preterm infants.rm5
CD001150 v. 6.0 Topical emollient for preventing infection in preterm infants.rm5
CD001153 v. 7.0 Mannitol for acute stroke.rm5
CD001155 v. 12.0 Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal wom.rm5
CD001157 v. 7.0 Cyclophosphamide for treating rheumatoid arthritis.rm5
CD001158 v. 6.0 Moderate-term low-dose corticosteroids for rheumatoid arthritis.rm5
CD001159 v. 12.0 Peripheral nerve blocks for hip fractures.rm5
CD001162 v. 9.0 Sulpiride for schizophrenia.rm5
CD001163 v. 5.0 Seclusion and restraint for people with serious mental illnesses.rm5
CD001164 v. 5.0 Zuclopenthixol decanoate for schizophrenia and other serious mental illnesses.rm5
CD001166 v. 10.0 Mycobacterium vaccae immunotherapy for treating tuberculosis.rm5
CD001167 v. 5.2 Antimicrobials for treating symptomatic non-typhoidal Salmonella infection.rm5
CD001168 v. 6.0 Interventions for treating oral lichen planus.rm5
CD001169 v. 14.0 Amantadine and rimantadine for influenza A in adults.rm5
CD001175 v. 7.0 Computer-generated reminders delivered on paper to healthcare professionals effects on professional.rm5
CD001176 v. 6.0 Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative coli.rm5
CD001177 v. 10.0 Topical agents or dressings for pain in venous leg ulcers.rm5
CD001180 v. 10.0 Therapeutic ultrasound for venous leg ulcers.rm5
CD001181 v. 7.0 Antimicrobial prophylaxis for colorectal surgery.rm5
CD001183 v. 10.0 Nedocromil sodium for preventing exercise-induced bronchoconstriction.rm5
CD001186 v. 6.0 Injection allergen immunotherapy for asthma.rm5
CD001187 v. 9.0 House dust mite control measures for asthma.rm5
CD001188 v. 11.0 Nursing interventions for smoking cessation.rm5
CD001190 v. 14.0 Donepezil for dementia due to Alzheimer's disease.rm5
CD001191 v. 18.0 Rivastigmine for Alzheimer's disease.rm5
CD001198 v. 14.0 Enteral tube feeding for cystic fibrosis.rm5
CD001199 v. 7.26 Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma.rm5
CD001202 v. 8.2 Electrical stimulation with non-implanted electrodes for urinary incontinence in men.rm5
CD001203 v. 4.0 Bromocriptine for levodopa-induced motor complications in Parkinson's disease.rm5
CD001206 v. 12.0 Pharmacotherapy for social anxiety disorder (SAnD).rm5
CD001208 v. 12.2 Human albumin solution for resuscitation and volume expansion in critically ill patients.rm5
CD001209 v. 11.0 Antibiotics for preventing recurrent urinary tract infection in non-pregnant women.rm5
CD001211 v. 13.2 Antibiotics versus placebo for acute bacterial conjunctivitis.rm5
CD001213 v. 10.0 Interventions for guttate psoriasis.rm5
CD001216 v. 8.0 Screening for colorectal cancer using the faecal occult blood test Hemoccult.rm5
CD001217 v. 8.2 Heparins and mechanical methods for thromboprophylaxis in colorectal surgery.rm5
CD001218 v. 11.0 Acupuncture for the prevention of episodic migraine.rm5
CD001219 v. 7.0 Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gas.rm5
CD001220 v. 8.2 Population-based biomedical sexually transmitted infection control interventions for reducing HIV in.rm5
CD001224 v. 5.0 Voluntary counseling and testing (VCT) for changing HIV-related risk behavior in developing countrie.rm5
CD001230 v. 3.2 Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with m.rm5
CD001231 v. 11.0 Ambulatory versus conventional methods for monitoring blood pressure during pregnancy.rm5
CD001233 v. 8.0 Mechanical methods for induction of labour.rm5
CD001236 v. 9.0 Routine perineal shaving on admission in labour.rm5
CD001239 v. 9.0 Intravenous immunoglobulin for suspected or proven infection in neonates.rm5
CD001240 v. 7.0 Prophylactic barbiturate use for the prevention of morbidity and mortality following perinatal asphy.rm5
CD001241 v. 9.0 Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weig.rm5
CD001242 v. 4.0 Dopamine versus dobutamine for hypotensive preterm infants.rm5
CD001243 v. 8.2 Prophylactic nasal continuous positive airway pressure for preventing morbidity and mortality in ver.rm5
CD001244 v. 4.0 Excitatory amino acid antagonists for acute stroke.rm5
CD001245 v. 6.0 Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage.rm5
CD001246 v. 7.0 Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in.rm5
CD001247 v. 7.3 Cooling therapy for acute stroke.rm5
CD001250 v. 8.0 Therapeutic ultrasound for acute ankle sprains.rm5
CD001255 v. 15.2 Hip protectors for preventing hip fractures in older people.rm5
CD001256 v. 9.0 Interventions for preventing lower limb soft-tissue running injuries.rm5
CD001257 v. 11.0 Polyunsaturated fatty acid supplementation for schizophrenia.rm5
CD001258 v. 10.0 Carbamazepine for schizophrenia.rm5
CD001261 v. 6.3 Vaccines for preventing typhoid fever.rm5
CD001263 v. 8.2 Interventions for treating melioidosis.rm5
CD001266 v. 9.0 Bronchodilators for bronchiolitis.rm5
CD001269 v. 16.3 Vaccines for preventing influenza in healthy adults.rm5
CD001270 v. 6.0 Teaching critical appraisal skills in healthcare settings.rm5
CD001271 v. 5.0 Substitution of doctors by nurses in primary care.rm5
CD001272 v. 7.0 Antiplatelet agents for intermittent claudication.rm5
CD001273 v. 15.0 Oral zinc for arterial and venous leg ulcers.rm5
CD001275 v. 12.0 Therapeutic ultrasound for pressure ulcers.rm5
CD001276 v. 9.0 Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronc.rm5
CD001277 v. 11.0 Breathing exercises for adults with asthma.rm5
CD001279 v. 9.0 Anticholinergic drugs for wheeze in children under the age of two years.rm5
CD001281 v. 8.0 Long-acting beta2-agonists versus theophylline for maintenance treatment of asthma.rm5
CD001282 v. 5.0 Beclomethasone for asthma in children effects on linear growth.rm5
CD001283 v. 11.1 Dietary marine fatty acids (fish oil) for asthma in adults and children.rm5
CD001284 v. 7.9 Combined inhaled beta-agonist and anticholinergic agents for emergency management in adults with ast.rm5
CD001285 v. 6.0 Inhaled short acting beta2-agonist use in chronic asthma regular versus as needed treatment.rm5
CD001287 v. 11.2 Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.rm5
CD001288 v. 7.0 Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.rm5
CD001289 v. 13.0 Mucolytics for bronchiectasis.rm5
CD001290 v. 7.0 Interventions for educating children who are at risk of asthma-related emergency department attendan.rm5
CD001291 v. 9.0 Community interventions for preventing smoking in young people.rm5
CD001292 v. 9.0 Individual behavioural counselling for smoking cessation.rm5
CD001293 v. 13.0 School-based programmes for preventing smoking.rm5
CD001296 v. 14.0 Aspirin for vascular dementia.rm5
CD001297 v. 5.0 Gonadotrophin-releasing hormone analogues for endometriosis bone mineral density.rm5
CD001298 v. 10.4 Fluid and pharmacological agents for adhesion prevention after gynaecological surgery.rm5
CD001301 v. 7.0 Intra-cytoplasmic sperm injection versus conventional techniques for oocyte insemination during in v.rm5
CD001302 v. 9.0 Volume expanders for the prevention of ovarian hyperstimulation syndrome.rm5
CD001304 v. 9.0 Dietary interventions for phenylketonuria.rm5
CD001308 v. 5.0 Bladder training for urinary incontinence in adults.rm5
CD001310 v. 7.0 Electrical stimulation for faecal incontinence in adults.rm5
CD001318 v. 10.0 Surgery for cervical intraepithelial neoplasia.rm5
CD001319 v. 13.0 Colloid solutions for fluid resuscitation.rm5
CD001321 v. 18.0 Cranberries for preventing urinary tract infections.rm5
CD001322 v. 9.0 Cranberries for treating urinary tract infections.rm5
CD001323 v. 7.2 Surgical interventions for age-related cataract.rm5
CD001324 v. 12.0 Interventions for emergency contraception.rm5
CD001326 v. 8.2 Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implan.rm5
CD001327 v. 13.0 Antibiotic prophylaxis for intrauterine contraceptive device insertion.rm5
CD001328 v. 9.0 Minilaparotomy and endoscopic techniques for tubal sterilisation.rm5
CD001329 v. 8.0 Lactational amenorrhoea method for family planning.rm5
CD001330 v. 6.0 Aminopyridines for symptomatic treatment in multiple sclerosis.rm5
CD001331 v. 6.0 Corticosteroids or ACTH for acute exacerbations in multiple sclerosis.rm5
CD001332 v. 6.0 Anti-spasticity agents for multiple sclerosis.rm5
CD001333 v. 16.0 Oral naltrexone maintenance treatment for opioid dependence.rm5
CD001337 v. 7.0 Umbilical vein injection for management of retained placenta.rm5
CD001338 v. 10.0 Oral misoprostol for induction of labour.rm5
CD001340 v. 5.0 Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants.rm5
CD001342 v. 10.0 Vitamin K antagonists versus antiplatelet therapy after transient ischaemic attack or minor ischaemi.rm5
CD001347 v. 9.0 Bisphosphonates for steroid-induced osteoporosis.rm5
CD001350 v. 9.4 Surgical interventions for lumbar disc prolapse.rm5
CD001351 v. 12.0 Acupuncture and dry-needling for low back pain.rm5
CD001352 v. 7.8 Surgery for degenerative lumbar spondylosis.rm5
CD001357 v. 11.3 Amisulpride for schizophrenia.rm5
CD001359 v. 12.0 Olanzapine for schizophrenia.rm5
CD001360 v. 10.0 Individual psychodynamic psychotherapy and psychoanalysis for schizophrenia and severe mental illnes.rm5
CD001361 v. 4.0 Depot haloperidol decanoate for schizophrenia.rm5
CD001362 v. 6.2 Regimens of less than six months for treating tuberculosis.rm5
CD001363 v. 7.0 Isoniazid for preventing tuberculosis in non-HIV infected persons.rm5
CD001366 v. 5.2 Dietary advice given by a dietitian versus other health professional or self-help resources to reduc.rm5
CD001367 v. 10.0  Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism.rm5
CD001368 v. 10.0 Naftidrofuryl for intermittent claudication.rm5
CD001384 v. 10.2 Ketotifen alone or as additional medication for long-term control of asthma and wheeze in children.rm5
CD001385 v. 9.0 Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contai.rm5
CD001387 v. 5.2 Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary dis.rm5
CD001390 v. 11.0 Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.rm5
CD001392 v. 10.0 Prolonged antibiotics for non-cystic fibrosis bronchiectasis in children and adults.rm5
CD001394 v. 9.0 Validation therapy for dementia.rm5
CD001395 v. 7.0 Phytoestrogens for menopausal vasomotor symptoms.rm5
CD001396 v. 7.3 Selective serotonin reuptake inhibitors for premenstrual syndrome.rm5
CD001399 v. 16.0 Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis.rm5
CD001401 v. 12.0 Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis.rm5
CD001402 v. 10.0 Newborn screening for cystic fibrosis.rm5
CD001405 v. 7.0 Oestrogen therapy for urinary incontinence in post-menopausal women.rm5
CD001406 v. 11.0 Absorbent products for light urinary incontinence in women.rm5
CD001408 v. 4.0 Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy.rm5
CD001415 v. 11.0 Gabapentin add-on for drug-resistant partial epilepsy.rm5
CD001416 v. 8.2 Zonisamide add-on for drug-resistant partial epilepsy.rm5
CD001417 v. 15.0 Topiramate add-on for drug-resistant partial epilepsy.rm5
CD001418 v. 8.0 Chemotherapy for advanced ovarian cancer.rm5
CD001419 v. 9.0 Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults.rm5
CD001421 v. 8.0 Interventions for preventing blood loss during the treatment of cervical intraepithelial neoplasia.rm5
CD001423 v. 12.0 Serenoa repens for benign prostatic hyperplasia.rm5
CD001427 v. 5.0 Sensory stimulation for brain injured individuals in coma or vegetative state.rm5
CD001429 v. 7.0 Emergency intubation for acutely ill and injured patients.rm5
CD001430 v. 11.0 Corticosteroids for treating optic neuritis.rm5
CD001431 v. 12.0 Decision aids for people facing health treatment or screening decisions.rm5
CD001433 v. 6.0 Interventions for chronic palmoplantar pustulosis.rm5
CD001434 v. 13.0 Topical treatments for fungal infections of the skin and nails of the foot..rm5
CD001435 v. 6.0 Interventions for toxic epidermal necrolysis.rm5
CD001439 v. 11.0 Antibiotics versus placebo for prevention of postoperative infection after appendicectomy..rm5
CD001440 v. 11.0 Single dose oral dextropropoxyphene alone and with paracetamol (acetaminophen) for postoperative p.rm5
CD001442 v. 6.0 Patient support and education for promoting adherence to highly active antiretroviral therapy for HI.rm5
CD001443 v. 6.0 Growth monitoring in children.rm5
CD001444 v. 6.4 Iron therapy for improving psychomotor development and cognitive function in children under the age .rm5
CD001446 v. 15.0 Corticosteroids for Guillain-Barr syndrome.rm5
CD001447 v. 11.4 Riluzole for amyotrophic lateral sclerosis (ALS)motor neuron disease (MND).rm5
CD001449 v. 10.0 Drugs for treatment of very high blood pressure during pregnancy.rm5
CD001450 v. 9.0 Fetal and umbilical Doppler ultrasound in normal pregnancy.rm5
CD001451 v. 9.0 Routine ultrasound in late pregnancy (after 24 weeks' gestation).rm5
CD001452 v. 10.0 Venepuncture versus heel lance for blood sampling in term neonates.rm5
CD001453 v. 11.0 Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease.rm5
CD001454 v. 10.0 Diuretics for respiratory distress syndrome in preterm infants.rm5
CD001456 v. 6.0 Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.rm5
CD001457 v. 9.0 Glutamine supplementation to prevent morbidity and mortality in preterm infants.rm5
CD001458 v. 5.0 Antiplatelet therapy for preventing stroke and other vascular events after carotid endarterectomy.rm5
CD001460 v. 6.0 Penicillamine for treating rheumatoid arthritis.rm5
CD001461 v. 6.0 Azathioprine for treating rheumatoid arthritis.rm5
CD001466 v. 8.4 Surgery for cervical radiculopathy or myelopathy.rm5
CD001467 v. 6.0 Internal fixation implants for intracapsular hip fractures in adults.rm5
CD001470 v. 4.0 Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders.rm5
CD001471 v. 7.0 Educational games for mental health professionals.rm5
CD001473 v. 5.0 Token economy for schizophrenia.rm5
CD001474 v. 8.0 Iron-chelating agents for treating malaria.rm5
CD001475 v. 10.2 Blood transfusion for treating malarial anaemia.rm5
CD001476 v. 7.0 Potassium containing toothpastes for dentine hypersensitivity.rm5
CD001477 v. 12.0 Antibiotics for preventing complications in children with measles.rm5
CD001478 v. 16.0 Acellular vaccines for preventing whooping cough in children.rm5
CD001479 v. 12.0 Vitamin A for treating measles in children.rm5
CD001480 v. 12.0 Pneumococcal conjugate vaccines for preventing otitis media.rm5
CD001481 v. 5.0 Interventions to improve the management of diabetes mellitus in primary care outpatient and communi.rm5
CD001484 v. 11.0 Graduated compression stockings for prevention of deep vein thrombosis.rm5
CD001486 v. 10.0 Surgery for varicose veins use of tourniquet.rm5
CD001487 v. 9.0 Graft type for femoro-popliteal bypass surgery.rm5
CD001488 v. 9.0 Patient education for preventing diabetic foot ulceration.rm5
CD001490 v. 7.0 Magnesium sulfate for treating exacerbations of acute asthma in the emergency department.rm5
CD001491 v. 8.2 Holding chambers versus nebulisers for inhaled steroids in chronic asthma.rm5
CD001493 v. 10.0 Inhaled beta2-agonists for asthma in mechanically ventilated patients.rm5
CD001495 v. 7.0 Short-acting beta2-agonists for stable chronic obstructive pulmonary disease.rm5
CD001496 v. 4.0 Gastro-oesophageal reflux treatment for asthma in adults and children.rm5
CD001497 v. 6.0 Interventions for preventing tobacco sales to minors.rm5
CD001498 v. 10.0 Thiamine for Alzheimer's disease.rm5
CD001499 v. 9.0 Physostigmine for dementia due to Alzheimer's disease.rm5
CD001500 v. 9.0 Local oestrogen for vaginal atrophy in postmenopausal women.rm5
CD001501 v. 8.0 Endometrial resection and ablation techniques for heavy menstrual bleeding.rm5
CD001502 v. 7.0 Intrauterine insemination versus fallopian tube sperm perfusion for non-tubal infertility.rm5
CD001505 v. 12.0 Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis.rm5
CD001506 v. 10.0 Nebulised hypertonic saline for cystic fibrosis.rm5
CD001507 v. 12.0 Tyrosine supplementation for phenylketonuria.rm5
CD001509 v. 6.0 Sphincterotomy for biliary sphincter of Oddi dysfunction.rm5
CD001511 v. 6.0 Glucocorticosteroids for people with alcoholic hepatitis.rm5
CD001514 v. 4.0 Lisuride versus bromocriptine for levodopa-induced complications in Parkinson's disease.rm5
CD001515 v. 4.0 Lisuride for levodopa-induced complications in Parkinson's disease.rm5
CD001516 v. 7.0 Ropinirole for levodopa-induced complications in Parkinson's disease.rm5
CD001517 v. 9.0 Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease.rm5
CD001518 v. 6.0 Cabergoline for levodopa-induced complications in Parkinson's disease.rm5
CD001519 v. 6.0 Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease.rm5
CD001520 v. 11.0 Melatonin for the prevention and treatment of jet lag.rm5
CD001524 v. 15.0 Yoga for epilepsy.rm5
CD001526 v. 5.0 Maximal androgen blockade for advanced prostate cancer.rm5
CD001527 v. 7.3 Aminosteroids for acute traumatic brain injury.rm5
CD001530 v. 6.2 Nutritional support for head-injured patients.rm5
CD001531 v. 6.0 Safety education of pedestrians for injury prevention.rm5
CD001532 v. 11.0 Interventions for primary vesicoureteric reflux.rm5
CD001533 v. 14.0 Corticosteroid therapy for nephrotic syndrome in children.rm5
CD001534 v. 10.0 Long-term antibiotics for preventing recurrent urinary tract infection in children.rm5
CD001535 v. 8.0 Antibiotic duration for treating uncomplicated symptomatic lower urinary tract infections in elderl.rm5
CD001537 v. 7.0 Interventions for minimal change disease in adults with nephrotic syndrome.rm5
CD001538 v. 11.0 Surgery for nonarteritic anterior ischemic optic neuropathy.rm5
CD001539 v. 6.0 Recordings or summaries of consultations for people with cancer.rm5
CD001541 v. 9.0 Interventions for ingrowing toenails.rm5
CD001543 v. 6.0 Shouldice technique versus other open techniques for inguinal hernia repair.rm5
CD001544 v. 8.0 Mechanical bowel preparation for elective colorectal surgery.rm5
CD001545 v. 5.0 Palliative chemotherapy for advanced or metastatic colorectal cancer.rm5
CD001546 v. 7.0 Laparoscopic versus open surgery for suspected appendicitis.rm5
CD001547 v. 8.0 Single dose oral paracetamol (acetaminophen) with codeine for postoperative pain in adults.rm5
CD001548 v. 11.0 Single dose oral ibuprofen for acute postoperative pain in adults.rm5
CD001552 v. 7.0 Surgical versus non-surgical treatment for carpal tunnel syndrome.rm5
CD001554 v. 8.0 Local corticosteroid injection for carpal tunnel syndrome.rm5
CD001555 v. 10.0 Treatment for inclusion body myositis.rm5
CD001556 v. 10.0 Preoperative chemotherapy for resectable thoracic esophageal cancer.rm5
CD001561 v. 10.0 Multiple risk factor interventions for primary prevention of coronary heart disease.rm5
CD001563 v. 6.2 House dust mite avoidance measures for perennial allergic rhinitis.rm5
CD001684 v. 6.0 Treatments for toxoplasmosis in pregnancy.rm5
CD001687 v. 6.0 Reduced salt intake compared to normal dietary salt or high intake in pregnancy.rm5
CD001688 v. 7.0 Interventions for promoting the initiation of breastfeeding.rm5
CD001689 v. 10.0 Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period.rm5
CD001690 v. 10.0 Oestrogens and progestins for preventing and treating postpartum depression.rm5
CD001691 v. 6.0 Postnatal phenobarbital for the prevention of intraventricular haemorrhage in preterm infants.rm5
CD001693 v. 4.0 Peripheral retinal ablation for threshold retinopathy of prematurity in preterm infants.rm5
CD001694 v. 8.0 Aerosolized diuretics for preterm infants with (or developing) chronic lung disease.rm5
CD001695 v. 10.2 Late versus early surgical correction for congenital diaphragmatic hernia in newborn infants.rm5
CD001697 v. 6.0 Timing of surgery for aneurysmal subarachnoid haemorrhage.rm5
CD001698 v. 5.0 Electrical stimulation for preventing and treating post-stroke shoulder pain.rm5
CD001703 v. 9.0 Antidepressants for non-specific low back pain.rm5
CD001704 v. 9.0 Interventions for improving mobility after hip fracture surgery in adults.rm5
CD001705 v. 5.0 Surgical approaches and ancillary techniques for internal fixation of intracapsular proximal femoral.rm5
CD001706 v. 9.0 Arthroplasties (with and without bone cement) for proximal femoral fractures in adults.rm5
CD001707 v. 4.0 Surgical approaches for inserting hemiarthroplasty of the hip.rm5
CD001708 v. 10.0 Internal fixation versus arthroplasty for intracapsular proximal femoral fractures in adults.rm5
CD001710 v. 5.0 Day centres for severe mental illness.rm5
CD001711 v. 7.3 User-held personalised information for routine care of people with severe mental illness.rm5
CD001715 v. 8.0 Sertindole for schizophrenia.rm5
CD001717 v. 7.0 Depot perphenazine decanoate and enanthate for schizophrenia.rm5
CD001718 v. 7.0 Depot fluspirilene for schizophrenia.rm5
CD001719 v. 9.0 Bromperidol decanoate (depot) for schizophrenia.rm5
CD001720 v. 7.0 Depot pipotiazine palmitate and undecylenate for schizophrenia.rm5
CD001724 v. 8.0 Guided tissue regeneration for periodontal infra-bony defects.rm5
CD001726 v. 11.0 Beta2-agonists for acute cough or a clinical diagnosis of acute bronchitis.rm5
CD001728 v. 14.0 Heated humidified air for the common cold.rm5
CD001730 v. 6.0 Medical day hospital care for older people versus alternative forms of care.rm5
CD001732 v. 7.0 Injection sclerotherapy for varicose veins.rm5
CD001733 v. 13.0 Pentoxifylline for treating venous leg ulcers.rm5
CD001735 v. 18.0 Support surfaces for pressure ulcer prevention.rm5
CD001737 v. 9.2 Skin grafting for venous leg ulcers.rm5
CD001738 v. 6.0 Antibiotic prophylaxis for mammalian bites.rm5
CD001740 v. 7.0 Corticosteroids for acute severe asthma in hospitalised patients.rm5
CD001741 v. 8.0 Speleotherapy for asthma.rm5
CD001744 v. 10.0 Domiciliary oxygen for chronic obstructive pulmonary disease.rm5
CD001745 v. 8.0 Community interventions for reducing smoking among adults.rm5
CD001746 v. 9.0 Family and carer smoking control programmes for reducing children's exposure to environmental tobacc.rm5
CD001747 v. 11.0 Galantamine for Alzheimer's disease and mild cognitive impairment.rm5
CD001749 v. 6.0 Nicotine for Alzheimer's disease.rm5
CD001750 v. 11.0 Gonadotrophin-releasing hormone antagonists for assisted reproductive technology.rm5
CD001751 v. 7.0 Nonsteroidal anti-inflammatory drugs for dysmenorrhoea.rm5
CD001753 v. 12.0 Vaccines for preventing influenza in people with cystic fibrosis.rm5
CD001754 v. 8.1 Traditional suburethral sling operations for urinary incontinence in women.rm5
CD001755 v. 11.0 Anterior vaginal repair for urinary incontinence in women.rm5
CD001756 v. 11.0 Mechanical devices for urinary incontinence in women.rm5
CD001757 v. 7.0 Surgery for faecal incontinence in adults.rm5
CD001758 v. 6.0 Surgery for complete (full-thickness) rectal prolapse in adults.rm5
CD001760 v. 10.0 Interventions for vaginismus.rm5
CD001765 v. 8.0 Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (O.rm5
CD001768 v. 11.0 Follow-up strategies for women treated for early breast cancer.rm5
CD001769 v. 15.0 Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic.rm5
CD001770 v. 18.3 Treatment of infantile spasms.rm5
CD001773 v. 8.0 Non-surgical interventions for late radiation cystitis in patients who have received radical radioth.rm5
CD001774 v. 10.0 Neoadjuvant chemotherapy for locally advanced cervix cancer.rm5
CD001775 v. 11.2 Ginkgo biloba extract for age-related macular degeneration.rm5
CD001776 v. 7.0 Progestogen-releasing intrauterine systems versus other forms of reversible contraceptives for contr.rm5
CD001777 v. 13.0 Immediate postabortal insertion of intrauterine devices.rm5
CD001779 v. 8.6 Antibiotics for incomplete abortion.rm5
CD001781 v. 11.0 Topical treatments for cutaneous warts.rm5
CD001784 v. 8.0 Prostaglandin E1 for treatment of erectile dysfunction.rm5
CD001785 v. 10.0 Laparoscopic techniques versus open techniques for inguinal hernia repair.rm5
CD001792 v. 10.0 Drug therapy for preventing post-dural puncture headache.rm5
CD001796 v. 8.0 Aerobic exercise interventions for adults living with HIVAIDS.rm5
CD001797 v. 8.0 Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.rm5
CD001798 v. 12.0 Plasma exchange for Guillain-Barr syndrome.rm5
CD001799 v. 15.0 Preoperative radiotherapy for esophageal carcinoma.rm5
CD001800 v. 15.0 Exercise-based cardiac rehabilitation for coronary heart disease.rm5
CD001801 v. 8.0 Grommets (ventilation tubes) for hearing loss associated with otitis media with effusion in children.rm5
CD001802 v. 7.0 Tonsillectomy or adenotonsillectomy versus non-surgical treatment for chronicrecurrent acute tonsil.rm5
CD001803 v. 5.0 Antenatal day care units versus hospital admission for women with complicated pregnancy.rm5
CD001805 v. 9.0 Plasma volume expansion for treatment of pre-eclampsia.rm5
CD001806 v. 5.0 Preconception and antenatal screening for the fragile site on the X-chromosome.rm5
CD001807 v. 10.0 Antibiotics for prelabour rupture of membranes at or near term.rm5
CD001808 v. 10.0 Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage.rm5
CD001814 v. 5.0 Developmental care for promoting development and preventing morbidity in preterm infants.rm5
CD001815 v. 6.6 Erythromycin for the prevention and treatment of feeding intolerance in preterm infants.rm5
CD001816 v. 12.0 Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth weight neonate.rm5
CD001817 v. 11.0 Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung di.rm5
CD001819 v. 6.0 Continuous nasogastric milk feeding versus intermittent bolus milk feeding for premature infants les.rm5
CD001820 v. 8.0 Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.rm5
CD001821 v. 8.0 Orthotic devices for the treatment of tennis elbow.rm5
CD001822 v. 12.1 Physical conditioning as part of a return to work strategy to reduce sickness absence for workers wi.rm5
CD001823 v. 10.0 Lumbar supports for prevention and treatment of low back pain.rm5
CD001824 v. 10.0 Injection therapy for subacute and chronic low-back pain.rm5
CD001825 v. 6.0 Closed suction surgical wound drainage after orthopaedic surgery.rm5
CD001829 v. 8.2 Interventions for treating oral leukoplakia to prevent oral cancer.rm5
CD001830 v. 7.2 Pit and fissure sealants for preventing dental decay in permanent teeth.rm5
CD001831 v. 17.0 Over-the-counter (OTC) medications for acute cough in children and adults in community settings.rm5
CD001832 v. 9.0 Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningi.rm5
CD001833 v. 6.0 Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults.rm5
CD001835 v. 8.0 Surgery for small asymptomatic abdominal aortic aneurysms.rm5
CD001836 v. 9.0 Dressings and topical agents for arterial leg ulcers.rm5
CD001837 v. 12.4 Interventions for smoking cessation in hospitalised patients.rm5
CD001838 v. 10.0 Intra-uterine insemination for unexplained subfertility.rm5
CD001841 v. 8.0 First-line drugs for hypertension.rm5
CD001842 v. 7.0 Adrenergic drugs for urinary incontinence in adults.rm5
CD001843 v. 11.0 Conservative management for postprostatectomy urinary incontinence.rm5
CD001848 v. 12.0 Psychological therapies for generalised anxiety disorder.rm5
CD001855 v. 11.0 Helmets for preventing head and facial injuries in bicyclists.rm5
CD001856 v. 6.0 Medical anti-shock trousers (pneumatic anti-shock garments) for circulatory support in patients with.rm5
CD001857 v. 7.0 Interventions for preventing injuries in problem drinkers.rm5
CD001860 v. 9.6 Antibiotics for trachoma.rm5
CD001861 v. 8.0 Interventions for recurrent corneal erosions.rm5
CD001863 v. 9.0 Education for contraceptive use by women after childbirth.rm5
CD001865 v. 8.4 Personalised risk communication for informed decision making about taking screening tests.rm5
CD001867 v. 11.0 Opioid antagonists for alcohol dependence.rm5
CD001869 v. 18.0 Antiviral treatment for Bell's palsy (idiopathic facial paralysis).rm5
CD001871 v. 14.2 Interventions for preventing obesity in children.rm5
CD001872 v. 6.15 Interventions for treating obesity in children.rm5
CD001873 v. 8.2 Betahistine for Mnire's disease or syndrome.rm5
CD001874 v. 4.0 Perioperative local anaesthesia for reducing pain following tonsillectomy.rm5
CD001876 v. 9.0 Corticosteroids for tuberculous pleurisy.rm5
CD001877 v. 12.0 Screening for breast cancer with mammography.rm5
CD001880 v. 11.0 Nutritional supplementation for hip fracture aftercare in older people.rm5
CD001884 v. 6.0 Desmopressin use for minimising perioperative blood transfusion.rm5
CD001886 v. 8.0 Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.rm5
CD001888 v. 10.0 Cell salvage for minimising perioperative allogeneic blood transfusion.rm5
CD001890 v. 11.0 Correction of chronic metabolic acidosis for chronic kidney disease patients.rm5
CD001892 v. 12.2 Low protein diets for chronic kidney disease in non diabetic adults.rm5
CD001893 v. 10.3 Epidural local anaesthetics versus opioid-based analgesic regimens for postoperative gastrointestina.rm5
CD001894 v. 12.0 Assisted hatching on assisted conception (in vitro fertilisation (IVF) and intracytoplasmic sperm in.rm5
CD001895 v. 8.0 Progestogens with or without oestrogen for irregular uterine bleeding associated with anovulation.rm5
CD001896 v. 5.0 Surgical interruption of pelvic nerve pathways for primary and secondary dysmenorrhoea.rm5
CD001897 v. 6.0 Postoperative procedures for improving fertility following pelvic reproductive surgery.rm5
CD001899 v. 12.0 Intermittent pneumatic compression for treating venous leg ulcers.rm5
CD001900 v. 11.0 Remacemide for drug-resistant localization related epilepsy.rm5
CD001901 v. 13.0 Levetiracetam add-on for drug-resistant focal epilepsy an updated Cochrane Review.rm5
CD001902 v. 14.4 Early versus late antiepileptic drug withdrawal for people with epilepsy in remission.rm5
CD001903 v. 14.0 Ketogenic diet and other dietary treatments for epilepsy.rm5
CD001904 v. 12.0 Carbamazepine versus phenobarbitone monotherapy for epilepsy an individual participant data review.rm5
CD001905 v. 11.0 Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in childr.rm5
CD001908 v. 10.0 Tiagabine add-on for drug-resistant partial epilepsy.rm5
CD001909 v. 14.0 Lamotrigine add-on for drug-resistant partial epilepsy.rm5
CD001911 v. 12.0 Carbamazepine versus phenytoin monotherapy for epilepsy an individual participant data review.rm5
CD001912 v. 14.0 Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.rm5
CD001913 v. 15.0 Neonatal screening for sickle cell disease.rm5
CD001914 v. 10.0 Oral protein calorie supplementation for children with chronic disease.rm5
CD001915 v. 13.0 Inhaled corticosteroids for cystic fibrosis.rm5
CD001916 v. 14.0 Psychological therapies for sickle cell disease and pain.rm5
CD001917 v. 14.0 Home versus hospital intravenous antibiotic therapy for cystic fibrosis.rm5
CD001918 v. 11.0 Dietary interventions (plant sterols stanols omega-3 fatty acids soy protein and dietary fibers) .rm5
CD001919 v. 7.0 Information provision for stroke patients and their caregivers.rm5
CD001920 v. 6.0 Physical rehabilitation approaches for the recovery of function and mobility following stroke.rm5
CD001921 v. 4.0 Eversion versus conventional carotid endarterectomy for preventing stroke.rm5
CD001922 v. 6.0 Physical methods for preventing deep vein thrombosis in stroke.rm5
CD001923 v. 4.0 Carotid endarterectomy for asymptomatic carotid stenosis.rm5
CD001924 v. 4.0 Lubeluzole for acute ischaemic stroke.rm5
CD001925 v. 6.0 Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no .rm5
CD001927 v. 4.0 Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no p.rm5
CD001928 v. 6.0 Calcium antagonists for acute ischemic stroke.rm5
CD001929 v. 12.12 Massage for low-back pain.rm5
CD001930 v. 8.4 Cognitive-behavioural interventions for children who have been sexually abused.rm5
CD001932 v. 12.2 Subjective barriers to prevent wandering of cognitively impaired people.rm5
CD001934 v. 8.0 Surgical versus non-surgical interventions for vocal cord nodules.rm5
CD001935 v. 9.2 Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in childr.rm5
CD001936 v. 4.0 Allergen injection immunotherapy for seasonal allergic rhinitis.rm5
CD001939 v. 11.2 Branched-chain amino acids for people with hepatic encephalopathy.rm5
CD001940 v. 5.0 Chinese medicinal herbs for chronic hepatitis B.rm5
CD001941 v. 6.0 Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and ches.rm5
CD001942 v. 11.0 Corticosteroids for Bell's palsy (idiopathic facial paralysis).rm5
CD001943 v. 11.0 Loxapine for schizophrenia.rm5
CD001944 v. 7.0 Thioridazine for schizophrenia.rm5
CD001945 v. 11.0 Ziprasidone for schizophrenia and severe mental illness.rm5
CD001946 v. 6.0 Central action beta-blockers versus placebo for neuroleptic-induced acute akathisia.rm5
CD001948 v. 7.0 Zotepine for schizophrenia.rm5
CD001949 v. 10.0 Pimozide for schizophrenia or related psychoses.rm5
CD001950 v. 5.0 Benzodiazepines for neuroleptic-induced acute akathisia.rm5
CD001951 v. 7.0 Haloperidol dose for the acute phase of schizophrenia.rm5
CD001954 v. 13.0 Azithromycin for acute lower respiratory tract infections.rm5
CD001955 v. 11.6 Glucocorticoids for croup.rm5
CD001957 v. 17.2 Homeopathic Oscillococcinum for preventing and treating influenza and influenza-like illness.rm5
CD001964 v. 8.0 Extent of lymph node dissection for adenocarcinoma of the stomach.rm5
CD001966 v. 10.0 Prophylactic doxapram for the prevention of morbidity and mortality in preterm infants undergoing en.rm5
CD001968 v. 6.0 Superoxide dismutase for preventing chronic lung disease in mechanically ventilated preterm infants.rm5
CD001969 v. 7.0 Early administration of inhaled corticosteroids for preventing chronic lung disease in very low birt.rm5
CD001970 v. 8.0 Delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low b.rm5
CD001971 v. 4.0 Vancomycin for prophylaxis against sepsis in preterm neonates.rm5
CD001972 v. 6.0 Interventions for treating oral candidiasis for patients with cancer receiving treatment.rm5
CD001973 v. 9.0 Interventions for treating oral mucositis for patients with cancer receiving treatment.rm5
CD001976 v. 8.0 Antistreptococcal interventions for guttate and chronic plaque psoriasis.rm5
CD001977 v. 8.0 Acupuncture for peripheral joint osteoarthritis.rm5
CD001980 v. 8.0 Mind and body therapy for fibromyalgia.rm5
CD001983 v. 7.0 Calcitonin for preventing and treating corticosteroid-induced osteoporosis.rm5
CD001984 v. 6.0 Multidisciplinary rehabilitation for fibromyalgia and musculoskeletal pain in working age adults.rm5
CD001986 v. 5.2 Intravesical Bacillus Calmette-Gurin in Ta and T1 bladder cancer.rm5
CD001987 v. 4.3 Laser prostatectomy for benign prostatic obstruction.rm5
CD001989 v. 8.4 Interventions for acute non-arteritic central retinal artery occlusion.rm5
CD001990 v. 13.0 Chemotherapy versus best supportive care for extensive small cell lung cancer.rm5
CD001991 v. 10.0 Screening for lung cancer.rm5
CD001992 v. 7.0 Cyclo-oxygenase (COX) inhibitors for treating preterm labour.rm5
CD001993 v. 7.0 Surgical procedures for evacuating incomplete miscarriage.rm5
CD001997 v. 7.0 Elective delivery in diabetic pregnant women.rm5
CD001998 v. 6.0 Interventions for suspected placenta praevia.rm5
CD001999 v. 8.0 Anticoagulants (heparin low molecular weight heparin and oral anticoagulants) for intermittent clau.rm5
CD002000 v. 8.0 Bypass surgery for chronic lower limb ischaemia.rm5
CD002001 v. 9.0 Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic.rm5
CD002002 v. 5.0 Interferon in relapsing-remitting multiple sclerosis.rm5
CD002003 v. 13.3 Beta-blockers for hypertension.rm5
CD002005 v. 7.0 Anticoagulation for cerebral venous sinus thrombosis.rm5
CD002006 v. 11.0 Position in the second stage of labour for women without epidural anaesthesia.rm5
CD002007 v. 15.0 Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fib.rm5
CD002008 v. 10.0 Dietary advice with or without oral nutritional supplements for disease-related malnutrition in adul.rm5
CD002009 v. 15.0 Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.rm5
CD002010 v. 14.0 Bisphosphonates for osteoporosis in people with cystic fibrosis.rm5
CD002011 v. 8.0 Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis.rm5
CD002013 v. 14.0 Pulse oximetry for perioperative monitoring.rm5
CD002014 v. 8.0 Behavioural treatment for chronic low-back pain.rm5
CD002018 v. 7.3 Antidepressant treatment for postnatal depression.rm5
CD002020 v. 12.0 Group-based parent training programmes for improving parental psychosocial health.rm5
CD002021 v. 12.0 Opioid antagonists with minimal sedation for opioid withdrawal.rm5
CD002022 v. 11.0 Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal.rm5
CD002024 v. 17.0 Alpha2-adrenergic agonists for the management of opioid withdrawal.rm5
CD002025 v. 14.0 Buprenorphine for managing opioid withdrawal.rm5
CD002026 v. 6.0 Hyperfractionated or accelerated radiotherapy for head and neck cancer.rm5
CD002027 v. 10.2 Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early lary.rm5
CD002030 v. 10.4 Photodynamic therapy for neovascular age-related macular degeneration.rm5
CD002031 v. 12.0 Diaphragm versus diaphragm with spermicides for contraception.rm5
CD002032 v. 11.0 Biphasic versus monophasic oral contraceptives for contraception.rm5
CD002033 v. 13.0 Nystatin prophylaxis and treatment in severely immunodepressed patients.rm5
CD002034 v. 12.0 Biopsy versus resection for high grade glioma.rm5
CD002036 v. 8.0 Surgical interventions for early squamous cell carcinoma of the vulva.rm5
CD002037 v. 6.0 Three- or four- versus two-drug antiretroviral maintenance regimens for HIV infection.rm5
CD002038 v. 6.0 Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected .rm5
CD002039 v. 5.0 Immediate versus deferred zidovudine (AZT) in asymptomatic or mildly symptomatic HIV infected adults.rm5
CD002040 v. 5.0 Stimulant laxatives for constipation and soiling in children.rm5
CD002041 v. 5.0 Hyperbaric oxygen for carbon monoxide poisoning.rm5
CD002042 v. 9.0 Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion.rm5
CD002043 v. 11.0 Routine intracranial pressure monitoring in acute coma.rm5
CD002045 v. 9.1 Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients.rm5
CD002047 v. 9.2 Leflunomide for the treatment of rheumatoid arthritis.rm5
CD002048 v. 6.0 Auranofin versus placebo in rheumatoid arthritis.rm5
CD002049 v. 7.0 Low level laser therapy (Classes I II and III) for treating rheumatoid arthritis.rm5
CD002052 v. 10.0 Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit.rm5
CD002053 v. 5.0 Sedatives for opiate withdrawal in newborn infants.rm5
CD002054 v. 5.0 Surfactant for meconium aspiration syndrome in term and late preterm infants.rm5
CD002055 v. 7.4 Early volume expansion for prevention of morbidity and mortality in very preterm infants.rm5
CD002056 v. 5.0 Early volume expansion versus inotrope for prevention of morbidity and mortality in very preterm inf.rm5
CD002057 v. 8.0 Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilate.rm5
CD002058 v. 7.0 Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very.rm5
CD002059 v. 6.0 Opiate treatment for opiate withdrawal in newborn infants.rm5
CD002060 v. 5.0 Fibreoptic phototherapy for neonatal jaundice.rm5
CD002061 v. 6.0 Permissive hypercapnia for the prevention of morbidity and mortality in mechanically ventilated newb.rm5
CD002062 v. 11.0 Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.rm5
CD002063 v. 12.0 Intravenous immunoglobulin for Guillain-Barr syndrome.rm5
CD002064 v. 8.2 Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sc.rm5
CD002067 v. 12.0 Single dose oral aspirin for acute postoperative pain in adults.rm5
CD002068 v. 10.0 Bisphosphonates for the relief of pain secondary to bone metastases.rm5
CD002069 v. 8.0 Calcium channel blockers for primary Raynaud's phenomenon.rm5
CD002070 v. 11.0 Intravenous naftidrofuryl for critical limb ischaemia.rm5
CD002071 v. 9.0 Antiplatelet and anticoagulant drugs for prevention of restenosisreocclusion following peripheral e.rm5
CD002073 v. 9.0 Interventions for the treatment of twin-twin transfusion syndrome.rm5
CD002079 v. 5.0 Surgery versus radiotherapy for muscle invasive bladder cancer.rm5
CD002080 v. 5.0 Interventions for chronic abacterial prostatitis.rm5
CD002083 v. 4.0 Molindone for schizophrenia and severe mental illness.rm5
CD002084 v. 5.0 Containment strategies for people with serious mental illness.rm5
CD002085 v. 7.0 Prompts to encourage appointment attendance for people with serious mental illness.rm5
CD002086 v. 9.0 Minocycline for acne vulgaris efficacy and safety.rm5
CD002087 v. 6.0 Tirilazad for acute ischaemic stroke.rm5
CD002088 v. 6.0 Interventions for dysarthria due to stroke and other adult-acquired non-progressive brain injury.rm5
CD002090 v. 6.0 Amphetamines for improving recovery after stroke.rm5
CD002091 v. 4.0 Interventions in the management of serum lipids for preventing stroke recurrence.rm5
CD002095 v. 12.0 Short-term treatment with proton pump inhibitors H2-receptor antagonists and prokinetics for gastro.rm5
CD002097 v. 7.0 Primary care professionals providing non-urgent care in hospital emergency departments.rm5
CD002098 v. 6.0 Interactive telemedicine effects on professional practice and health care outcomes.rm5
CD002099 v. 4.0 Nursing record systems effects on nursing practice and healthcare outcomes.rm5
CD002100 v. 6.0 Intra-abdominal drains for the prophylaxis of anastomotic leak in elective colorectal surgery.rm5
CD002101 v. 8.0 Curative surgery for obstruction from primary left colorectal carcinoma Primary or staged resection.rm5
CD002102 v. 6.0 Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma.rm5
CD002104 v. 11.0 Written information about individual medicines for consumers.rm5
CD002106 v. 8.0 Dressings for superficial and partial thickness burns.rm5
CD002109 v. 8.0 Antibiotics for community-acquired pneumonia in adult outpatients.rm5
CD002111 v. 8.0 Biofeedback andor sphincter exercises for the treatment of faecal incontinence in adults.rm5
CD002112 v. 6.0 Desmopressin for nocturnal enuresis in children.rm5
CD002113 v. 5.0 Prompted voiding for the management of urinary incontinence in adults.rm5
CD002114 v. 11.0 Weighted vaginal cones for urinary incontinence.rm5
CD002115 v. 10.4 Management of faecal incontinence and constipation in adults with central neurological diseases.rm5
CD002116 v. 6.0 Drug treatment for faecal incontinence in adults.rm5
CD002117 v. 8.0 Tricyclic and related drugs for nocturnal enuresis in children.rm5
CD002118 v. 12.0 Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology.rm5
CD002119 v. 6.0 Spinal manipulation for dysmenorrhoea.rm5
CD002120 v. 6.0 Oral contraceptive pill for primary dysmenorrhoea.rm5
CD002122 v. 5.0 Progestagens and anti-progestagens for pain associated with endometriosis.rm5
CD002123 v. 5.0 Transcutaneous electrical nerve stimulation for primary dysmenorrhoea.rm5
CD002124 v. 6.0 Dietary supplements for dysmenorrhoea.rm5
CD002125 v. 6.0 Surgical treatment for tubal disease in women due to undergo in vitro fertilisation.rm5
CD002126 v. 6.0 Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.rm5
CD002127 v. 6.0 Mitoxantrone for multiple sclerosis.rm5
CD002128 v. 8.0 Dietary advice for reducing cardiovascular risk.rm5
CD002130 v. 10.0 Platelet glycoprotein IIbIIIa blockers during percutaneous coronary intervention and as the initial.rm5
CD002132 v. 9.0 Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes.rm5
CD002133 v. 7.0 Ticlopidine versus oral anticoagulation for coronary stenting.rm5
CD002137 v. 9.0 Reduced or modified dietary fat for preventing cardiovascular disease.rm5
CD002138 v. 7.0 Hypothermia to reduce neurological damage following coronary artery bypass surgery.rm5
CD002139 v. 11.0 Chemotherapy for non-small cell lung cancer.rm5
CD002140 v. 7.0 Concurrent chemoradiotherapy in non-small cell lung cancer.rm5
CD002141 v. 10.0 Drugs for preventing lung cancer in healthy people.rm5
CD002142 v. 15.0 Postoperative radiotherapy for non-small cell lung cancer.rm5
CD002143 v. 14.2 Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer.rm5
CD002146 v. 7.0 Pharmacotherapy for hypertension in women of different races.rm5
CD002147 v. 8.0 Terlipressin for acute esophageal variceal hemorrhage.rm5
CD002148 v. 10.0 Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis.rm5
CD002150 v. 6.0 Antibiotics for treating scrub typhus.rm5
CD002151 v. 7.0 Antipyretic measures for treating fever in malaria.rm5
CD002152 v. 7.0 Routine anticonvulsants for treating cerebral malaria.rm5
CD002153 v. 4.0 Interventions for preventing reactions to snake antivenom.rm5
CD002154 v. 10.0 Feather versus non-feather bedding for asthma.rm5
CD002155 v. 9.0 Long-acting beta2-agonists for bronchiectasis.rm5
CD002158 v. 6.0 Pressurised metered dose inhalers versus all other hand-held inhaler devices to deliver beta-2 agoni.rm5
CD002160 v. 11.0 Inhaled versus oral steroids for adults with chronic asthma.rm5
CD002162 v. 11.0 Oral corticosteroids for bronchiectasis (stable and acute exacerbations).rm5
CD002163 v. 11.0 Anticholinergic therapy for bronchiectasis.rm5
CD002165 v. 10.0 Pneumococcal vaccine for asthma.rm5
CD002166 v. 7.0 Physical training for bronchiectasis.rm5
CD002168 v. 6.0 Methylxanthines for exacerbations of chronic obstructive pulmonary disease.rm5
CD002170 v. 5.0 Pressurised metered-dose inhalers versus all other hand-held inhalers devices to deliver bronchodila.rm5
CD002173 v. 10.0 Inhaled sodium cromoglycate for asthma in children.rm5
CD002174 v. 11.0 Leukotriene receptor antagonists for non-cystic fibrosis bronchiectasis.rm5
CD002178 v. 6.0 Early emergency department treatment of acute asthma with systemic corticosteroids.rm5
CD002179 v. 8.0 Oxatomide for stable asthma in adults and children.rm5
CD002180 v. 10.0 Surgery versus non-surgical treatment for bronchiectasis.rm5
CD002181 v. 4.0 Protein restriction for diabetic renal disease.rm5
CD002187 v. 5.0 Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus.rm5
CD002190 v. 10.0 Vaccines for the common cold.rm5
CD002192 v. 10.0 Premedication for anxiety in adult day surgery.rm5
CD002193 v. 8.150 Multidisciplinary biopsychosocial rehabilitation for subacute low back pain.rm5
CD002194 v. 8.1 Multidisciplinary biopsychosocial rehabilitation for neck and shoulder pain among working age adults.rm5
CD002195 v. 10.0 Systemic therapy for treating locoregional recurrence in women with breast cancer.rm5
CD002197 v. 6.0 Open Mesh versus non-Mesh for groin hernia repair.rm5
CD002199 v. 13.0 Operative procedures for fissure in ano.rm5
CD002200 v. 6.0 Follow-up strategies for patients treated for non-metastatic colorectal cancer.rm5
CD002201 v. 13.0 Omega-3 fatty acids for cystic fibrosis.rm5
CD002202 v. 13.0 Hydroxyurea (hydroxycarbamide) for sickle cell disease.rm5
CD002203 v. 10.0 Macrolide antibiotics for cystic fibrosis.rm5
CD002204 v. 15.0 Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.rm5
CD002206 v. 9.2 Media-based behavioural treatments for behavioural problems in children.rm5
CD002207 v. 13.4 Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.rm5
CD002208 v. 10.0 Methadone maintenance at different dosages for opioid dependence.rm5
CD002209 v. 11.0 Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.rm5
CD002210 v. 10.0 LAAM maintenance vs methadone maintenance for heroin dependence.rm5
CD002211 v. 5.0 Dissection versus diathermy for tonsillectomy.rm5
CD002212 v. 5.2 Effectiveness of organisational infrastructures to promote evidence-based nursing practice.rm5
CD002213 v. 7.5 Interprofessional education effects on professional practice and healthcare outcomes (update).rm5
CD002214 v. 6.0 Effectiveness of intermediate care in nursing-led in-patient units.rm5
CD002215 v. 4.0 Capitation salary fee-for-service and mixed systems of payment effects on the behaviour of primar.rm5
CD002216 v. 6.2 Therapeutic monitoring of antiepileptic drugs for epilepsy.rm5
CD002217 v. 10.0 Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalised onset tonic-c.rm5
CD002218 v. 9.0 Antibiotics versus no treatment for toxoplasma retinochoroiditis.rm5
CD002219 v. 13.0 Ivermectin for onchocercal eye disease (river blindness).rm5
CD002221 v. 9.2 Interventions for involutional lower lid entropion.rm5
CD002224 v. 10.2 Primary groin irradiation versus primary groin surgery for early vulvar cancer.rm5
CD002225 v. 9.0 Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix.rm5
CD002227 v. 9.0 Penicillin for secondary prevention of rheumatic fever.rm5
CD002229 v. 15.0 Hormone therapy for preventing cardiovascular disease in post-menopausal women.rm5
CD002230 v. 5.0 Phosphodiesterase III inhibitors for heart failure.rm5
CD002231 v. 5.0 Chinese medicinal herbs for asymptomatic carriers of hepatitis B virus infection.rm5
CD002232 v. 8.9 Antibiotics for spontaneous bacterial peritonitis in cirrhotic patients.rm5
CD002233 v. 5.2 Emergency sclerotherapy versus vasoactive drugs for bleeding oesophageal varices in cirrhotic patien.rm5
CD002238 v. 8.0 Drugs for nocturnal enuresis in children (other than desmopressin and tricyclics).rm5
CD002239 v. 9.0 Laparoscopic colposuspension for urinary incontinence in women.rm5
CD002240 v. 6.0 Behavioural and cognitive interventions with or without other treatments for the management of faeca.rm5
CD002242 v. 6.0 Antibiotic treatment for travellers' diarrhoea.rm5
CD002243 v. 9.0 Corticosteroids for treating sepsis.rm5
CD002244 v. 8.1 Corticosteroids for managing tuberculous meningitis.rm5
CD002245 v. 6.0 Timing and volume of fluid administration for patients with bleeding.rm5
CD002246 v. 6.0 Interventions for promoting smoke alarm ownership and function.rm5
CD002247 v. 13.0 Primary repair for penetrating colon injuries.rm5
CD002248 v. 8.0 Behavioural interventions for dysmenorrhoea.rm5
CD002249 v. 7.0 Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome.rm5
CD002250 v. 8.0 Antibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes an.rm5
CD002251 v. 10.0 Techniques for preventing hypotension during spinal anaesthesia for caesarean section.rm5
CD002252 v. 9.4 Antihypertensive drug therapy for mild to moderate hypertension during pregnancy.rm5
CD002253 v. 7.0 Medical treatment for early fetal death (less than 24 weeks).rm5
CD002254 v. 9.0 Near-infrared spectroscopy for fetal assessment during labour.rm5
CD002255 v. 12.0 Calcium channel blockers for inhibiting preterm labour and birth.rm5
CD002256 v. 9.0 Treatments for symptomatic urinary tract infections during pregnancy.rm5
CD002258 v. 4.0 Bromocriptine versus levodopa in early Parkinson's disease.rm5
CD002259 v. 4.3 Pramipexole versus bromocriptine for levodopa-induced complications in Parkinson's disease.rm5
CD002261 v. 4.2 Pramipexole for levodopa-induced complications in Parkinson's disease.rm5
CD002265 v. 9.0 Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lup.rm5
CD002270 v. 7.0 Diuretic therapy for newborn infants with posthemorrhagic ventricular dilatation.rm5
CD002271 v. 6.0 Continuous distending pressure for respiratory distress in preterm infants.rm5
CD002272 v. 5.0 Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pre.rm5
CD002273 v. 7.0 Air versus oxygen for resuscitation of infants at birth.rm5
CD002275 v. 7.0 Plasma exchange for generalised myasthenia gravis.rm5
CD002276 v. 6.0 Drug treatment for facioscapulohumeral muscular dystrophy.rm5
CD002277 v. 10.0 Intravenous immunoglobulin for myasthenia gravis.rm5
CD002278 v. 6.0 Fluoride toothpastes for preventing dental caries in children and adolescents.rm5
CD002279 v. 7.0 Fluoride varnishes for preventing dental caries in children and adolescents.rm5
CD002280 v. 6.0 Fluoride gels for preventing dental caries in children and adolescents.rm5
CD002281 v. 6.4 Powered versus manual toothbrushing for oral health.rm5
CD002282 v. 7.0 Adhesives for fixed orthodontic brackets.rm5
CD002283 v. 6.2 Retention procedures for stabilising tooth position after treatment with orthodontic braces.rm5
CD002284 v. 6.1 Fluoride mouthrinses for preventing dental caries in children and adolescents.rm5
CD002286 v. 9.0 Feverfew for preventing migraine.rm5
CD002290 v. 12.0 Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in childre.rm5
CD002292 v. 13.0 Interventions for bullous pemphigoid.rm5
CD002293 v. 6.0 Cognitive rehabilitation for memory deficits after stroke.rm5
CD002294 v. 10.0 Interventions for preoperative smoking cessation.rm5
CD002295 v. 10.0 Exercise interventions for smoking cessation.rm5
CD002296 v. 13.0 Prevention of NSAID-induced gastroduodenal ulcers.rm5
CD002299 v. 12.1 Nitrates for achalasia.rm5
CD002300 v. 14.0 Cisapride treatment for gastro-oesophageal reflux in children.rm5
CD002302 v. 5.0 Pressure-relieving interventions for treating diabetic foot ulcers.rm5
CD002303 v. 8.0 Compression for preventing recurrence of venous ulcers.rm5
CD002304 v. 9.0 Clotiapine for acute psychotic illnesses.rm5
CD002305 v. 10.0 Antidepressants for people with both schizophrenia and depression.rm5
CD002307 v. 8.2 Mast-cell stabilising agents to prevent exercise-induced bronchoconstriction.rm5
CD002308 v. 8.18 Early use of inhaled corticosteroids in the emergency department treatment of acute asthma.rm5
CD002309 v. 9.0 Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.rm5
CD002310 v. 11.2 Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children.rm5
CD002311 v. 7.0 Late ( 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.rm5
CD002312 v. 5.0 Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneu.rm5
CD002314 v. 6.0 Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent andor ch.rm5
CD002316 v. 9.14 Inhaled steroids for acute asthma following emergency department discharge.rm5
CD002317 v. 10.0 Tricyclic drugs for depression in children and adolescents.rm5
CD002731 v. 6.0 Nedocromil sodium versus sodium cromoglycate for preventing exercise-induced bronchoconstriction.rm5
CD002733 v. 10.0 Influenza vaccine for patients with chronic obstructive pulmonary disease.rm5
CD002734 v. 11.0 Oral methylxanthines for bronchiectasis.rm5
CD002738 v. 5.0 Beclomethasone versus placebo for chronic asthma.rm5
CD002739 v. 6.0 Inhaled corticosteroids compared to placebo for prevention of exercise induced bronchoconstriction.rm5
CD002741 v. 7.0 Antibiotics for acute asthma.rm5
CD002742 v. 7.4 Addition of intravenous aminophylline to inhaled beta2-agonists in adults with acute asthma.rm5
CD002744 v. 10.0 Neuraminidase inhibitors for preventing and treating influenza in children (published trials only).rm5
CD002745 v. 8.0 Amantadine and rimantadine for influenza A in children and the elderly.rm5
CD002747 v. 11.0 Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer.rm5
CD002748 v. 10.0 Risk-reducing mastectomy for the prevention of primary breast cancer.rm5
CD002750 v. 11.0 Calcium antagonists as an add-on therapy for drug-resistant epilepsy.rm5
CD002751 v. 13.0 Active chest compression-decompression for cardiopulmonary resuscitation.rm5
CD002752 v. 9.0 Clinical service organisation for heart failure.rm5
CD002755 v. 6.0 Intravenous magnesium for acute myocardial infarction.rm5
CD002759 v. 7.0 Progressive resistance strength training for improving physical function in older adults.rm5
CD002760 v. 11.0 Single dose oral dihydrocodeine for acute postoperative pain.rm5
CD002762 v. 8.0 Single dose oral piroxicam for acute postoperative pain.rm5
CD002763 v. 11.0 Single dose oral oxycodone and oxycodone plus paracetamol (acetaminophen) for acute postoperative pa.rm5
CD002764 v. 6.0 Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and.rm5
CD002765 v. 11.1 Effects of nonsteroidal anti-inflammatory drugs on postoperative renal function in adults with norma.rm5
CD002767 v. 14.0 Elective versus symptomatic intravenous antibiotic therapy for cystic fibrosis.rm5
CD002768 v. 14.0 Physical exercise training for cystic fibrosis.rm5
CD002769 v. 13.0 Non-invasive ventilation for cystic fibrosis.rm5
CD002770 v. 8.0 Mechanical ventilation for newborn infants with respiratory failure due to pulmonary disease.rm5
CD002771 v. 9.0 Kangaroo mother care to reduce morbidity and mortality in low birthweight infants.rm5
CD002772 v. 8.4 Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripheral.rm5
CD002773 v. 4.0 Neuromuscular paralysis for newborn infants receiving mechanical ventilation.rm5
CD002774 v. 8.2 Heparin for prolonging peripheral intravenous catheter use in neonates.rm5
CD002775 v. 8.0 Alpha-1 proteinase inhibitor (a1PI) for preventing chronic lung disease in preterm infants.rm5
CD002776 v. 4.0 Prophylactic vitamin K for vitamin K deficiency bleeding in neonates.rm5
CD002777 v. 7.0 High versus low medium chain triglyceride content of formula for promoting short-term growth of pret.rm5
CD002779 v. 7.0 Interventions for treating burning mouth syndrome.rm5
CD002780 v. 4.0 One topical fluoride (toothpastes or mouthrinses or gels or varnishes) versus another for prevent.rm5
CD002781 v. 4.0 Combinations of topical fluoride (toothpastes mouthrinses gels varnishes) versus single topical f.rm5
CD002782 v. 6.0 Topical fluoride (toothpastes mouthrinses gels or varnishes) for preventing dental caries in child.rm5
CD002783 v. 9.0 Thrombolysis for acute deep vein thrombosis.rm5
CD002784 v. 10.0 Surgery versus thrombolysis for initial management of acute limb ischaemia.rm5
CD002785 v. 5.0 Chelation therapy for atherosclerotic cardiovascular disease.rm5
CD002786 v. 5.0 Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts.rm5
CD002787 v. 11.0 Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults.rm5
CD002788 v. 9.0 Rocuronium versus succinylcholine for rapid sequence induction intubation.rm5
CD002792 v. 8.0 Screening and case finding instruments for depression.rm5
CD002795 v. 9.0 Pharmacotherapy for post traumatic stress disorder (PTSD).rm5
CD002796 v. 9.5 'Scared Straight' and other juvenile awareness programs for preventing juvenile delinquency.rm5
CD002798 v. 13.0 Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy.rm5
CD002799 v. 7.0 Alpha-foetoprotein andor liver ultrasonography for screening of hepatocellular carcinoma in patient.rm5
CD002800 v. 7.0 Propylthiouracil for alcoholic liver disease.rm5
CD002801 v. 7.0 Habit retraining for the management of urinary incontinence in adults.rm5
CD002802 v. 7.0 Timed voiding for the management of urinary incontinence in adults.rm5
CD002803 v. 7.0 Spinal immobilisation for trauma patients.rm5
CD002804 v. 10.0 Second-line chemotherapy for non-small cell lung cancer.rm5
CD002806 v. 10.0 Embryo freezing for preventing ovarian hyperstimulation syndrome.rm5
CD002807 v. 8.0 Techniques for surgical retrieval of sperm prior to intra-cytoplasmic sperm injection (ICSI) for azo.rm5
CD002808 v. 6.0 Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary.rm5
CD002809 v. 5.0 Intra-uterine insemination versus timed intercourse or expectant management for cervical hostility i.rm5
CD002811 v. 12.0 Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome.rm5
CD002812 v. 9.5 Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's dis.rm5
CD002813 v. 8.0 Occupational therapy for patients with Parkinson's disease.rm5
CD002814 v. 9.26 Comparison of speech and language therapy techniques for speech problems in Parkinson's disease.rm5
CD002815 v. 7.0 Physiotherapy for Parkinson's disease a comparison of techniques.rm5
CD002816 v. 6.0 Non-pharmacological therapies for dysphagia in Parkinson's disease.rm5
CD002817 v. 11.0 Physiotherapy versus placebo or no intervention in Parkinson's disease.rm5
CD002818 v. 6.0 Amantadine for fatigue in multiple sclerosis.rm5
CD002819 v. 6.0 Cyclophosphamide for multiple sclerosis.rm5
CD002822 v. 8.0 Physiotherapy interventions for ankylosing spondylitis.rm5
CD002823 v. 8.2 Transcutaneous electrostimulation for osteoarthritis of the knee.rm5
CD002824 v. 5.0 Intra-articular steroids and splintsrest for children with juvenile idiopathic arthritis and adults.rm5
CD002825 v. 5.0 Fluoride for treating postmenopausal osteoporosis.rm5
CD002826 v. 10.0 Thermotherapy for treating rheumatoid arthritis.rm5
CD002827 v. 11.0 Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropat.rm5
CD002828 v. 9.0 Corticosteroids for myasthenia gravis.rm5
CD002829 v. 8.0 Antioxidant treatment for amyotrophic lateral sclerosis or motor neuron disease.rm5
CD002830 v. 10.0 Droperidol for psychosis-induced aggression or agitation.rm5
CD002831 v. 9.0 Psychoeducation for schizophrenia.rm5
CD002832 v. 9.0 Perazine for schizophrenia.rm5
CD002834 v. 8.0 Interventions targeted at women to encourage the uptake of cervical screening.rm5
CD002835 v. 6.0 Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure.rm5
CD002837 v. 10.0 Enteral versus parenteral nutrition for acute pancreatitis.rm5
CD002839 v. 6.0 Vasoactive drugs for acute stroke.rm5
CD002840 v. 7.0 Treadmill training and body weight support for walking after stroke.rm5
CD002842 v. 5.0 Cognitive rehabilitation for attention deficits following stroke.rm5
CD002843 v. 6.0 Strategies for partner notification for sexually transmitted infections including HIV.rm5
CD002845 v. 6.0 Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal.rm5
CD002847 v. 6.0 Reduced osmolarity oral rehydration solution for treating dehydration caused by acute diarrhoea in c.rm5
CD002848 v. 8.3 Rotavirus vaccine for preventing diarrhoea.rm5
CD002849 v. 11.0 Anxiolytics for smoking cessation.rm5
CD002850 v. 11.0 Telephone counselling for smoking cessation.rm5
CD002851 v. 9.0 Scopolamine (hyoscine) for preventing and treating motion sickness.rm5
CD002852 v. 11.0 Haloperidol for agitation in dementia.rm5
CD002853 v. 6.0 Propentofylline for dementia.rm5
CD002854 v. 10.1 Vitamin E for Alzheimer's dementia and mild cognitive impairment.rm5
CD002855 v. 8.0 Medical methods for first trimester abortion.rm5
CD002856 v. 7.0 Giving women their own case notes to carry during pregnancy.rm5
CD002857 v. 4.0 Uterine muscle relaxant drugs for threatened miscarriage.rm5
CD002859 v. 7.0 Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant.rm5
CD002860 v. 7.0 Nitric oxide donors for treating preterm labour.rm5
CD002862 v. 7.0 Amniotomy alone for induction of labour.rm5
CD002863 v. 7.0 Oral beta-blockers for mild to moderate hypertension during pregnancy.rm5
CD002864 v. 6.0 Intravenous prostaglandin for induction of labour.rm5
CD002865 v. 5.0 Mifepristone for induction of labour.rm5
CD002866 v. 9.0 Methods of repair for obstetric anal sphincter injury.rm5
CD002867 v. 5.0 Treatments for secondary postpartum haemorrhage.rm5
CD002869 v. 6.0 Individual or group antenatal education for childbirth or parenthood or both.rm5
CD002872 v. 11.0 Nebulised morphine for severe interstitial lung disease.rm5
CD002873 v. 6.0 Short acting beta2-agonists for recurrent wheeze in children under two years of age.rm5
CD002875 v. 10.0 Lifestyle modification for obstructive sleep apnoea.rm5
CD002876 v. 8.0 Tiotropium for stable chronic obstructive pulmonary disease.rm5
CD002878 v. 7.0 Nocturnal non-invasive positive pressure ventilation for stable chronic obstructive pulmonary diseas.rm5
CD002879 v. 5.0 Beclomethasone at different doses for chronic asthma.rm5
CD002880 v. 7.0 Corticosteroids for idiopathic pulmonary fibrosis.rm5
CD002881 v. 7.0 Carbonic anhydrase inhibitors for hypercapnic ventilatory failure in chronic obstructive pulmonary d.rm5
CD002883 v. 10.0 Domiciliary oxygen for interstitial lung disease.rm5
CD002884 v. 11.0 Heliox for non-intubated acute asthma patients.rm5
CD002885 v. 5.4 Oral xanthines as maintenance treatment for asthma in children.rm5
CD002886 v. 4.0 Corticosteroids for hospitalised children with acute asthma.rm5
CD002890 v. 15.0 Psychological therapies for thalassaemia.rm5
CD002891 v. 6.0 Interventions for preventing eating disorders in children and adolescents.rm5
CD002892 v. 10.0 Preventing occupational stress in healthcare workers.rm5
CD002893 v. 10.0 Sublingual immunotherapy for allergic rhinitis.rm5
CD002894 v. 7.0 Computerized advice on drug dosage to improve prescribing practice.rm5
CD002896 v. 14.0 Vagus nerve stimulation for partial seizures.rm5
CD002897 v. 7.0 Intraoperative Mitomycin C for glaucoma surgery.rm5
CD002898 v. 11.0 Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratiti.rm5
CD002900 v. 6.0 Surgical methods for first trimester termination of pregnancy.rm5
CD002901 v. 12.0 Digitalis for treatment of heart failure in patients in sinus rhythm.rm5
CD002902 v. 10.0 Psychological interventions for coronary heart disease.rm5
CD002904 v. 4.0 Glucocorticosteroids for viral hepatitis C.rm5
CD002907 v. 8.2 Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding.rm5
CD002911 v. 6.0 Alarm interventions for nocturnal enuresis in children.rm5
CD002912 v. 15.0 Open retropubic colposuspension for urinary incontinence in women.rm5
CD002913 v. 8.2 Budesonide for maintenance of remission in Crohn's disease.rm5
CD002914 v. 8.13 Acupuncture for Bell's palsy.rm5
CD002918 v. 12.0 Cervico-thoracic or lumbar sympathectomy for neuropathic pain and complex regional pain syndrome.rm5
CD002919 v. 11.0 Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SN.rm5
CD002922 v. 9.2 Treatment for lupus nephritis.rm5
CD002923 v. 11.0 Penfluridol for schizophrenia.rm5
CD002924 v. 5.0 In-hospital care pathways for stroke.rm5
CD002925 v. 6.0 Therapy-based rehabilitation services for stroke patients at home.rm5
CD002928 v. 7.0 Enhancing partner support to improve smoking cessation.rm5
CD002929 v. 12.0 Disposable surgical face masks for preventing surgical wound infection in clean surgery.rm5
CD002930 v. 9.0 Electromagnetic therapy for treating pressure ulcers.rm5
CD002933 v. 9.0 Electromagnetic therapy for treating venous leg ulcers.rm5
CD002936 v. 6.0 Intravenous immunoglobulins for multiple sclerosis.rm5
CD002941 v. 8.0 Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis.rm5
CD002942 v. 8.0 Interventions for relieving the pain and discomfort of screening mammography.rm5
CD002943 v. 7.0 Strategies for increasing the participation of women in community breast cancer screening.rm5
CD002944 v. 8.0 Balloon angioplasty with and without stenting versus medical therapy for hypertensive patients wit.rm5
CD002945 v. 8.0 Screening for abdominal aortic aneurysm.rm5
CD002946 v. 8.0 Glucosamine therapy for treating osteoarthritis.rm5
CD002947 v. 7.0 Oral herbal therapies for treating osteoarthritis.rm5
CD002948 v. 5.0 Herbal therapy for treating rheumatoid arthritis.rm5
CD002950 v. 10.2 Antidepressants for cocaine dependence and problematic cocaine use.rm5
CD002954 v. 6.0 Drugs for discoid lupus erythematosus.rm5
CD002955 v. 7.0 Naftidrofuryl for dementia.rm5
CD002958 v. 6.0 Early postnatal discharge from hospital for healthy mothers and term infants.rm5
CD002959 v. 10.0 Vaccines for women for preventing neonatal tetanus.rm5
CD002960 v. 7.0 Magnesium sulphate versus lytic cocktail for eclampsia.rm5
CD002961 v. 5.0 Critical incident audit and feedback to improve perinatal and maternal mortality and morbidity.rm5
CD002962 v. 10.0 Acupuncture or acupressure for induction of labour.rm5
CD002963 v. 6.0 Fetal vibroacoustic stimulation for facilitation of tests of fetal wellbeing.rm5
CD002964 v. 6.4 Individual and group based parenting programmes for improving psychosocial outcomes for teenage pare.rm5
CD002967 v. 10.0 Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.rm5
CD002968 v. 4.0 Exercise for type 2 diabetes mellitus.rm5
CD002969 v. 6.0 Interventions for improving communication with children and adolescents about their cancer.rm5
CD002971 v. 7.0 Formula versus donor breast milk for feeding preterm or low birth weight infants.rm5
CD002972 v. 5.0 Formula milk versus maternal breast milk for feeding preterm or low birth weight infants.rm5
CD002973 v. 5.2 Tracheal gas insufflation for the prevention of morbidity and mortality in mechanically ventilated n.rm5
CD002974 v. 6.0 High frequency oscillatory ventilation versus conventional ventilation for infants with severe pulmo.rm5
CD002975 v. 7.0 Early versus delayed initiation of continuous distending pressure for respiratory distress syndrome .rm5
CD002976 v. 4.0 Rapid correction of early metabolic acidaemia in comparison with placebo no intervention or slow co.rm5
CD002977 v. 6.0 Devices and pressure sources for administration of nasal continuous positive airway pressure (NCPAP).rm5
CD002978 v. 3.0 Oral oestrogen and combined oestrogenprogestogen therapy versus placebo for hot flushes.rm5
CD002980 v. 17.0 Acyclovir for treating varicella in otherwise healthy children and adolescents.rm5
CD002982 v. 9.0 Psychological interventions for adults with asthma.rm5
CD002984 v. 4.0 Inhaled short-acting beta2-agonists versus ipratropium for acute exacerbations of chronic obstructiv.rm5
CD002985 v. 8.0 Gold as an oral corticosteroid sparing agent in stable asthma.rm5
CD002986 v. 11.0 Ionisers for chronic asthma.rm5
CD002987 v. 10.0 Troleandomycin as an oral corticosteroid sparing agent in stable asthma.rm5
CD002988 v. 6.5 Intravenous beta2-agonists for acute asthma in the emergency department.rm5
CD002989 v. 8.3 Pet allergen control measures for allergic asthma in children and adults.rm5
CD002990 v. 13.0 Self management for patients with chronic obstructive pulmonary disease.rm5
CD002991 v. 8.0 Inhaled corticosteroids for stable chronic obstructive pulmonary disease.rm5
CD002992 v. 11.0 Cardioselective beta-blockers for reversible airway disease.rm5
CD002993 v. 9.0 Cyclosporin as an oral corticosteroid sparing agent in stable asthma.rm5
CD002994 v. 8.0 Prostacyclin for pulmonary hypertension in adults.rm5
CD002996 v. 8.0 Inhaled hyperosmolar agents for bronchiectasis.rm5
CD002997 v. 11.0 Macrolides for chronic asthma.rm5
CD002999 v. 7.0 Smoking cessation for chronic obstructive pulmonary disease.rm5
CD003000 v. 9.0 Education interventions for adults who attend the emergency room for acute asthma.rm5
CD003002 v. 9.4 Drug therapy for obstructive sleep apnoea in adults.rm5
CD003004 v. 10.3 Perioperative fluid volume optimization following proximal femoral fracture.rm5
CD003005 v. 6.0 Caudal epidural block versus other methods of postoperative pain relief for circumcision in boys.rm5
CD003006 v. 8.0 Transient neurologic symptoms (TNS) following spinal anaesthesia with lidocaine versus other local a.rm5
CD003007 v. 12.0 Rehabilitation after lumbar disc surgery.rm5
CD003008 v. 11.0 Transcutaneous electrical nerve stimulation (TENS) versus placebo for chronic low-back pain.rm5
CD003009 v. 9.0 Neuroreflexotherapy for non-specific low-back pain.rm5
CD003010 v. 9.0 Traction for low-back pain with or without sciatica.rm5
CD003012 v. 11.0 Active placebos versus antidepressants for depression.rm5
CD003013 v. 12.0 Lithium for maintenance treatment of mood disorders.rm5
CD003015 v. 2.0 Family and parenting interventions in children and adolescents with conduct disorder and delinquency.rm5
CD003018 v. 6.2 Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5.rm5
CD003020 v. 12.0 Universal school-based prevention for illicit drug use.rm5
CD003021 v. 10.2 Treatment for amphetamine withdrawal.rm5
CD003026 v. 10.0 Treatment for amphetamine psychosis.rm5
CD003030 v. 6.5 Continuing education meetings and workshops effects on professional practice and health care outcom.rm5
CD003031 v. 8.0 Prophylactic drug management for febrile seizures in children.rm5
CD003032 v. 12.0 Ethosuximide sodium valproate or lamotrigine for absence seizures in children and adolescents.rm5
CD003034 v. 10.0 Techniques for the interruption of tubal patency for female sterilisation.rm5
CD003036 v. 11.0 Immediate postpartum insertion of intrauterine device for contraception.rm5
CD003037 v. 8.0 Medical versus surgical methods for first trimester termination of pregnancy.rm5
CD003038 v. 12.0 Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropeni.rm5
CD003039 v. 8.0 Colony-stimulating factors for chemotherapy-induced febrile neutropenia.rm5
CD003040 v. 5.0 Angiotensin receptor blockers for heart failure.rm5
CD003042 v. 10.0 Mediastinal chest drain clearance for cardiac surgery.rm5
CD003043 v. 5.0 Ursodeoxycholic acid andor antibiotics for prevention of biliary stent occlusion.rm5
CD003044 v. 9.0 Non-absorbable disaccharides versus placebono intervention and lactulose versus lactitol for the pr.rm5
CD003045 v. 8.0 Anabolic-androgenic steroids for alcoholic liver disease.rm5
CD003046 v. 6.0 Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular c.rm5
CD003047 v. 6.7 Dopamine agents for hepatic encephalopathy.rm5
CD003048 v. 6.0 Probiotics for treating acute infectious diarrhoea.rm5
CD003049 v. 7.0 Community animal health services for improving household wealth and health status of low income farm.rm5
CD003051 v. 11.0 Surgical sealant for preventing air leaks after pulmonary resections in patients with lung cancer.rm5
CD003052 v. 5.0 Oral versus injectable ovulation induction agents for unexplained subfertility.rm5
CD003053 v. 12.0 Insulin-sensitising drugs (metformin rosiglitazone pioglitazone D-chiro-inositol) for women with .rm5
CD003054 v. 6.2 Diet physical activity or both for prevention or delay of type 2 diabetes mellitus and its associat.rm5
CD003057 v. 7.0 Hyperbaric oxygen therapy for multiple sclerosis.rm5
CD003059 v. 10.0 Cromolyn sodium for the prevention of chronic lung disease in preterm infants.rm5
CD003062 v. 5.0 Cot-nursing versus incubator care for preterm infants.rm5
CD003063 v. 6.2 Early surfactant administration with brief ventilation vs. selective surfactant and continued mechan.rm5
CD003064 v. 7.0 Diuretics for transient tachypnoea of the newborn.rm5
CD003065 v. 6.0 Tracheal suctioning without disconnection in intubated ventilated neonates.rm5
CD003066 v. 5.0 G-CSF and GM-CSF for treating or preventing neonatal infections.rm5
CD003067 v. 9.8 Pit and fissure sealants versus fluoride varnishes for preventing dental decay in the permanent teet.rm5
CD003069 v. 10.0 Interventions for replacing missing teeth maintaining and recovering soft tissue health around dent.rm5
CD003071 v. 9.0 Epidural analgesia for pain relief following hip or knee replacement.rm5
CD003073 v. 7.0 Prevention of infection in arterial reconstruction.rm5
CD003074 v. 10.0 Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembo.rm5
CD003075 v. 6.0 Treatment of hypertension in peripheral arterial disease.rm5
CD003076 v. 7.0 Home versus in-patient treatment for deep vein thrombosis.rm5
CD003078 v. 14.0 Double bag or Y-set versus standard transfer systems for continuous ambulatory peritoneal dialysis i.rm5
CD003079 v. 9.2 Benzodiazepines for psychosis-induced aggression or agitation.rm5
CD003080 v. 6.0 Vocational rehabilitation for people with severe mental illness.rm5
CD003081 v. 6.0 Outcome measures and needs assessment tools for schizophrenia and related disorders.rm5
CD003082 v. 13.0 Haloperidol versus placebo for schizophrenia.rm5
CD003083 v. 7.0 Benperidol for schizophrenia.rm5
CD003085 v. 4.0 Endovascular coiling versus neurosurgical clipping for patients with aneurysmal subarachnoid haemorr.rm5
CD003086 v. 10.2 Opioid antagonists for smoking cessation.rm5
CD003087 v. 9.0 Double gloving to reduce surgical cross-infection.rm5
CD003091 v. 9.2 Dressings for the prevention of surgical site infection.rm5
CD003092 v. 7.0 Extra-amniotic prostaglandin for induction of labour.rm5
CD003093 v. 5.0 Sexual intercourse for cervical ripening and induction of labour.rm5
CD003094 v. 9.0 Treatments for iron-deficiency anaemia in pregnancy.rm5
CD003096 v. 11.0 Hydration for treatment of preterm labour.rm5
CD003097 v. 4.0 Hyaluronidase for cervical ripening and induction of labour.rm5
CD003098 v. 7.0 Oral prostaglandin E2 for induction of labour.rm5
CD003099 v. 7.4 Castor oil bath andor enema for cervical priming and induction of labour.rm5
CD003100 v. 5.0 Corticosteroids for cervical ripening and induction of labour.rm5
CD003101 v. 7.0 Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term.rm5
CD003103 v. 5.0 Relaxin for cervical ripening and induction of labour.rm5
CD003106 v. 7.0 Interventionist versus expectant care for severe pre-eclampsia between 24 and 34 weeks' gestation.rm5
CD003108 v. 4.0 Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV.rm5
CD003109 v. 7.2 Advanced training in trauma life support for ambulance crews.rm5
CD003110 v. 7.7 Area-wide traffic calming for preventing traffic related injuries.rm5
CD003113 v. 7.0 Opioid therapy for treating rheumatoid arthritis pain.rm5
CD003114 v. 7.0 Occupational therapy for rheumatoid arthritis.rm5
CD003115 v. 7.2 Oral or transdermal opioids for osteoarthritis of the knee or hip.rm5
CD003118 v. 7.0 Interventions for the treatment of Morton's neuroma.rm5
CD003119 v. 10.0 Vinpocetine for cognitive impairment and dementia.rm5
CD003120 v. 12.0 Ginkgo biloba for cognitive impairment and dementia.rm5
CD003122 v. 9.0 Hormone replacement therapy for cognitive function in postmenopausal women.rm5
CD003123 v. 11.0 Epinephrine for bronchiolitis.rm5
CD003124 v. 8.0 Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatri.rm5
CD003129 v. 6.2 Methotrexate for treating juvenile idiopathic arthritis.rm5
CD003130 v. 6.4 Mobile bearing vs fixed bearing prostheses for posterior cruciate retaining total knee arthroplasty .rm5
CD003132 v. 6.0 Therapeutic ultrasound for osteoarthritis of the knee or hip.rm5
CD003133 v. 10.0 Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma.rm5
CD003134 v. 5.0 Non-steroid agents for idiopathic pulmonary fibrosis.rm5
CD003135 v. 7.0 Fluticasone versus placebo for chronic asthma in adults and children.rm5
CD003137 v. 11.0 Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chron.rm5
CD003139 v. 12.0 High-dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional c.rm5
CD003140 v. 12.0 Benzo-pyrones for reducing and controlling lymphoedema of the limbs.rm5
CD003141 v. 9.7 Physical therapies for reducing and controlling lymphoedema of the limbs.rm5
CD003142 v. 10.0 High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional c.rm5
CD003144 v. 5.0 Stapled versus handsewn methods for colorectal anastomosis surgery.rm5
CD003145 v. 5.0 Short term benefits for laparoscopic colorectal resection.rm5
CD003146 v. 12.0 Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.rm5
CD003147 v. 7.0 Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis.rm5
CD003148 v. 7.0 Psychological interventions for individuals with cystic fibrosis and their families.rm5
CD003149 v. 12.0 Preoperative blood transfusions for sickle cell disease.rm5
CD003150 v. 8.0 Aromatherapy for dementia.rm5
CD003152 v. 9.0 Snoezelen for dementia.rm5
CD003153 v. 9.0 D-cycloserine for Alzheimer's disease.rm5
CD003154 v. 14.0 Memantine for dementia.rm5
CD003155 v. 6.0 Metrifonate for Alzheimer's disease.rm5
CD003157 v. 5.0 Shunting for normal pressure hydrocephalus (NPH).rm5
CD003158 v. 7.0 Acetyl-l-carnitine for dementia.rm5
CD003159 v. 5.0 Nicergoline for dementia and other age associated forms of cognitive impairment.rm5
CD003160 v. 9.0 Statins for the prevention of dementia.rm5
CD003161 v. 7.4 Cognitive behavioural interventions for sleep problems in adults aged 60.rm5
CD003162 v. 9.0 The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo.rm5
CD003163 v. 6.0 Topical nasal steroids for intermittent and persistent allergic rhinitis in children.rm5
CD003164 v. 5.2 Care home versus hospital and own home environments for rehabilitation of older people.rm5
CD003167 v. 5.0 Medical interventions for primary open angle glaucoma and ocular hypertension.rm5
CD003169 v. 9.0 Multifocal versus monofocal intraocular lenses after cataract extraction.rm5
CD003170 v. 9.0 Interventions for asymptomatic retinal breaks and lattice degeneration for preventing retinal detach.rm5
CD003171 v. 6.0 Surgical interventions for bilateral congenital cataract.rm5
CD003172 v. 10.0 Sponge versus diaphragm for contraception.rm5
CD003175 v. 7.0 Adjuvant chemotherapy for endometrial cancer after hysterectomy.rm5
CD003176 v. 11.0 Anti-inflammatory treatment for carditis in acute rheumatic fever.rm5
CD003177 v. 5.0 Omega 3 fatty acids for prevention and treatment of cardiovascular disease.rm5
CD003178 v. 7.0 Continuous infusion versus bolus injection of loop diuretics in congestive heart failure.rm5
CD003180 v. 8.0 Interventions for promoting physical activity.rm5
CD003181 v. 6.0 Bile acids for viral hepatitis.rm5
CD003183 v. 6.0 Medicinal herbs for hepatitis C virus infection.rm5
CD003186 v. 7.0 Antiplatelet agents and anticoagulants for hypertension.rm5
CD003187 v. 11.0 Chemotherapy radiotherapy and combined modality for Hodgkin's disease with emphasis on second canc.rm5
CD003188 v. 16.0 Bisphosphonates in multiple myeloma an updated network meta-analysis.rm5
CD003189 v. 13.2 Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.rm5
CD003190 v. 7.0 Anticholinergic drugs versus other medications for overactive bladder syndrome in adults.rm5
CD003193 v. 7.0 Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrom.rm5
CD003195 v. 7.0 Urodynamic studies for management of urinary incontinence in children and adults.rm5
CD003196 v. 14.2 Valproic acid valproate and divalproex in the maintenance treatment of bipolar disorder.rm5
CD003197 v. 8.0 Low dosage tricyclic antidepressants for depression.rm5
CD003198 v. 8.0 Tryptophan and 5-Hydroxytryptophan for depression.rm5
CD003200 v. 16.0 Exercise therapy for chronic fatigue syndrome.rm5
CD003201 v. 5.1 School-based driver education for the prevention of traffic crashes.rm5
CD003204 v. 5.0 Iodised salt for preventing iodine deficiency disorders.rm5
CD003205 v. 4.0 Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus.rm5
CD003208 v. 6.0 Methotrexate for multiple sclerosis.rm5
CD003210 v. 7.2 Conservative treatment for closed fifth (small finger) metacarpal neck fractures.rm5
CD003211 v. 5.0 Feed thickener for infants up to six months of age with gastro-oesophageal reflux.rm5
CD003212 v. 7.0 Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pre.rm5
CD003213 v. 6.0 Dopamine versus no treatment to prevent renal dysfunction in indomethacin-treated preterm newborn in.rm5
CD003214 v. 8.0 Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants.rm5
CD003215 v. 5.0 Base administration or fluid bolus for preventing morbidity and mortality in preterm infants with me.rm5
CD003216 v. 9.0 Nutritional interventions for preventing and treating pressure ulcers.rm5
CD003217 v. 7.0 Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy.rm5
CD003218 v. 9.0 Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy.rm5
CD003219 v. 10.0 Non-surgical treatment (other than steroid injection) for carpal tunnel syndrome.rm5
CD003220 v. 6.0 Pulp treatment for extensive decay in primary teeth.rm5
CD003223 v. 12.2 Calcitonin for metastatic bone pain.rm5
CD003228 v. 7.0 Endovascular stents for intermittent claudication.rm5
CD003229 v. 6.0 Phlebotonics for venous insufficiency.rm5
CD003230 v. 10.0 Horse chestnut seed extract for chronic venous insufficiency.rm5
CD003232 v. 9.0 Interventions for renal vasculitis in adults.rm5
CD003233 v. 8.0 Immunosuppressive treatment for focal segmental glomerulosclerosis in adults.rm5
CD003234 v. 12.0 Cellulose modified cellulose and synthetic membranes in the haemodialysis of patients with end-stag.rm5
CD003235 v. 8.0 Emergency interventions for hyperkalaemia.rm5
CD003236 v. 7.0 Exercise training for adults with chronic kidney disease.rm5
CD003237 v. 8.0 Modes of administration of antibiotics for symptomatic severe urinary tract infections.rm5
CD003240 v. 7.0 Day hospital versus outpatient care for people with schizophrenia.rm5
CD003241 v. 6.0 Electrostimulation for promoting recovery of movement or functional ability after stroke.rm5
CD003242 v. 8.0 Anticoagulants versus antiplatelet agents for acute ischaemic stroke.rm5
CD003243 v. 7.0 Laparoscopic fundoplication surgery versus medical management for gastro-oesophageal reflux disease .rm5
CD003246 v. 6.0 Intravenous oxytocin alone for cervical ripening and induction of labour.rm5
CD003247 v. 6.0 Interventions for treating placental abruption.rm5
CD003248 v. 8.7 Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion .rm5
CD003249 v. 9.0 Treatment for primary postpartum haemorrhage.rm5
CD003250 v. 6.0 Amniotomy plus intravenous oxytocin for induction of labour.rm5
CD003252 v. 8.0 Amniocentesis and chorionic villus sampling for prenatal diagnosis.rm5
CD003253 v. 6.2 Cervical stitch (cerclage) for preventing pregnancy loss in women.rm5
CD003254 v. 10.0 Antibiotic regimens for management of intraamniotic infection.rm5
CD003255 v. 10.0 Condom effectiveness in reducing heterosexual HIV transmission.rm5
CD003256 v. 5.12 Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults.rm5
CD003257 v. 10.1 Symptomatic treatment of the cough in whooping cough.rm5
CD003260 v. 8.0 Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer's disease and vascula.rm5
CD003261 v. 8.2 Interventions for impetigo.rm5
CD003262 v. 11.7 Interventions for rosacea.rm5
CD003263 v. 13.0 Interventions for vitiligo.rm5
CD003264 v. 11.0 Growth hormone for children with chronic kidney disease.rm5
CD003265 v. 12.0 Methenamine hippurate for preventing urinary tract infections.rm5
CD003266 v. 13.0 Recombinant human erythropoietin versus placebo or no treatment for the anaemia of chronic kidney di.rm5
CD003267 v. 7.2 Interventions for providers to promote a patient-centred approach in clinical consultations.rm5
CD003268 v. 11.0 Dapsone as an oral corticosteroid sparing agent for asthma.rm5
CD003269 v. 8.0 Anticholinergic agents for chronic asthma in adults.rm5
CD003270 v. 9.2 Azathioprine as an oral corticosteroid sparing agent for asthma.rm5
CD003271 v. 5.0 Budesonide at different doses for chronic asthma.rm5
CD003272 v. 9.0 Psychological interventions for children with asthma.rm5
CD003273 v. 8.0 Colchicine as an oral corticosteroid sparing agent for asthma.rm5
CD003274 v. 4.0 Budesonide versus placebo for chronic asthma in children and adults.rm5
CD003275 v. 9.0 Chloroquine as a steroid sparing agent for asthma.rm5
CD003277 v. 16.2 Treatment of Lennox-Gastaut syndrome.rm5
CD003278 v. 8.0 Scapular fixation in muscular dystrophy.rm5
CD003279 v. 8.0 Treatment for Lambert-Eaton myasthenic syndrome.rm5
CD003280 v. 11.0 Immunomodulatory treatment other than corticosteroids immunoglobulin and plasma exchange for chroni.rm5
CD003281 v. 8.0 Stimulation of the wrist acupuncture point PC6 for preventing postoperative nausea and vomiting.rm5
CD003282 v. 5.3 Frameless versus classical intrauterine device for contraception.rm5
CD003283 v. 8.0 Biphasic versus triphasic oral contraceptives for contraception.rm5
CD003285 v. 6.0 Homocysteine lowering interventions for peripheral arterial disease and bypass grafts.rm5
CD003286 v. 4.0 Specialist nurses in diabetes mellitus.rm5
CD003287 v. 7.0 Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.rm5
CD003288 v. 6.0 Protein and energy supplementation in elderly people at risk from malnutrition.rm5
CD003289 v. 10.0 Tobacco cessation interventions for young people.rm5
CD003290 v. 7.0 Open general medical wards versus specialist psychiatric units for acute psychoses.rm5
CD003292 v. 8.0 Surgical resection and whole brain radiation therapy versus whole brain radiation therapy alone for .rm5
CD003293 v. 7.0 Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced .rm5
CD003295 v. 11.0 Prophylactic antibiotics for preventing Gram positive infections associated with long-term central v.rm5
CD003296 v. 9.0 Retinoids for preventing the progression of cervical intra-epithelial neoplasia.rm5
CD003297 v. 7.0 Mistletoe therapy in oncology.rm5
CD003298 v. 10.0 Nutritional support in children and young people with cancer undergoing chemotherapy.rm5
CD003299 v. 5.0 Pharmacological management for agitation and aggression in people with acquired brain injury.rm5
CD003300 v. 7.0 Graduated driver licensing for reducing motor vehicle crashes among young drivers.rm5
CD003303 v. 9.2 Reading aids for adults with low vision.rm5
CD003306 v. 10.2 Urinary diversion and bladder reconstructionreplacement using intestinal segments for intractable i.rm5
CD003309 v. 5.0 Deep versus shallow suction of endotracheal tubes in ventilated neonates and young infants.rm5
CD003310 v. 7.0 Calcium and phosphorus supplementation of human milk for preterm infants.rm5
CD003311 v. 8.4 Cooling for newborns with hypoxic ischaemic encephalopathy.rm5
CD003312 v. 4.0 Selenium supplementation to prevent short-term morbidity in preterm neonates.rm5
CD003313 v. 7.3 Immunoglobulin for alloimmune hemolytic disease in neonates.rm5
CD003314 v. 6.0 Laryngeal mask airway versus bag-mask ventilation or endotracheal intubation for neonatal resuscitat.rm5
CD003315 v. 5.2 Feeding interventions for growth and development in infants with cleft lip cleft palate or cleft li.rm5
CD003316 v. 8.0 Physical fitness training for stroke patients.rm5
CD003317 v. 5.2 Acupuncture for acute stroke.rm5
CD003318 v. 6.0 Strategies for integrating primary health services in low- and middle-income countries at the point .rm5
CD003320 v. 10.0 Anaesthesia for treating distal radial fracture in adults.rm5
CD003323 v. 7.0 Autologous chondrocyte implantation for full thickness articular cartilage defects of the knee.rm5
CD003324 v. 11.0 Rehabilitation for distal radial fractures in adults.rm5
CD003325 v. 9.0 Removal of nail polish and finger rings to prevent surgical infection.rm5
CD003326 v. 9.0 Tissue adhesives for traumatic lacerations in children and adults.rm5
CD003327 v. 7.0 Surgical versus endoscopic treatment of bile duct stones.rm5
CD003328 v. 8.0 Interventions for paracetamol (acetaminophen) overdose.rm5
CD003329 v. 4.2 Psychological interventions for depression in heart failure.rm5
CD003331 v. 9.0 Exercise-based rehabilitation for heart failure.rm5
CD003333 v. 12.0 Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm.rm5
CD003334 v. 7.0 Percutaneous transluminal rotational atherectomy for coronary artery disease.rm5
CD003336 v. 11.0 Anticoagulation versus placebo for heart failure in sinus rhythm.rm5
CD003338 v. 9.0 Conservative treatments for whiplash.rm5
CD003340 v. 7.0 Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization.rm5
CD003341 v. 6.0 High first dose quinine regimen for treating severe malaria.rm5
CD003343 v. 11.2 Directly observed therapy for treating tuberculosis.rm5
CD003344 v. 8.2 Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy .rm5
CD003345 v. 11.1 Systemic administration of local anesthetic agents to relieve neuropathic pain.rm5
CD003348 v. 11.0 Patient controlled opioid analgesia versus non-patient controlled opioid analgesia for postoperative.rm5
CD003351 v. 14.0 Ketamine as an adjuvant to opioids for cancer pain.rm5
CD003352 v. 10.0 Dopamine agonists for the treatment of cocaine dependence.rm5
CD003353 v. 9.2 Metoclopramide for post-pyloric placement of naso-enteral feeding tubes.rm5
CD003357 v. 8.0 In vitro fertilisation for unexplained subfertility.rm5
CD003361 v. 7.0 Beta-blocker therapy for tremor in Parkinson's disease.rm5
CD003362 v. 8.0 Male circumcision for prevention of heterosexual acquisition of HIV in men.rm5
CD003363 v. 5.2 Structural and community-level interventions for increasing condom use to prevent the transmission o.rm5
CD003366 v. 11.0 Taxane-containing regimens for metastatic breast cancer.rm5
CD003367 v. 9.0 Antitumour antibiotic containing regimens for metastatic breast cancer.rm5
CD003368 v. 12.0 Addition of drugs to a chemotherapy regimen for metastatic breast cancer.rm5
CD003370 v. 11.0 Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women.rm5
CD003372 v. 8.0 Single agent versus combination chemotherapy for metastatic breast cancer.rm5
CD003373 v. 8.0 Regular self-examination or clinical examination for early detection of breast cancer.rm5
CD003374 v. 10.0 Platinum-containing regimens for metastatic breast cancer.rm5
CD003376 v. 8.0 Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal wome.rm5
CD003380 v. 13.0 Cognitive behavioural therapy (CBT) third-wave CBT and interpersonal therapy (IPT) based interventi.rm5
CD003382 v. 13.0 Strategies for managing sexual dysfunction induced by antidepressant medication.rm5
CD003383 v. 13.2 Kava extract versus placebo for treating anxiety.rm5
CD003384 v. 12.0 Topiramate for acute affective episodes in bipolar disorder in adults.rm5
CD003385 v. 14.0 Antidepressants versus psychological treatments and their combination for bulimia nervosa.rm5
CD003387 v. 7.0 Transcranial magnetic stimulation for the treatment of obsessive-compulsive disorder.rm5
CD003388 v. 15.0 Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults.rm5
CD003390 v. 7.0 Folate for depressive disorders.rm5
CD003391 v. 7.0 Antidepressants versus placebo for people with bulimia nervosa.rm5
CD003392 v. 5.0 Breast stimulation for cervical ripening and induction of labour.rm5
CD003393 v. 6.0 Oestrogens alone or with amniotomy for cervical ripening or induction of labour.rm5
CD003395 v. 7.0 Treatments for gestational diabetes.rm5
CD003396 v. 8.0 Fetal manipulation for facilitating tests of fetal wellbeing.rm5
CD003397 v. 7.0 Maternal glucose administration for facilitating tests of fetal wellbeing.rm5
CD003399 v. 6.0 Homoeopathy for induction of labour.rm5
CD003401 v. 6.0 Combined spinal-epidural versus epidural analgesia in labour.rm5
CD003402 v. 7.0 Marine oil and other prostaglandin precursor supplementation for pregnancy uncomplicated by pre-ec.rm5
CD003403 v. 5.6 Bright light therapy for sleep problems in adults aged 60.rm5
CD003404 v. 5.4 Physical exercise for sleep problems in adults aged 60.rm5
CD003406 v. 6.0 Behavioural and cognitive-behavioural interventions for outwardly-directed aggressive behaviour in p.rm5
CD003407 v. 13.2 Erythropoietin or darbepoetin for patients with cancer.rm5
CD003408 v. 10.4 Pulmonary artery catheters for adult patients in intensive care.rm5
CD003409 v. 19.0 Methadone at tapered doses for the management of opioid withdrawal.rm5
CD003410 v. 20.2 Heroin maintenance for chronic heroin-dependent individuals.rm5
CD003412 v. 8.0 Interventions for basal cell carcinoma of the skin.rm5
CD003414 v. 6.0 Cycle regimens for frozen-thawed embryo transfer.rm5
CD003415 v. 8.0 Progesterone for premenstrual syndrome.rm5
CD003416 v. 7.0 Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection.rm5
CD003418 v. 5.0 Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with t.rm5
CD003419 v. 5.0 Thyroid hormone replacement for subclinical hypothyroidism.rm5
CD003420 v. 7.2 Antithyroid drug regimen for treating Graves' hyperthyroidism.rm5
CD003421 v. 8.0 Calcium channel blockers for preventing acute tubular necrosis in kidney transplant recipients.rm5
CD003422 v. 7.0 Vasodilators and vasoactive substances for idiopathic sudden sensorineural hearing loss.rm5
CD003423 v. 4.2 Antihistamines andor decongestants for otitis media with effusion (OME) in children.rm5
CD003424 v. 12.0 Drug therapies for reducing gastric acidity in people with cystic fibrosis.rm5
CD003425 v. 16.0 Splenectomy versus conservative management for acute sequestration crises in people with sickle cell.rm5
CD003426 v. 11.0 Drugs for preventing red blood cell dehydration in people with sickle cell disease.rm5
CD003427 v. 15.0 Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease.rm5
CD003429 v. 9.0 Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people .rm5
CD003430 v. 6.0 Dietary fibre for the prevention of recurrent colorectal adenomas and carcinomas.rm5
CD003431 v. 9.2 Non surgical therapy for anal fissure.rm5
CD003432 v. 5.0 Long-term results of laparoscopic colorectal cancer resection.rm5
CD003433 v. 7.0 Beta radiation for glaucoma surgery.rm5
CD003434 v. 9.0 Interventions for idiopathic intracranial hypertension.rm5
CD003435 v. 5.0 Surgical decompression for cerebral oedema in acute ischaemic stroke.rm5
CD003436 v. 4.0 Interventions for treating brain arteriovenous malformations in adults.rm5
CD003437 v. 4.2 Interventions for treating depression after stroke.rm5
CD003438 v. 9.8 Interventions for increasing pedestrian and cyclist visibility for the prevention of death and injur.rm5
CD003439 v. 6.5 Impact of tobacco advertising and promotion on increasing adolescent smoking behaviours.rm5
CD003440 v. 11.0 Workplace interventions for smoking cessation.rm5
CD003441 v. 8.3 'As required' medication regimens for seriously mentally ill people in hospital.rm5
CD003442 v. 4.0 Compliance therapy for schizophrenia.rm5
CD003443 v. 6.2 Perphenazine for schizophrenia.rm5
CD003444 v. 9.0 Chinese herbal medicine for schizophrenia.rm5
CD003445 v. 8.0 Supportive care for patients with gastrointestinal cancer.rm5
CD003448 v. 11.2 Laxatives for the management of constipation in people receiving palliative care.rm5
CD003449 v. 12.0 Treatment of vaginal bleeding irregularities induced by progestin only contraceptives.rm5
CD003451 v. 5.0 Orthodontic treatment for prominent lower front teeth (Class III malocclusion) in children.rm5
CD003452 v. 10.0 Orthodontic treatment for prominent upper front teeth (Class II malocclusion) in children and adoles.rm5
CD003455 v. 6.4 Non-surgical interventions for late rectal problems (proctopathy) of radiotherapy in people who have.rm5
CD003456 v. 8.0 Drug therapy for chronic idiopathic axonal polyneuropathy.rm5
CD003458 v. 8.0 Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V).rm5
CD003459 v. 9.0 Methotrexate for induction of remission in refractory Crohn's disease.rm5
CD003460 v. 9.0 Bulking agents antispasmodics and antidepressants for the treatment of irritable bowel syndrome.rm5
CD003462 v. 8.0 Heparin versus placebo for non-ST elevation acute coronary syndromes.rm5
CD003463 v. 7.0 Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection.rm5
CD003464 v. 9.0 Antiplatelet and anticoagulation for patients with prosthetic heart valves.rm5
CD003465 v. 6.0 Therapies for depression in Parkinson's disease.rm5
CD003466 v. 5.0 Speech and language therapy to improve the communication skills of children with cerebral palsy.rm5
CD003467 v. 6.0 Amantadine for dyskinesia in Parkinson's disease.rm5
CD003468 v. 4.0 Amantadine in Parkinson's disease.rm5
CD003469 v. 7.0 Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with sp.rm5
CD003470 v. 3.0 Pharmacotherapy for patellofemoral pain syndrome.rm5
CD003474 v. 16.3 Bisphosphonates and other bone agents for breast cancer.rm5
CD003475 v. 9.6 Manual lymphatic drainage for lymphedema following breast cancer treatment.rm5
CD003476 v. 10.0 Atypical antipsychotics for aggression and psychosis in Alzheimer's disease.rm5
CD003477 v. 9.0 Music-based therapeutic interventions for people with dementia.rm5
CD003478 v. 7.0 Prophylactic oraltopical non-absorbed antifungal agents to prevent invasive fungal infection in ver.rm5
CD003480 v. 5.0 Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in prete.rm5
CD003481 v. 10.0 Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) inf.rm5
CD003482 v. 4.0 Supplemental oxygen for the treatment of prethreshold retinopathy of prematurity.rm5
CD003483 v. 6.3 Naloxone for opiate-exposed newborn infants.rm5
CD003484 v. 5.0 Dopamine for prevention of morbidity and mortality in term newborn infants with suspected perinatal .rm5
CD003485 v. 3.0 Steroid therapy for meconium aspiration syndrome in newborn infants.rm5
CD003486 v. 3.0 Lung lavage for meconium aspiration syndrome in newborn infants.rm5
CD003487 v. 5.2 Transpyloric versus gastric tube feeding for preterm infants.rm5
CD003488 v. 8.0 Corticosteroids for dengue infection.rm5
CD003489 v. 5.2 Malaria chemoprophylaxis in sickle cell disease.rm5
CD003490 v. 10.0 Low level laser therapy for treating tuberculosis.rm5
CD003491 v. 11.0 Antidepressants for depressed elderly.rm5
CD003492 v. 10.0 Lithium versus antidepressants in the long-term treatment of unipolar affective disorder.rm5
CD003493 v. 10.0 Transcranial magnetic stimulation for treating depression.rm5
CD003494 v. 11.0 Psychosocial interventions by general practitioners.rm5
CD003495 v. 5.2 Intravenous secretin for autism spectrum disorders (ASD).rm5
CD003497 v. 5.0 Combined vitamin B6-magnesium treatment in autism spectrum disorder.rm5
CD003498 v. 6.0 Gluten- and casein-free diets for autistic spectrum disorder.rm5
CD003499 v. 5.2 Antiepileptics for aggression and associated impulsivity.rm5
CD003504 v. 7.0 Intravascular brachytherapy for peripheral vascular disease.rm5
CD003505 v. 7.0 Lifestyle interventions for the treatment of urinary incontinence in adults.rm5
CD003506 v. 5.0 Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.rm5
CD003508 v. 5.0 Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection.rm5
CD003510 v. 8.0 Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.rm5
CD003511 v. 9.0 Progestogen for preventing miscarriage.rm5
CD003514 v. 7.0 Bed rest with or without hospitalisation for hypertension during pregnancy.rm5
CD003515 v. 5.0 Low-dose dopamine for women with severe pre-eclampsia.rm5
CD003516 v. 5.0 Early compared with delayed oral fluids and food after caesarean section.rm5
CD003517 v. 5.0 Optimal duration of exclusive breastfeeding.rm5
CD003518 v. 8.0 Expectant care versus surgical treatment for miscarriage.rm5
CD003519 v. 7.2 Early skin-to-skin contact for mothers and their healthy newborn infants.rm5
CD003520 v. 7.0 Vaginal chlorhexidine during labour to prevent early-onset neonatal group B streptococcal infection.rm5
CD003521 v. 5.0 Complementary and alternative therapies for pain management in labour.rm5
CD003522 v. 4.0 Post-operative therapy for metacarpophalangeal arthroplasty.rm5
CD003523 v. 7.0 Electromagnetic fields for treating osteoarthritis.rm5
CD003524 v. 8.0 Shock wave therapy for lateral elbow pain.rm5
CD003525 v. 7.0 Surgery for lateral elbow pain.rm5
CD003526 v. 11.0 Preoperative education for hip or knee replacement.rm5
CD003527 v. 5.0 Acupuncture for lateral elbow pain.rm5
CD003528 v. 6.61 Deep transverse friction massage for treating lateral elbow or lateral knee tendinitis.rm5
CD003530 v. 5.0 Beclomethasone versus budesonide for chronic asthma.rm5
CD003531 v. 6.0 Pressure modification for improving usage of continuous positive airway pressure machines in adults .rm5
CD003533 v. 5.0 Primary care based clinics for asthma.rm5
CD003534 v. 9.2 Fluticasone at different doses for chronic asthma in adults and children.rm5
CD003535 v. 11.0 Anticholinergic therapy for chronic asthma in children over two years of age.rm5
CD003536 v. 7.0 Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis.rm5
CD003537 v. 4.0 Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary d.rm5
CD003538 v. 5.0 Selenium supplementation for asthma.rm5
CD003539 v. 7.0 Interventions to improve antibiotic prescribing practices in ambulatory care.rm5
CD003540 v. 6.0 Interventions to increase or decrease the length of primary care physicians' consultation.rm5
CD003543 v. 12.0 Interventions to improve antibiotic prescribing practices for hospital inpatients.rm5
CD003544 v. 6.0 Pharmacological treatments for psychosis-related polydipsia.rm5
CD003545 v. 7.0 Trifluoperazine for schizophrenia.rm5
CD003546 v. 7.0 Management of sexual dysfunction due to antipsychotic drug therapy.rm5
CD003548 v. 9.0 Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps.rm5
CD003550 v. 11.0 Nonlatex versus latex male condoms for contraception.rm5
CD003551 v. 9.0 Cervical cap versus diaphragm for contraception.rm5
CD003552 v. 9.0 Skin patch and vaginal ring versus combined oral contraceptives for contraception.rm5
CD003553 v. 10.2 Triphasic versus monophasic oral contraceptives for contraception.rm5
CD003554 v. 11.0 Dressings and topical agents for surgical wounds healing by secondary intention.rm5
CD003556 v. 14.0 Debridement of diabetic foot ulcers.rm5
CD003557 v. 10.0 Antibiotics and antiseptics for venous leg ulcers.rm5
CD003558 v. 5.0 Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma.rm5
CD003559 v. 6.4 Omalizumab for asthma in adults and children.rm5
CD003562 v. 7.0 Phosphodiesterase 5 inhibitors for pulmonary hypertension.rm5
CD003563 v. 7.0 Dehumidifiers for chronic asthma.rm5
CD003564 v. 5.3 Beta2-agonists for exercise-induced asthma.rm5
CD003566 v. 6.0 Cardioselective beta-blockers for chronic obstructive pulmonary disease.rm5
CD003570 v. 5.0 Intranasal corticosteroids for asthma control in people with coexisting asthma and rhinitis.rm5
CD003571 v. 4.0 Heliox for treatment of exacerbations of chronic obstructive pulmonary disease.rm5
CD003572 v. 8.0 Short acting beta2-agonists for bronchiectasis.rm5
CD003573 v. 8.6 Hospital at home for acute exacerbations of chronic obstructive pulmonary disease.rm5
CD003574 v. 7.0 Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease.rm5
CD003575 v. 15.0 Interventions for treating collagenous colitis.rm5
CD003576 v. 6.0 Bed rest during pregnancy for preventing miscarriage.rm5
CD003577 v. 11.6 Techniques and materials for skin closure in caesarean section.rm5
CD003580 v. 7.0 Heparin for pregnant women with acquired or inherited thrombophilias.rm5
CD003581 v. 7.0 Bed rest in singleton pregnancies for preventing preterm birth.rm5
CD003582 v. 10.0 Elective birth at 37 weeks gestation for women with an uncomplicated twin pregnancy.rm5
CD003583 v. 6.0 Interventions for melasma.rm5
CD003584 v. 8.0 Oral treatments for fungal infections of the skin of the foot.rm5
CD003585 v. 6.0 Occupational therapy for adults with problems in activities of daily living after stroke.rm5
CD003586 v. 5.0 Cognitive rehabilitation for spatial neglect following stroke.rm5
CD003587 v. 11.0 Fast-track cardiac care for adult cardiac surgical patients.rm5
CD003588 v. 6.0 Optimal timing for intravascular administration set replacement.rm5
CD003590 v. 9.0 Interventions for protecting renal function in the perioperative period.rm5
CD003591 v. 8.3 Nonsteroidal anti-inflammatory drugs and perioperative bleeding in paediatric tonsillectomy.rm5
CD003593 v. 9.0 Electroconvulsive therapy for the depressed elderly.rm5
CD003594 v. 13.2 Interventions for idiopathic steroid-resistant nephrotic syndrome in children.rm5
CD003595 v. 5.6 Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura.rm5
CD003597 v. 6.0 Quinolones for uncomplicated acute cystitis in women.rm5
CD003598 v. 8.0 Antihypertensive treatment for kidney transplant recipients.rm5
CD003599 v. 7.0 Diuretics for Mnire's disease or syndrome.rm5
CD003600 v. 10.6 Modification of the home environment for the reduction of injuries.rm5
CD003602 v. 6.0 Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion.rm5
CD003603 v. 7.0 Interventions for replacing missing teeth hyperbaric oxygen therapy for irradiated patients who req.rm5
CD003607 v. 10.0 Interventions for replacing missing teeth horizontal and vertical bone augmentation techniques for .rm5
CD003608 v. 5.0 Occupational therapy for multiple sclerosis.rm5
CD003611 v. 7.0 Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.rm5
CD003615 v. 9.0 Oxcarbazepine versus phenytoin monotherapy for epilepsy.rm5
CD003617 v. 6.55 Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.rm5
CD003619 v. 6.0 Weight reduction for non-alcoholic fatty liver disease.rm5
CD003620 v. 10.3 Milk thistle for alcoholic andor hepatitis B or C virus liver diseases.rm5
CD003623 v. 5.0 Percutaneous needle aspiration injection and re-aspiration with or without benzimidazole coverage .rm5
CD003626 v. 6.0 Bile acids for primary sclerosing cholangitis.rm5
CD003628 v. 6.0 Artificial and bioartificial support systems for liver failure.rm5
CD003631 v. 8.20 Chinese herbal medicines for acute pancreatitis.rm5
CD003633 v. 4.0 Botulinum toxin type A therapy for cervical dystonia.rm5
CD003634 v. 4.0 Bromocriptinelevodopa combined versus levodopa alone for early Parkinson's disease.rm5
CD003635 v. 9.0 Cerebrospinal fluid drainage for thoracic and thoracoabdominal aortic aneurysm surgery.rm5
CD003636 v. 7.0 Bladder neck needle suspension for urinary incontinence in women.rm5
CD003637 v. 6.0 Simple behavioural interventions for nocturnal enuresis in children.rm5
CD003638 v. 4.0 Interventions for improving adherence to treatment recommendations in people with type 2 diabetes me.rm5
CD003639 v. 6.0 Alpha-glucosidase inhibitors for type 2 diabetes mellitus.rm5
CD003641 v. 12.0 Surgery for weight loss in adults.rm5
CD003642 v. 3.0 Chinese herbal medicines for type 2 diabetes mellitus.rm5
CD003643 v. 11.0 Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.rm5
CD003645 v. 10.0 Positioning for acute respiratory distress in hospitalised infants and children.rm5
CD003648 v. 9.0 Vitamin A supplements for reducing mother-to-child HIV transmission.rm5
CD003650 v. 9.0 Micronutrient supplementation in adults with HIV infection.rm5
CD003651 v. 7.0 Vaginal disinfection for preventing mother-to-child transmission of HIV infection.rm5
CD003653 v. 8.0 Pharmacological interventions for hypertensive emergencies.rm5
CD003654 v. 7.0 Calcium channel blockers versus other classes of drugs for hypertension.rm5
CD003656 v. 9.0 Advice to reduce dietary salt for prevention of cardiovascular disease.rm5
CD003658 v. 6.2 Needling for encapsulated trabeculectomy filtering blebs.rm5
CD003659 v. 8.0 Face washing promotion for preventing active trachoma.rm5
CD003662 v. 6.0 Corticosteroids for treating hypotension in preterm infants.rm5
CD003665 v. 7.0 Vitamin E supplementation for prevention of morbidity and mortality in preterm infants.rm5
CD003666 v. 7.2 Volume-targeted versus pressure-limited ventilation in neonates.rm5
CD003667 v. 4.0 Intramuscular penicillin for the prevention of early onset group B streptococcal infection in newbor.rm5
CD003668 v. 9.0 Infant position in neonates receiving mechanical ventilation.rm5
CD003669 v. 4.0  Regional (spinal epidural caudal) versus general anaesthesia in preterm infants undergoing inguin.rm5
CD003670 v. 9.0 Gowning by attendants and visitors in newborn nurseries for prevention of neonatal morbidity and mor.rm5
CD003671 v. 5.2 Ward reduction without general anaesthesia versus reduction and repair under general anaesthesia for.rm5
CD003672 v. 7.0 Cholinesterase inhibitors for dementia with Lewy bodies.rm5
CD003673 v. 6.0 Indomethacin for Alzheimer's disease.rm5
CD003674 v. 7.2 Surgical interventions for treating acute Achilles tendon ruptures.rm5
CD003676 v. 7.0 Paracetamol versus placebo or physical methods for treating fever in children.rm5
CD003677 v. 9.0 Surgical approach to hysterectomy for benign gynaecological disease.rm5
CD003678 v. 6.0 Pre and post-operative medical therapy for endometriosis surgery.rm5
CD003680 v. 14.0 Group-based parent training programmes for improving emotional and behavioural adjustment in young c.rm5
CD003681 v. 7.2 Auditory integration training and other sound therapies for autism spectrum disorders (ASD).rm5
CD003682 v. 5.0 Interventions for learning disabled sex offenders.rm5
CD003683 v. 6.0 Exercise to improve self-esteem in children and young people.rm5
CD003685 v. 8.0 Rofecoxib for rheumatoid arthritis.rm5
CD003686 v. 7.0 Non-steroidal anti-inflammatory drugs (NSAIDs) for treating lateral elbow pain in adults.rm5
CD003687 v. 7.0 Electrical stimulation for the treatment of rheumatoid arthritis.rm5
CD003688 v. 7.0 Patient education for adults with rheumatoid arthritis.rm5
CD003689 v. 5.2 Interventions for preventing depression after stroke.rm5
CD003690 v. 6.0 Pharmaceutical interventions for emotionalism after stroke.rm5
CD003691 v. 5.0 Ginkgo biloba for acute ischaemic stroke.rm5
CD003692 v. 4.0 Fibrinolytic therapy for intraventricular hemorrhage in adults.rm5
CD003693 v. 6.0 Thrombolysis for cerebral vein and dural sinus thrombosis.rm5
CD003697 v. 6.0 Statins and fibrates for preventing melanoma.rm5
CD003698 v. 6.2 Community pharmacy personnel interventions for smoking cessation.rm5
CD003699 v. 10.0 Continuous negative extrathoracic pressure or continuous positive airway pressure compared to conven.rm5
CD003700 v. 11.3 Vitamin A for non-measles pneumonia in children.rm5
CD003703 v. 8.0 Selenium supplementation for critically ill adults.rm5
CD003707 v. 7.0 Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and a.rm5
CD003709 v. 6.0 Vasopressors for hypotensive shock.rm5
CD003710 v. 6.0 Dual chamber versus single chamber ventricular pacemakers for sick sinus syndrome and atrioventricul.rm5
CD003712 v. 5.0 Transmyocardial laser revascularization versus medical therapy for refractory angina.rm5
CD003715 v. 8.0 Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease.rm5
CD003716 v. 6.0 Written and verbal information versus verbal information only for patients being discharged from acu.rm5
CD003717 v. 7.2 Audio-visual presentation of information for informed consent for participation in clinical trials.rm5
CD003718 v. 9.1 Tubal flushing for subfertility.rm5
CD003719 v. 10.0 Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in I.rm5
CD003720 v. 5.0 Timing of breast surgery in premenopausal breast cancer patients.rm5
CD003721 v. 7.2 Cancer genetic risk assessment for individuals at risk of familial breast cancer.rm5
CD003723 v. 7.9 Anticonvulsant therapy for status epilepticus.rm5
CD003724 v. 6.0 Antidepressant drugs for narcolepsy.rm5
CD003725 v. 10.0 Corticosteroids for the treatment of Duchenne muscular dystrophy.rm5
CD003726 v. 8.0 Tramadol for neuropathic pain in adults.rm5
CD003727 v. 9.0 Anticholinergics for neuroleptic-induced acute akathisia.rm5
CD003728 v. 5.0 Art therapy for schizophrenia or schizophrenia-like illnesses.rm5
CD003729 v. 7.0 Olanzapine IM or velotab for acutely disturbedagitated people with suspected serious mental illness.rm5
CD003730 v. 10.0 Glutamatergic drugs for schizophrenia.rm5
CD003733 v. 13.0 Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease.rm5
CD003734 v. 8.0 Post-licence driver education for the prevention of road traffic crashes.rm5
CD003735 v. 3.0 Anticholinergics for symptomatic management of Parkinsons disease.rm5
CD003737 v. 8.2 Interventions for intermittent exotropia.rm5
CD003738 v. 6.0 Interventions for preventing posterior capsule opacification.rm5
CD003740 v. 7.0 Oral immunoglobulin for the prevention of rotavirus infection in low birth weight infants.rm5
CD003741 v. 7.0 Soy formula for prevention of allergy and food intolerance in infants.rm5
CD003742 v. 8.0 Oral immunoglobulin for the treatment of rotavirus diarrhea in low birth weight infants.rm5
CD003743 v. 8.0 Early discharge with home support of gavage feeding for stable preterm infants who have not establis.rm5
CD003744 v. 3.0 Erythromycin for the prevention of chronic lung disease in intubated preterm infants at risk for or.rm5
CD003745 v. 5.0 Indomethacin for asymptomatic patent ductus arteriosus in preterm infants.rm5
CD003746 v. 5.1 Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboem.rm5
CD003747 v. 10.0 Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stro.rm5
CD003748 v. 7.1 Cilostazol for intermittent claudication.rm5
CD003749 v. 7.0 Type of incision for below knee amputation.rm5
CD003750 v. 6.0 Interventions for the physical aspects of sexual dysfunction in women following pelvic radiotherapy.rm5
CD003751 v. 9.0 Communication skills training for healthcare professionals working with people who have cancer.rm5
CD003752 v. 7.0 Chemoradiation for advanced primary vulval cancer.rm5
CD003753 v. 8.0 Albendazole for lymphatic filariasis.rm5
CD003754 v. 7.8 Oral rehydration salt solution for treating cholera  270 mOsmL solutions vs  310 mOsmL solution.rm5
CD003755 v. 10.0 Insecticide-treated nets for preventing malaria in pregnancy.rm5
CD003756 v. 6.2 Intermittent preventive treatment for malaria in children living in areas with seasonal transmission.rm5
CD003758 v. 5.0 Diethylcarbamazine (DEC)-medicated salt for community-based control of lymphatic filariasis.rm5
CD003760 v. 8.3 Behavioural and cognitive behavioural training interventions for assisting foster carers in the mana.rm5
CD003763 v. 9.0 Closed reduction methods for treating distal radial fractures in adults.rm5
CD003764 v. 5.0 Antibiotics for preventing infection in open limb fractures.rm5
CD003765 v. 7.0 Spinal versus epidural anaesthesia for caesarean section.rm5
CD003766 v. 14.0 Continuous support for women during childbirth.rm5
CD003767 v. 8.5 Antibiotics for ureaplasma in the vagina in pregnancy.rm5
CD003769 v. 9.0 Antibiotic prophylaxis for hernia repair..rm5
CD003770 v. 6.0 Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer .rm5
CD003772 v. 13.0 Antibiotics for acute pyelonephritis in children.rm5
CD003773 v. 8.0 Intermittent versus continuous renal replacement therapy for acute renal failure in adults.rm5
CD003774 v. 13.0 Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.rm5
CD003775 v. 3.0 Hepatitis B vaccination for patients with chronic renal failure.rm5
CD003778 v. 4.0 Glucocorticosteroids for primary biliary cirrhosis.rm5
CD003781 v. 6.0 Anticholinergic drugs versus placebo for overactive bladder syndrome in adults.rm5
CD003782 v. 9.0 Parasympathomimetic drugs for the treatment of salivary gland dysfunction due to radiotherapy.rm5
CD003785 v. 7.0 Infliximab for the treatment of rheumatoid arthritis.rm5
CD003786 v. 7.0 Exercise for treating fibromyalgia syndrome.rm5
CD003787 v. 7.0 Therapeutic ultrasound for the treatment of rheumatoid arthritis.rm5
CD003788 v. 7.0 Acupuncture and electroacupuncture for the treatment of rheumatoid arthritis.rm5
CD003789 v. 6.0 Paracetamol versus nonsteroidal anti-inflammatory drugs for rheumatoid arthritis.rm5
CD003792 v. 8.0 Inspiratory muscle training for asthma.rm5
CD003793 v. 9.0 Pulmonary rehabilitation for chronic obstructive pulmonary disease.rm5
CD003794 v. 15.0 Combined corticosteroid and long-acting beta2-agonist in one inhaler versus placebo for chronic obst.rm5
CD003797 v. 7.2 Anticholinergic therapy for acute asthma in children.rm5
CD003798 v. 5.0 Specialist outreach clinics in primary care and rural hospital settings..rm5
CD003799 v. 5.2 Hormone replacement therapy to maintain cognitive function in women with dementia.rm5
CD003802 v. 9.0 Melatonin for the treatment of dementia.rm5
CD003803 v. 9.4 Homeopathy for dementia.rm5
CD003804 v. 8.0 Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and d.rm5
CD003805 v. 10.0 Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma.rm5
CD003807 v. 5.2 Interventions for preventing oral candidiasis for patients with cancer receiving treatment.rm5
CD003808 v. 6.0 Operative caries management in adults and children.rm5
CD003809 v. 5.0 Fluorides for the prevention of early tooth decay (demineralised white lesions) during fixed brace t.rm5
CD003811 v. 6.0 Antibiotics to prevent complications following tooth extractions.rm5
CD003813 v. 5.0 Antibiotics for the prophylaxis of bacterial endocarditis in dentistry.rm5
CD003814 v. 5.2 Interventions for replacing missing teeth partially absent dentition.rm5
CD003815 v. 12.0 Interventions for replacing missing teeth different types of dental implants.rm5
CD003816 v. 4.9 'Human' insulin versus animal insulin in people with diabetes mellitus.rm5
CD003817 v. 5.2 Exercise for overweight or obesity.rm5
CD003819 v. 4.2 Iodine supplementation for preventing iodine deficiency disorders in children.rm5
CD003822 v. 7.0 Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension.rm5
CD003823 v. 7.0 Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hyper.rm5
CD003824 v. 8.0 Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension.rm5
CD003825 v. 10.0 Blood pressure-lowering efficacy of loop diuretics for primary hypertension.rm5
CD003826 v. 8.0 Silicone gel sheeting for preventing and treating hypertrophic and keloid scars.rm5
CD003828 v. 8.0 Posterior versus lateral surgical approach for total hip arthroplasty in adults with osteoarthritis.rm5
CD003833 v. 10.0 Omega-3 fatty acids for intermittent claudication.rm5
CD003834 v. 6.0 Lithium for schizophrenia.rm5
CD003836 v. 6.0 Bed rest for acute uncomplicated myocardial infarction.rm5
CD003839 v. 8.0 Self-monitoring and self-management of oral anticoagulation.rm5
CD003840 v. 11.0 Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people.rm5
CD003842 v. 7.0 Single double or multiple-injection techniques for non-ultrasound guided axillary brachial plexus b.rm5
CD003843 v. 9.0 Bispectral index for improving anaesthetic delivery and postoperative recovery.rm5
CD003844 v. 7.0 Lung protective ventilation strategy for the acute respiratory distress syndrome.rm5
CD003845 v. 7.0 Partial liquid ventilation for the prevention of mortality and morbidity in paediatric acute lung in.rm5
CD003846 v. 3.0 Early intravenous nutrition for the prevention of neonatal jaundice.rm5
CD003848 v. 4.0 Replacement of estrogens and progestins to prevent morbidity and mortality in preterm infants.rm5
CD003849 v. 7.0 Epinephrine for the resuscitation of apparently stillborn or extremely bradycardic newborn infants.rm5
CD003850 v. 10.0 Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight .rm5
CD003852 v. 7.0 Ginkgo biloba for tinnitus.rm5
CD003853 v. 7.2 Antidepressants for patients with tinnitus.rm5
CD003854 v. 7.0 Single versus double intrauterine insemination (IUI) in stimulated cycles for subfertile couples.rm5
CD003855 v. 7.0 Surgery versus medical therapy for heavy menstrual bleeding.rm5
CD003857 v. 6.0 Surgical treatment of fibroids for subfertility.rm5
CD003858 v. 4.0 Information for pregnant women about caesarean birth.rm5
CD003859 v. 4.0 Disclosing to parents newborn carrier status identified by routine blood spot screening.rm5
CD003860 v. 10.0 Hypofractionated radiation therapy for early breast cancer.rm5
CD003861 v. 13.0 Water for wound cleansing.rm5
CD003862 v. 8.0 Red-light cameras for the prevention of road traffic crashes.rm5
CD003863 v. 3.0 Supportive devices for preventing and treating subluxation of the shoulder after stroke.rm5
CD003864 v. 5.2 Staff-led interventions for improving oral hygiene in patients following stroke.rm5
CD003867 v. 11.0 Single dose dipyrone for acute renal colic pain.rm5
CD003868 v. 17.0 Oral morphine for cancer pain.rm5
CD003869 v. 12.0 Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases.rm5
CD003870 v. 14.0 Oxycodone for cancer-related pain.rm5
CD003871 v. 9.0 Interventions to reduce Staphylococcus aureus in the management of atopic eczema.rm5
CD003873 v. 5.0 Interventions for growth failure in childhood Crohn's disease.rm5
CD003875 v. 8.3 Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects.rm5
CD003876 v. 7.0 Fluoridated milk for preventing dental caries.rm5
CD003877 v. 6.0 Sedation of children undergoing dental treatment.rm5
CD003878 v. 10.2 Interventions for replacing missing teeth different times for loading dental implants.rm5
CD003879 v. 6.2 Surgical removal versus retention for the management of asymptomatic disease-free impacted wisdom te.rm5
CD003880 v. 11.0 Radiotherapy for malignant pleural mesothelioma.rm5
CD003881 v. 8.6 Urethral injection therapy for urinary incontinence in women.rm5
CD003882 v. 6.0 Conservative prevention and management of pelvic organ prolapse in women.rm5
CD003884 v. 11.0 Oxygen therapy for cystic fibrosis.rm5
CD003885 v. 9.2 Pneumococcal vaccines for sickle cell disease.rm5
CD003887 v. 5.0 Recombinant growth hormone for children and adolescents with Turner syndrome.rm5
CD003892 v. 4.0 Chitosan for overweight or obesity.rm5
CD003893 v. 8.0 Methyldopa for primary hypertension.rm5
CD003895 v. 14.0 Frequency of administration of erythropoiesis-stimulating agents for the anaemia of end-stage kidney.rm5
CD003897 v. 12.0 Interleukin 2 receptor antagonists for kidney transplant recipients.rm5
CD003898 v. 9.0 Inhaled magnesium sulfate in the treatment of acute asthma.rm5
CD003900 v. 7.0 Anticholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chron.rm5
CD003901 v. 5.0 Regular treatment with long acting beta agonists versus daily regular treatment with short acting be.rm5
CD003902 v. 6.0 Oral theophylline for chronic obstructive pulmonary disease.rm5
CD003904 v. 10.0 Exercise for people with peripheral neuropathy.rm5
CD003905 v. 9.0 Surgical treatment options for carpal tunnel syndrome.rm5
CD003906 v. 11.0 Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.rm5
CD003907 v. 6.2 Strength training and aerobic exercise training for muscle disease.rm5
CD003909 v. 14.4 Individual psychological therapy in the outpatient treatment of adults with anorexia nervosa.rm5
CD003911 v. 7.0 Short versus long duration infusions of paclitaxel for any advanced adenocarcinoma.rm5
CD003913 v. 6.0 Chemotherapy for high-grade glioma.rm5
CD003914 v. 13.0 Empirical antibiotics targeting gram-positive bacteria for the treatment of febrile neutropenic pati.rm5
CD003915 v. 10.0 Chemotherapy for advanced recurrent or metastatic endometrial carcinoma.rm5
CD003916 v. 10.0 Adjuvant radiotherapy for stage I endometrial cancer.rm5
CD003917 v. 15.0 Cardioprotective interventions for cancer patients receiving anthracyclines.rm5
CD003918 v. 7.0 Concomitant hydroxyurea plus radiotherapy versus radiotherapy for carcinoma of the uterine cervix.rm5
CD003919 v. 3.0 Laser trabeculoplasty for open angle glaucoma.rm5
CD003925 v. 6.0 Orientation and mobility training for adults with low vision.rm5
CD003927 v. 8.0 Oral betamimetics for maintenance therapy after threatened preterm labour.rm5
CD003928 v. 7.0 Cephalic version by moxibustion for breech presentation.rm5
CD003930 v. 9.1 Restricting oral fluid and food intake during labour.rm5
CD003931 v. 4.0 Rectal analgesia for pain from perineal trauma following childbirth.rm5
CD003932 v. 13.0 Reduction of the number of fetuses for women with a multiple pregnancy.rm5
CD003933 v. 8.0 Terbutaline pump maintenance therapy after threatened preterm labor for preventing preterm birth.rm5
CD003934 v. 5.0 Maternal positions and mobility during first stage labour.rm5
CD003935 v. 13.0 Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal h.rm5
CD003936 v. 6.0 Nonoxynol-9 for preventing vaginal acquisition of HIV infection by women from men.rm5
CD003937 v. 5.0 Herbal medicines for treating HIV infection and AIDS.rm5
CD003938 v. 6.0 Provider training and experience for people living with HIVAIDS.rm5
CD003939 v. 5.0 Nonoxynol-9 for preventing vaginal acquisition of sexually transmitted infections by women from men.rm5
CD003940 v. 6.0 Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV inf.rm5
CD003941 v. 9.2 Patient reminder and recall interventions to improve immunization rates.rm5
CD003942 v. 6.0 Professional structural and organisational interventions in primary care for reducing medication er.rm5
CD003943 v. 6.0 Gastrostomy feeding versus oral feeding alone for children with cerebral palsy.rm5
CD003944 v. 5.0 Antidepressants for treating depression in dementia.rm5
CD003945 v. 9.0 Valproate preparations for agitation in dementia.rm5
CD003946 v. 11.0 Light therapy for improving cognition activities of daily living sleep challenging behaviour and.rm5
CD003948 v. 11.0 Topical agents and dressings for fungating wounds.rm5
CD003949 v. 9.0 Preoperative skin antiseptics for preventing surgical wound infections after clean surgery.rm5
CD003951 v. 6.0 Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arter.rm5
CD003952 v. 6.0 Nasal versus oral route for placing feeding tubes in preterm or low birth weight infants.rm5
CD003953 v. 4.0 Antifungal therapy for newborn infants with invasive fungal infection.rm5
CD003954 v. 4.0 Diazepam for treating tetanus.rm5
CD003955 v. 4.2 Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks' gestati.rm5
CD003956 v. 8.0 Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropenia.rm5
CD003957 v. 3.0 Prophylactic versus selective antibiotics for term newborn infants of mothers with risk factors for .rm5
CD003958 v. 4.0 Adrenaline for prevention of morbidity and mortality in preterm infants with cardiovascular compromi.rm5
CD003959 v. 5.1 Higher versus lower protein intake in formula-fed low birth weight infants.rm5
CD003960 v. 7.0 Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.rm5
CD003961 v. 9.0 Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients.rm5
CD003962 v. 6.0 Non-immunosuppressive treatment for IgA nephropathy.rm5
CD003963 v. 14.0 Continuous ambulatory peritoneal dialysis (CAPD) versus hospital or home haemodialysis for end-stage.rm5
CD003964 v. 12.0 Interventions for preventing infection in nephrotic syndrome.rm5
CD003965 v. 12.3 Immunosuppressive agents for treating IgA nephropathy.rm5
CD003966 v. 12.0 Short versus standard duration oral antibiotic therapy for acute urinary tract infection in children.rm5
CD003967 v. 11.0 Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease.rm5
CD003968 v. 16.0 Psychological therapies for the management of chronic and recurrent pain in children and adolescents.rm5
CD003971 v. 13.0 Methadone for cancer pain.rm5
CD003974 v. 5.0 Placebo interventions for all clinical conditions.rm5
CD003976 v. 6.0 Pharmacological interventions for pain relief during orthodontic treatment.rm5
CD003978 v. 7.0 Prescription of prosthetic ankle-foot mechanisms after lower limb amputation.rm5
CD003980 v. 8.0 Exercise therapy for multiple sclerosis.rm5
CD003982 v. 5.0 Azathioprine for multiple sclerosis.rm5
CD003983 v. 6.0 Decompressive craniectomy for the treatment of refractory high intracranial pressure in traumatic br.rm5
CD003984 v. 7.0 Monoaminergic agonists for acute traumatic brain injury.rm5
CD003985 v. 8.0 Non-legislative interventions for the promotion of cycle helmet wearing by children.rm5
CD003986 v. 6.0 Excitatory amino acid inhibitors for traumatic brain injury.rm5
CD003987 v. 10.0 Combination contraceptives effects on weight.rm5
CD003988 v. 12.0 Combined hormonal versus nonhormonal versus progestin-only contraception in lactation.rm5
CD003989 v. 12.0 20 g versus 20 g estrogen combined oral contraceptives for contraception.rm5
CD003990 v. 9.0 Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2.rm5
CD003991 v. 11.0 Vasectomy occlusion techniques for male sterilization.rm5
CD003992 v. 10.0 Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients.rm5
CD003993 v. 9.0 Thymic peptides for treatment of cancer patients.rm5
CD003996 v. 7.0 Antibiotic prophylaxis in clean and clean-contaminated ear surgery.rm5
CD003997 v. 5.2 Steroids for improving recovery following tonsillectomy in children.rm5
CD003998 v. 5.0 Steroids for idiopathic sudden sensorineural hearing loss.rm5
CD003999 v. 7.0 Relapse prevention interventions for smoking cessation.rm5
CD004000 v. 5.0 Intravenous immunoglobulin for the treatment of Kawasaki disease in children.rm5
CD004001 v. 7.0 Spinal cord stimulation for non-reconstructable chronic critical leg ischaemia.rm5
CD004002 v. 9.0 Compression stockings for preventing deep vein thrombosis in airline passengers.rm5
CD004003 v. 7.3 Environmental sanitary interventions for preventing active trachoma.rm5
CD004004 v. 4.2 Radiotherapy for neovascular age-related macular degeneration.rm5
CD004008 v. 7.0 Interventions for trachoma trichiasis.rm5
CD004009 v. 4.0 Intrarectal quinine versus intravenous or intramuscular quinine for treating Plasmodium falciparum m.rm5
CD004010 v. 6.0 Pessaries (mechanical devices) for pelvic organ prolapse in women.rm5
CD004011 v. 5.0 Strategies for the removal of short-term indwelling urethral catheters in adults.rm5
CD004012 v. 8.2 Washout policies in long-term indwelling urinary catheterisation in adults.rm5
CD004013 v. 9.0 Types of indwelling urethral catheters for short-term catheterisation in hospitalised adults.rm5
CD004014 v. 10.0 Surgery for women with anterior compartment prolapse.rm5
CD004015 v. 6.3 Lay health workers in primary and community health care for maternal and child health and the manage.rm5
CD004016 v. 6.0 Corticosteroid injections for shoulder pain.rm5
CD004017 v. 5.0 Home versus center based physical activity programs in older adults.rm5
CD004018 v. 6.0 Splints and Orthosis for treating rheumatoid arthritis.rm5
CD004019 v. 5.0 Osteotomy for treating knee osteoarthritis.rm5
CD004020 v. 7.0 Braces and orthoses for treating osteoarthritis of the knee.rm5
CD004022 v. 9.0 Effects of low sodium diet versus high sodium diet on blood pressure renin aldosterone catecholam.rm5
CD004023 v. 8.0 Early versus deferred treatment for early stage multiple myeloma.rm5
CD004024 v. 10.0 High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggr.rm5
CD004025 v. 8.0 Music therapy for people with schizophrenia and schizophrenia-like disorders.rm5
CD004026 v. 6.0 Day hospital versus admission for acute psychiatric disorders.rm5
CD004027 v. 7.0 Antipsychotic medication for childhood-onset schizophrenia.rm5
CD004028 v. 8.0 Valproate for schizophrenia.rm5
CD004029 v. 8.0 Non-antiepileptic drugs for trigeminal neuralgia.rm5
CD004030 v. 5.1 Enteral tube feeding for amyotrophic lateral sclerosismotor neuron disease.rm5
CD004031 v. 6.2 Ibuprofen for Alzheimer's disease.rm5
CD004032 v. 8.0 Transcutaneous Electrical Nerve Stimulation (TENS) for dementia.rm5
CD004033 v. 7.0 Thiamine for prevention and treatment of Wernicke-Korsakoff Syndrome in people who abuse alcohol.rm5
CD004034 v. 8.0 Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitiv.rm5
CD004036 v. 6.2 Glucocorticosteroids for primary sclerosing cholangitis.rm5
CD004040 v. 10.0 Olanzapine alone or in combination for acute mania.rm5
CD004043 v. 7.0 Risperidone alone or in combination for acute mania.rm5
CD004044 v. 7.0 Pharmacological treatment for psychotic depression.rm5
CD004046 v. 8.0 Acupuncture for depression.rm5
CD004047 v. 6.0 Pharmacotherapy for dysthymia.rm5
CD004049 v. 8.0 Inositol for depressive disorders.rm5
CD004050 v. 9.0 Light therapy for non-seasonal depression.rm5
CD004052 v. 9.0 Valproate for acute mood episodes in bipolar disorder.rm5
CD004054 v. 8.0 Psychological and educational interventions for atopic eczema in children.rm5
CD004056 v. 11.0 Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita.rm5
CD004057 v. 9.0 Individual patient education for low back pain.rm5
CD004058 v. 6.4 Radiofrequency denervation for neck and back pain.rm5
CD004059 v. 10.0 Prolotherapy injections for chronic low-back pain.rm5
CD004060 v. 8.0 Treatment for Barrett's oesophagus.rm5
CD004062 v. 11.1 Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy (with or without l.rm5
CD004063 v. 8.0 Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer.rm5
CD004064 v. 11.4 Chemotherapy for advanced gastric cancer.rm5
CD004065 v. 9.0 Non-surgical interventions for eosinophilic esophagitis.rm5
CD004068 v. 6.0 Postnatal parental education for optimizing infant general health and parent-infant relationships.rm5
CD004069 v. 9.0 Vitamin E supplementation in pregnancy.rm5
CD004070 v. 9.0 Vaginal chlorhexidine during labour for preventing maternal and neonatal infections (excluding Group.rm5
CD004071 v. 6.0 Maintenance therapy with calcium channel blockers for preventing preterm birth after threatened pret.rm5
CD004072 v. 9.0 Vitamin C supplementation in pregnancy.rm5
CD004073 v. 7.0 Vitamin supplementation for preventing miscarriage.rm5
CD004074 v. 9.0 Effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes.rm5
CD004075 v. 13.0 Fetal pulse oximetry for fetal assessment in labour.rm5
CD004077 v. 7.0 Conservative management of symptomatic andor complicated haemorrhoids in pregnancy and the puerperi.rm5
CD004078 v. 4.0 Postoperative adjuvant chemotherapy in rectal cancer operated for cure..rm5
CD004079 v. 5.0 Non steroidal anti-inflammatory drugs (NSAID) and aspirin for preventing colorectal adenomas and car.rm5
CD004080 v. 7.0 Early enteral nutrition within 24h of colorectal surgery versus later commencement of feeding for po.rm5
CD004081 v. 7.0 Lidocaine for preventing postoperative sore throat.rm5
CD004082 v. 12.0 Perioperative increase in global blood flow to explicit defined goals and outcomes following surgery.rm5
CD004083 v. 6.0 Peribulbar versus retrobulbar anaesthesia for cataract surgery.rm5
CD004084 v. 5.0 Central venous access sites for the prevention of venous thrombosis stenosis and infection.rm5
CD004085 v. 6.6 High-frequency oscillatory ventilation versus conventional ventilation for acute respiratory distres.rm5
CD004087 v. 4.8 Pharmacological agents for preventing morbidity associated with the haemodynamic response to trachea.rm5
CD004089 v. 11.0 Perioperative administration of buffered versus non-buffered crystalloid intravenous fluid to improv.rm5
CD004093 v. 3.0 Surgical treatment for the thumb-in-palm deformity in patients with cerebral palsy.rm5
CD004094 v. 6.0 Long-term pharmacotherapy for obesity and overweight.rm5
CD004095 v. 4.0 Long-term non-pharmacological weight loss interventions for adults with type 2 diabetes mellitus.rm5
CD004096 v. 4.0 Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus.rm5
CD004097 v. 6.0 Dietary advice for treatment of type 2 diabetes mellitus in adults.rm5
CD004098 v. 5.0 Levothyroxine or minimally invasive therapies for benign thyroid nodules.rm5
CD004099 v. 4.0 Routine hospital admission versus out-patient or home care in children at diagnosis of type 1 diabet.rm5
CD004101 v. 8.0 Psychological interventions for symptomatic management of non-specific chest pain in patients with n.rm5
CD004102 v. 5.0 Trypanocidal drugs for late stage symptomatic Chagas disease (Trypanosoma cruzi infection).rm5
CD004104 v. 7.0 Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerba.rm5
CD004106 v. 9.0 Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for c.rm5
CD004107 v. 4.0 Options for self-management education for adults with asthma.rm5
CD004108 v. 9.0 Nedocromil sodium for chronic asthma in children.rm5
CD004109 v. 4.0 High dose versus low dose inhaled corticosteroid as initial starting dose for asthma in adults and c.rm5
CD004110 v. 7.0 Speech and language therapy interventions for children with primary speech and language delay or dis.rm5
CD004111 v. 11.0 Totally implantable vascular access devices for cystic fibrosis.rm5
CD004112 v. 12.0 Scalpel versus no-scalpel incision for vasectomy.rm5
CD004115 v. 4.2 Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis.rm5
CD004116 v. 6.0 Herbal medicines for treatment of irritable bowel syndrome.rm5
CD004118 v. 4.0 Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.rm5
CD004121 v. 7.4 Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical .rm5
CD004122 v. 8.2 Preoperative hair removal to reduce surgical site infection.rm5
CD004123 v. 10.0 Hyperbaric oxygen therapy for chronic wounds.rm5
CD004124 v. 8.0 Interventions for treating chronic ankle instability.rm5
CD004126 v. 8.0 Alpha-2 adrenergic agonists for the prevention of cardiac complications among adults undergoing surg.rm5
CD004127 v. 8.0 Noninvasive positive-pressure ventilation as a weaning strategy for intubated adults with respirator.rm5
CD004128 v. 11.2 Hypothermia for neuroprotection in adults after cardiopulmonary resuscitation.rm5
CD004129 v. 4.0 Force platform feedback for standing balance training after stroke.rm5
CD004131 v. 8.0 Acupuncture for stroke rehabilitation.rm5
CD004132 v. 6.0 Interventions for motor apraxia following stroke.rm5
CD004133 v. 5.0 Angioplasty for intracranial artery stenosis.rm5
CD004134 v. 6.0 Interventions for improving patients' trust in doctors and groups of doctors.rm5
CD004135 v. 6.0 Microwave thermotherapy for benign prostatic hyperplasia.rm5
CD004136 v. 13.0 Antihypertensive agents for preventing diabetic kidney disease.rm5
CD004137 v. 8.0 Nonsteroidal anti-inflammatory drugs (NSAIDS) versus opioids for acute renal colic.rm5
CD004139 v. 12.0 Colony-stimulating factors for prevention of myelosuppressive therapy-induced febrile neutropenia in.rm5
CD004143 v. 7.2 Long-term hormone therapy for perimenopausal and postmenopausal women.rm5
CD004144 v. 5.0 In vitro fertilisation versus tubal reanastomosis (sterilisation reversal) for subfertility after tu.rm5
CD004145 v. 10.0 Oral substitution treatment of injecting opioid users for prevention of HIV infection.rm5
CD004146 v. 7.0 Treatment for Methaqualone dependence in adults.rm5
CD004147 v. 10.0 Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alon.rm5
CD004148 v. 11.0 Effectiveness of brief alcohol interventions in primary care populations.rm5
CD004149 v. 4.0 Constraint-induced movement therapy in the treatment of the upper limb in children with hemiplegic c.rm5
CD004150 v. 7.2 Screening programmes for the early detection and prevention of oral cancer.rm5
CD004151 v. 7.0 Interventions for replacing missing teeth dental implants in zygomatic bone for the rehabilitation .rm5
CD004152 v. 7.0 Interventions for replacing missing teeth antibiotics at dental implant placement to prevent compli.rm5
CD004153 v. 4.0 Ozone therapy for the treatment of dental caries.rm5
CD004154 v. 12.0 Clobazam as an add-on in the management of refractory epilepsy.rm5
CD004156 v. 9.0 Treatment for spasticity in amyotrophic lateral sclerosismotor neuron disease.rm5
CD004157 v. 4.0 Treatment for cramps in amyotrophic lateral sclerosismotor neuron disease.rm5
CD004158 v. 6.0 Rehabilitation following carpal tunnel release.rm5
CD004159 v. 6.0 Treatment for meralgia paraesthetica.rm5
CD004160 v. 7.0 Hypnosis for schizophrenia.rm5
CD004161 v. 8.0 Risperidone (depot) for schizophrenia.rm5
CD004162 v. 7.0 Antipsychotic drug treatment for elderly people with late-onset schizophrenia.rm5
CD004163 v. 5.0 Identification of children in the first four years of life for early treatment for otitis media with.rm5
CD004166 v. 7.0 Interventions for acute auricular haematoma.rm5
CD004168 v. 3.0 Alcohol ignition interlock programmes for reducing drink driving recidivism.rm5
CD004169 v. 5.0 Hypotonic vs isotonic saline solutions for intravenous fluid management of acute infections.rm5
CD004170 v. 10.11 Multi-disciplinary rehabilitation for acquired brain injury in adults of working age.rm5
CD004171 v. 5.11 Fibrin sealant use for minimising peri-operative allogeneic blood transfusion.rm5
CD004172 v. 5.0 Platelet-rich-plasmapheresis for minimising peri-operative allogeneic blood transfusion.rm5
CD004173 v. 9.2 Advanced trauma life support training for hospital staff.rm5
CD004174 v. 6.0 Compression therapy for prevention of post-thrombotic syndrome.rm5
CD004175 v. 7.0 Salicylate for the treatment of Kawasaki disease in children.rm5
CD004177 v. 6.0 Compression therapy for treating stage I and II (Widmer) post-thrombotic syndrome.rm5
CD004178 v. 4.0 Endovascular repair of abdominal aortic aneurysm.rm5
CD004179 v. 6.0 Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or k.rm5
CD004180 v. 5.0 Telephone consultation and triage effects on health care use and patient satisfaction.rm5
CD004181 v. 6.0 Immunoglobulins for preventing hepatitis A.rm5
CD004182 v. 7.0 D-penicillamine for primary sclerosing cholangitis.rm5
CD004183 v. 10.0 Antioxidant supplements for preventing gastrointestinal cancers.rm5
CD004184 v. 7.0 Evening versus morning dosing regimen drug therapy for hypertension.rm5
CD004185 v. 10.0 Fluoxetine versus other types of pharmacotherapy for depression.rm5
CD004186 v. 10.0 Amitriptyline for depression.rm5
CD004188 v. 5.0 Marital therapy for depression.rm5
CD004191 v. 9.0 Self-help and guided self-help for eating disorders.rm5
CD004192 v. 8.0 Dietary interventions for multiple sclerosis.rm5
CD004194 v. 7.0 Drugs and pacemakers for vasovagal carotid sinus and situational syncope.rm5
CD004197 v. 11.0 Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.rm5
CD004198 v. 8.0 Treatments for priapism in boys and men with sickle cell disease.rm5
CD004200 v. 10.0 Palliative biliary stents for obstructing pancreatic carcinoma.rm5
CD004201 v. 6.0 Urinary catheter policies for long-term bladder drainage.rm5
CD004202 v. 3.2 Sacral neuromodulation with implanted devices for urinary storage and voiding dysfunction in adults.rm5
CD004203 v. 6.3 Urethral (indwelling or intermittent) or suprapubic routes for short-term catheterisation in hospita.rm5
CD004205 v. 7.1 Pentoxifylline for treatment of sepsis and necrotizing enterocolitis in neonates.rm5
CD004206 v. 4.0 Antiviral agents for treatment of herpes simplex virus infection in neonates.rm5
CD004207 v. 4.0 Metalloporphyrins for treatment of unconjugated hyperbilirubinemia in neonates.rm5
CD004208 v. 7.0 Albumin infusion for low serum albumin in preterm newborn infants.rm5
CD004210 v. 8.0 Interventions to prevent hypothermia at birth in preterm andor low birth weight infants.rm5
CD004211 v. 7.0 Clinical decision support systems for neonatal care.rm5
CD004212 v. 6.0 Opioids for neonates receiving mechanical ventilation.rm5
CD004213 v. 6.0 Ibuprofen for the prevention of patent ductus arteriosus in preterm andor low birth weight infants.rm5
CD004214 v. 7.0 Transfer of preterm infants from incubator to open cot at lower versus higher body weight.rm5
CD004215 v. 4.1 Double wall versus single wall incubator for reducing heat loss in very low birth weight infants in .rm5
CD004217 v. 8.0 Pain relief for neonatal circumcision.rm5
CD004218 v. 3.0 Anticonvulsants for neonates with seizures.rm5
CD004219 v. 5.0 Percutaneous central venous catheters versus peripheral cannulae for delivery of parenteral nutritio.rm5
CD004220 v. 5.1 Thyroid hormone supplementation for the prevention of morbidity and mortality in infants undergoing .rm5
CD004221 v. 5.0 Buccal or sublingual misoprostol for cervical ripening and induction of labour.rm5
CD004222 v. 7.2 Treatment for women with postpartum iron deficiency anaemia.rm5
CD004223 v. 5.0 Topically applied anaesthetics for treating perineal pain after childbirth.rm5
CD004224 v. 7.0 Planned elective repeat caesarean section versus planned vaginal birth for women with a previous cae.rm5
CD004225 v. 5.0 Exercise for diabetic pregnant women.rm5
CD004226 v. 7.0 Antenatal interventions for fetomaternal alloimmune thrombocytopenia.rm5
CD004227 v. 7.0 Antioxidants for preventing pre-eclampsia.rm5
CD004228 v. 4.0 Psychological andor educational interventions for reducing alcohol consumption in pregnant women an.rm5
CD004230 v. 4.0 Interventions for ketosis during labour.rm5
CD004231 v. 6.0 Inhaled corticosteroids for non-specific chronic cough in children.rm5
CD004233 v. 11.0 Single dose oral celecoxib for acute postoperative pain in adults.rm5
CD004234 v. 9.0 Single dose oral naproxen and naproxen sodium for acute postoperative pain in adults.rm5
CD004239 v. 5.2 Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surger.rm5
CD004240 v. 7.1 Adjustable versus non-adjustable sutures for strabismus.rm5
CD004241 v. 7.0 Medical interventions for fungal keratitis.rm5
CD004242 v. 11.2 Day care versus in-patient surgery for age-related cataract.rm5
CD004244 v. 5.0 Alpha lipoic acid for dementia.rm5
CD004246 v. 9.0 Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse .rm5
CD004248 v. 4.0 Progressive resistive exercise interventions for adults living with HIVAIDS.rm5
CD004249 v. 10.0 Manipulation and mobilisation for neck pain contrasted against an inactive control or another active.rm5
CD004250 v. 9.0 Exercises for mechanical neck disorders.rm5
CD004251 v. 10.10 Electrotherapy for neck pain.rm5
CD004252 v. 8.0 Muscle relaxants for non-specific low-back pain.rm5
CD004253 v. 11.0 Psychological interventions for women with metastatic breast cancer.rm5
CD004257 v. 6.0 Acetaminophen for osteoarthritis.rm5
CD004258 v. 7.0 Physiotherapy interventions for shoulder pain.rm5
CD004260 v. 10.0 Continuous passive motion following total knee arthroplasty in people with arthritis.rm5
CD004262 v. 7.0 Disposable nappies for preventing napkin dermatitis in infants.rm5
CD004263 v. 5.0 Vaccines for preventing Japanese encephalitis.rm5
CD004264 v. 7.0 Physical methods versus drug placebo or no treatment for managing fever in children.rm5
CD004265 v. 8.0 Hand washing promotion for preventing diarrhoea.rm5
CD004267 v. 10.0 Antibiotics for ventilator-associated pneumonia.rm5
CD004269 v. 10.6 Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorde.rm5
CD004270 v. 10.0 Purine Antagonists for Chronic Lymphocytic Leukaemia.rm5
CD004272 v. 9.0 Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 yea.rm5
CD004273 v. 3.0 Interventions for improving older patients' involvement in primary care episodes.rm5
CD004274 v. 5.0 Interactive Health Communication Applications for people with chronic disease.rm5
CD004275 v. 10.0 Additional bedtime H2-receptor antagonist for the control of nocturnal gastric acid breakthrough.rm5
CD004276 v. 14.0 Endoscopic mucosal resection for early gastric cancer.rm5
CD004277 v. 3.0 Cyclosporine A for induction of remission in severe ulcerative colitis.rm5
CD004278 v. 9.0 Haloperidol versus chlorpromazine for schizophrenia.rm5
CD004282 v. 8.0 Non-invasive interventions for improving well-being and quality of life in patients with lung cancer.rm5
CD004284 v. 7.0 Palliative endobronchial brachytherapy for non-small cell lung cancer.rm5
CD004287 v. 9.2 Tissue adhesives for closure of surgical incisions.rm5
CD004288 v. 8.0 Surgical hand antisepsis to reduce surgical site infection.rm5
CD004289 v. 10.0 HMG CoA reductase inhibitors (statins) for dialysis patients.rm5
CD004290 v. 8.0 Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in ki.rm5
CD004291 v. 11.0 Antifungal agents for preventing fungal infections in solid organ transplant recipients.rm5
CD004292 v. 7.0 Water for preventing urinary stones.rm5
CD004293 v. 8.0 Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.rm5
CD004294 v. 6.3 Physical rehabilitation for older people in long-term care.rm5
CD004295 v. 6.0 Dan Shen agents for acute ischaemic stroke.rm5
CD004296 v. 6.0 Triflusal for preventing serious vascular events in people at high risk.rm5
CD004298 v. 4.0 Interventions for apraxia of speech following stroke.rm5
CD004299 v. 3.0 Interventions for cellulitis and erysipelas.rm5
CD004300 v. 6.0 Topical Vitamin A or its derivatives for treating and preventing napkin dermatitis in infants.rm5
CD004302 v. 6.0 Ciliary neurotrophic factor (CNTF) for amyotrophic lateral sclerosis or motor neuron disease.rm5
CD004303 v. 9.2 Interventions for dysphagia in long-term progressive muscle disease.rm5
CD004304 v. 5.1 Vitamins for epilepsy.rm5
CD004305 v. 9.4 Healthcare financing systems for increasing the use of tobacco dependence treatment.rm5
CD004306 v. 10.0 Interventions for smokeless tobacco use cessation.rm5
CD004307 v. 11.2 Incentives for smoking cessation.rm5
CD004308 v. 11.1 Single dose oral indometacin for the treatment of acute postoperative pain.rm5
CD004309 v. 10.0 Single dose oral etoricoxib for acute postoperative pain in adults.rm5
CD004310 v. 9.0 Megestrol acetate for treatment of anorexia-cachexia syndrome.rm5
CD004312 v. 3.0 Botulinum toxin type A versus anticholinergics for cervical dystonia.rm5
CD004314 v. 5.3 Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.rm5
CD004315 v. 4.0 Botulinum toxin type B for cervical dystonia.rm5
CD004316 v. 11.1 Steroid hormones for contraception in men.rm5
CD004317 v. 9.0 Strategies to improve adherence and acceptability of hormonal methods of contraception.rm5
CD004318 v. 3.2 Prolonged thromboprophylaxis with Low Molecular Weight heparin for abdominal or pelvic surgery.rm5
CD004320 v. 5.0 Stapled versus handsewn methods for ileocolic anastomoses.rm5
CD004322 v. 6.0 Phlebotonics for haemorrhoids.rm5
CD004323 v. 8.0 Quality of life after rectal resection for cancer with or without permanent colostomy..rm5
CD004325 v. 8.0 Surgical versus non-surgical treatment for acute anterior shoulder dislocation.rm5
CD004326 v. 5.0 Ear drops for the removal of ear wax.rm5
CD004327 v. 6.0 Botulinum toxin injections for the treatment of spasmodic dysphonia.rm5
CD004329 v. 7.0 Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinoma.rm5
CD004332 v. 12.0 Acamprosate for alcohol dependence.rm5
CD004333 v. 6.0 Helmets for preventing injury in motorcycle riders.rm5
CD004334 v. 5.0 Interventions for promoting booster seat use in four to eight year olds travelling in motor vehicles.rm5
CD004335 v. 11.0 Community-based interventions for the prevention of burns and scalds in children.rm5
CD004337 v. 3.0 Fluid restriction for term infants with hypoxic-ischaemic encephalopathy following perinatal asphyxi.rm5
CD004338 v. 7.0 Prophylactic antibiotics to reduce morbidity and mortality in ventilated newborn infants.rm5
CD004339 v. 6.0 Arginine supplementation for prevention of necrotising enterocolitis in preterm infants.rm5
CD004341 v. 5.0 Positive end-expiratory pressure for resuscitation of newborn infants at birth.rm5
CD004342 v. 6.0 Thrombolytic agents for arterial and venous thromboses in neonates.rm5
CD004343 v. 3.0 Ethamsylate for the prevention of morbidity and mortality in preterm or very low birth weight infant.rm5
CD004344 v. 13.0 Treatment for avascular necrosis of bone in people with sickle cell disease.rm5
CD004345 v. 5.0 Surgical techniques for the removal of mandibular wisdom teeth.rm5
CD004346 v. 6.0 Recall intervals for oral health in primary care patients.rm5
CD004348 v. 4.0 Setting and organization of care for persons living with HIVAIDS.rm5
CD004349 v. 6.0 Treatment blood pressure targets for hypertension.rm5
CD004350 v. 7.0 Regional versus general anaesthesia for caesarean section.rm5
CD004351 v. 6.2 Prevention and treatment of postpartum hypertension.rm5
CD004352 v. 8.0 Betamimetics for inhibiting preterm labour.rm5
CD004353 v. 4.0 Oestrogen supplementation mainly diethylstilbestrol for preventing miscarriages and other adverse .rm5
CD004356 v. 6.0 Short-term ambulatory oxygen for chronic obstructive pulmonary disease.rm5
CD004357 v. 6.0 Monosodium glutamate avoidance for chronic asthma in adults and children.rm5
CD004358 v. 12.0 Anticholinergics for prolonged non-specific cough in children.rm5
CD004359 v. 6.0 Nurse specialist care for bronchiectasis.rm5
CD004360 v. 6.6 Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute .rm5
CD004362 v. 7.0 Haloperidol alone or in combination for acute mania.rm5
CD004363 v. 6.0 Antidepressants for preventing postnatal depression.rm5
CD004364 v. 4.0 Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia.rm5
CD004365 v. 6.0 Antidepressants for anorexia nervosa.rm5
CD004366 v. 12.5 Exercise for depression.rm5
CD004367 v. 8.0 Olanzapine in long-term treatment for bipolar disorder.rm5
CD004370 v. 7.0 Intravenous immunoglobulin for presumed viral myocarditis in children and adults.rm5
CD004371 v. 10.0 Interventions to improve adherence to lipid-lowering medication.rm5
CD004372 v. 6.0 Psychological interventions for depression in adolescent and adult congenital heart disease.rm5
CD004374 v. 3.0 Short term urinary catheter policies following urogenital surgery in adults.rm5
CD004375 v. 6.0 Catheter policies for management of long term voiding problems in adults with neurogenic bladder dis.rm5
CD004376 v. 6.0 Exercise for osteoarthritis of the knee.rm5
CD004377 v. 7.0 Transcutaneous electrical nerve stimulation (TENS) for the treatment of rheumatoid arthritis in the .rm5
CD004378 v. 6.0 Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm .rm5
CD004379 v. 5.4 Interventions for 'poor responders' to controlled ovarian hyper stimulation (COH) in in-vitro fertil.rm5
CD004380 v. 5.15 School-based education programmes for the prevention of child sexual abuse.rm5
CD004381 v. 7.0 Music therapy for people with autism spectrum disorder.rm5
CD004383 v. 5.2 Specialist home-based nursing services for children with acute and chronic illnesses.rm5
CD004385 v. 6.0 Methotrexate for primary biliary cirrhosis.rm5
CD004386 v. 12.0 Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemother.rm5
CD004387 v. 6.0 Chlorproguanil-dapsone for treating uncomplicated malaria.rm5
CD004388 v. 11.0 Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients.rm5
CD004389 v. 4.0 Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine.rm5
CD004390 v. 5.0 Oral versus intravenous rehydration for treating dehydration due to gastroenteritis in children.rm5
CD004391 v. 7.0 Intramuscular arteether for treating severe malaria.rm5
CD004393 v. 8.1 Vitamin B6 for cognition.rm5
CD004394 v. 6.0 Vitamin B12 for cognition.rm5
CD004395 v. 7.0 Donepezil for vascular cognitive impairment.rm5
CD004396 v. 8.0 Respite care for people with dementia and their carers.rm5
CD004398 v. 11.0 Printed educational materials effects on professional practice and healthcare outcomes.rm5
CD004399 v. 6.1 Medical versus surgical interventions for open angle glaucoma.rm5
CD004400 v. 10.0 Granulocyte-Colony Stimulating Factor (G-CSF) as an adjunct to antibiotics in the treatment of pneum.rm5
CD004401 v. 10.0 Antibiotics for the prevention of acute and chronic suppurative otitis media in children.rm5
CD004402 v. 12.0 Steroids for symptom control in infectious mononucleosis.rm5
CD004404 v. 9.0 Antibiotics for whooping cough (pertussis).rm5
CD004405 v. 10.0 Corticosteroids for acute bacterial meningitis.rm5
CD004406 v. 9.0 Different antibiotic treatments for group A streptococcal pharyngitis.rm5
CD004407 v. 9.0 Vaccines for measles mumps and rubella in children.rm5
CD004408 v. 12.0 Compulsory community and involuntary outpatient treatment for people with severe mental disorders.rm5
CD004409 v. 4.4 Twenty-four hour care for schizophrenia.rm5
CD004410 v. 4.0 New generation antipsychotics for first episode schizophrenia.rm5
CD004411 v. 4.0 Antipsychotic drugs for non-affective psychosis during pregnancy and postpartum.rm5
CD004412 v. 6.0 Exercise therapy for schizophrenia.rm5
CD004413 v. 9.0 Interventions for alopecia areata.rm5
CD004414 v. 5.0 Interventions for preventing occupational irritant hand dermatitis.rm5
CD004415 v. 5.0 Interventions for actinic keratoses.rm5
CD004416 v. 8.0 Oral evening primrose oil and borage oil for eczema.rm5
CD004417 v. 23.0 Delayed antibiotic prescriptions for respiratory infections.rm5
CD004418 v. 13.0 Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized a.rm5
CD004419 v. 9.0 Advising patients to increase fluid intake for treating acute respiratory infections.rm5
CD004421 v. 8.0 Taxanes for adjuvant treatment of early breast cancer.rm5
CD004423 v. 7.0 Preoperative fasting for adults to prevent perioperative complications.rm5
CD004424 v. 12.3 Antiepileptic drugs for preventing seizures in people with brain tumors.rm5
CD004425 v. 10.0 Combined oral contraceptive pills for treatment of acne.rm5
CD004426 v. 7.2 Treatment for mitochondrial disorders.rm5
CD004427 v. 6.0 Mechanical ventilation for amyotrophic lateral sclerosismotor neuron disease.rm5
CD004429 v. 4.0 Intravenous immunoglobulin for multifocal motor neuropathy.rm5
CD004431 v. 5.0 Psychological interventions for multiple sclerosis.rm5
CD004433 v. 7.0 Constraint-induced movement therapy for upper extremities in people with stroke.rm5
CD004434 v. 8.2 Endothelin receptor antagonists for pulmonary arterial hypertension.rm5
CD004435 v. 8.2 Oral appliances for obstructive sleep apnoea.rm5
CD004436 v. 10.2 Inhaled cromones for prolonged non-specific cough in children.rm5
CD004437 v. 7.0 Thrombolytic therapy for pulmonary embolism.rm5
CD004439 v. 7.0 Antibiotics for treating chronic osteomyelitis in adults.rm5
CD004440 v. 3.0 Recombinant growth hormone for idiopathic short stature in children and adolescents.rm5
CD004441 v. 8.0 Population-based interventions for the prevention of fall-related injuries in older people.rm5
CD004442 v. 4.0 Spinal injuries centres (SICs) for acute traumatic spinal cord injury.rm5
CD004443 v. 5.0 Naloxone for shock.rm5
CD004444 v. 4.0 Gangliosides for acute spinal cord injury.rm5
CD004445 v. 8.0 The 'WHO Safe Communities' model for the prevention of injury in whole populations.rm5
CD004446 v. 10.0 Emergency ultrasound-based algorithms for diagnosing blunt abdominal trauma.rm5
CD004447 v. 12.0 Recombinant growth hormone therapy for X-linked hypophosphatemia in children.rm5
CD004448 v. 10.0 Phytomedicines (medicines derived from plants) for sickle cell disease.rm5
CD004449 v. 8.0 Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding e.rm5
CD004450 v. 7.0 Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-depende.rm5
CD004451 v. 6.0 Diuretics for preventing pre-eclampsia.rm5
CD004452 v. 12.0 Oxytocin receptor antagonists for inhibiting preterm labour.rm5
CD004453 v. 6.2 Abdominal surgical incisions for caesarean section.rm5
CD004454 v. 7.4 Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.rm5
CD004455 v. 8.0 Antibiotic prophylaxis for operative vaginal delivery.rm5
CD004456 v. 5.0 Home visits during pregnancy and after birth for women with an alcohol or drug problem.rm5
CD004457 v. 8.0 Discontinuation of epidural analgesia late in labour for reducing the adverse delivery outcomes asso.rm5
CD004458 v. 5.0 Functional endoscopic sinus surgery for chronic rhinosinusitis.rm5
CD004459 v. 6.0 Surgical interventions for pharyngeal pouch.rm5
CD004460 v. 4.0 Capsaicin for allergic rhinitis in adults.rm5
CD004461 v. 6.0 Interventions for recurrent idiopathic epistaxis (nosebleeds) in children.rm5
CD004462 v. 6.0 Treatment of urinary incontinence after stroke in adults.rm5
CD004464 v. 7.0 Sacral nerve stimulation for faecal incontinence and constipation in adults.rm5
CD004465 v. 6.0 Danshen (Chinese medicinal herb) preparations for acute myocardial infarction.rm5
CD004466 v. 5.0 Incentive spirometry for preventing pulmonary complications after coronary artery bypass graft.rm5
CD004467 v. 6.0 Low glycaemic index diets for the prevention of cardiovascular disease.rm5
CD004468 v. 5.0 Traditional Chinese herbal products for stable angina.rm5
CD004469 v. 7.0 Antibiotics for brain abscesses in people with cyanotic congenital heart disease.rm5
CD004471 v. 6.1 Corticosteroids for viral myocarditis.rm5
CD004472 v. 4.0 Preoperative intra aortic balloon pumps in patients undergoing coronary artery bypass grafting.rm5
CD004473 v. 7.0 Chinese herbal medicine suxiao jiuxin wan for angina pectoris.rm5
CD004474 v. 6.0 Tongxinluo (Tong xin luo or Tong-xin-luo) capsule for unstable angina pectoris.rm5
CD004476 v. 5.0 Perioperative beta-blockers for preventing surgery-related mortality and morbidity.rm5
CD004477 v. 7.0 Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome.rm5
CD004479 v. 11.0 Simple aspiration versus intercostal tube drainage for primary spontaneous pneumothorax in adults.rm5
CD004480 v. 7.3 Bicyclol for chronic hepatitis B.rm5
CD004481 v. 6.0 Colchicine for primary biliary cirrhosis.rm5
CD004485 v. 8.0 Adhesives for fixed orthodontic bands.rm5
CD004487 v. 7.0 Paracetamol for pain relief after surgical removal of lower wisdom teeth.rm5
CD004492 v. 9.0 Stage-based interventions for smoking cessation.rm5
CD004493 v. 9.179 Family-based programmes for preventing smoking by children and adolescents.rm5
CD004495 v. 4.0 Antibiotic regimens for suspected early neonatal sepsis.rm5
CD004496 v. 7.2 Intraventricular antibiotics for bacterial meningitis in neonates.rm5
CD004497 v. 6.0 Carnitine supplementation for preterm infants with recurrent apnoea.rm5
CD004498 v. 3.0 Multiple versus single lumen umbilical venous catheters for newborn infants.rm5
CD004500 v. 3.0 Positive end expiratory pressure for preterm infants requiring conventional mechanical ventilation f.rm5
CD004501 v. 6.0 Antibiotic regimens for suspected late onset sepsis in newborn infants.rm5
CD004502 v. 3.0 Audio recordings of consultations with doctors for parents of critically sick babies.rm5
CD004503 v. 3.0 Long versus short inspiratory times in neonates receiving mechanical ventilation.rm5
CD004504 v. 10.27 Herbal medicine for low-back pain.rm5
CD004507 v. 6.0 Semen preparation techniques for intrauterine insemination.rm5
CD004508 v. 5.0 Early versus delayed oral fluids and food for reducing complications after major abdominal gynaecolo.rm5
CD004509 v. 6.0 Testosterone for peri and postmenopausal women.rm5
CD004510 v. 4.2 Telephone follow-up initiated by a hospital-based health professional for postdischarge problems i.rm5
CD004511 v. 3.0 Interventions for improving communication with children and adolescents about a family member's canc.rm5
CD004514 v. 9.0 Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demen.rm5
CD004515 v. 5.0 Valerian for anxiety disorders.rm5
CD004517 v. 9.4 Music therapy for depression.rm5
CD004518 v. 4.0 Passiflora for anxiety disorder.rm5
CD004520 v. 11.0 Chinese herbal medicine for oesophageal cancer.rm5
CD004522 v. 7.0 Thermotherapy for treatment of osteoarthritis.rm5
CD004523 v. 10.0 Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal wom.rm5
CD004524 v. 8.0 Methotrexate for ankylosing spondylitis.rm5
CD004525 v. 7.0 Etanercept for the treatment of rheumatoid arthritis.rm5
CD004529 v. 3.0 Atovaquone-proguanil for treating uncomplicated malaria.rm5
CD004530 v. 8.0 Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever).rm5
CD004531 v. 5.0 Artesunate plus mefloquine versus mefloquine for treating uncomplicated malaria.rm5
CD004532 v. 7.3 Routine surgery in addition to chemotherapy for treating spinal tuberculosis.rm5
CD004534 v. 5.2 Educational and skills-based interventions for preventing relationship and dating violence in adoles.rm5
CD004535 v. 7.0 Stavudine lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in .rm5
CD004536 v. 7.0 Nutritional interventions for reducing morbidity and mortality in people with HIV.rm5
CD004538 v. 5.28 Public release of performance data in changing the behaviour of healthcare consumers professionals .rm5
CD004539 v. 5.0 Antibiotic regimens for secondary peritonitis of gastrointestinal origin in adults.rm5
CD004540 v. 3.0 Chinese medical herbs for chemotherapy side effects in colorectal cancer patients.rm5
CD004541 v. 10.0 Antidepressants for treating depression in adults with end-stage kidney disease treated with dialysi.rm5
CD004542 v. 9.0 Psychosocial interventions for depression in dialysis patients.rm5
CD004544 v. 6.2 Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults.rm5
CD004547 v. 4.0 Chinese medicinal herbs for cholelithiasis.rm5
CD004549 v. 9.0 Wound drainage for caesarean section.rm5
CD004551 v. 6.0 Pin site care for preventing infections associated with external bone fixators and pins.rm5
CD004552 v. 3.0 Intrathecal baclofen for treating spasticity in children with cerebral palsy.rm5
CD004553 v. 4.0 Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications.rm5
CD004554 v. 4.0 Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease.rm5
CD004559 v. 12.0 Chinese medicinal herbs for influenza.rm5
CD004560 v. 15.0 Chinese medicinal herbs for acute bronchitis.rm5
CD004561 v. 9.0 Axillary treatment for operable primary breast cancer.rm5
CD004562 v. 7.0 LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.rm5
CD004563 v. 6.0 Methods of consumer involvement in developing healthcare policy and research clinical practice guid.rm5
CD004565 v. 3.0 Interventions before consultations for helping patients address their information needs.rm5
CD004567 v. 5.0 Antioxidant vitamin supplementation for preventing and slowing the progression of age-related catara.rm5
CD004568 v. 12.0 Combination injectable contraceptives for contraception.rm5
CD004571 v. 6.0 Calcium antagonists for Duchenne muscular dystrophy.rm5
CD004572 v. 6.0 Aldose reductase inhibitors for the treatment of diabetic polyneuropathy.rm5
CD004573 v. 7.0 Vitamin B for treating peripheral neuropathy.rm5
CD004574 v. 4.0 Interventions for treating mallet finger injuries.rm5
CD004575 v. 5.0 Rehabilitation for hamstring injuries.rm5
CD004577 v. 6.0 Stretching to prevent or reduce muscle soreness after exercise.rm5
CD004578 v. 10.0 Aripiprazole for schizophrenia.rm5
CD004580 v. 10.0 Inpatient versus other settings for detoxification for opioid dependence.rm5
CD004581 v. 7.0 Closed tracheal suction systems versus open tracheal suction systems for mechanically ventilated adu.rm5
CD004583 v. 3.0 Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage.rm5
CD004584 v. 5.0 Tongxinluo capsule for acute stroke.rm5
CD004585 v. 5.0 EMG biofeedback for the recovery of motor function after stroke.rm5
CD004588 v. 6.0 Percutaneous transluminal coronary angioplasty with stents versus coronary artery bypass grafting fo.rm5
CD004591 v. 6.0 Lactase treated feeds to promote growth and feeding tolerance in preterm infants.rm5
CD004592 v. 3.0 Single versus double volume exchange transfusion in jaundiced newborn infants.rm5
CD004593 v. 4.0 Continuous infusion versus intermittent flushing to prevent loss of function of peripheral intraveno.rm5
CD004595 v. 4.2 Screening programmes for developmental dysplasia of the hip in newborn infants.rm5
CD004596 v. 12.0 Drug therapy for symptoms associated with anxiety in adult palliative care patients.rm5
CD004597 v. 11.0 Eicosapentaenoic acid (EPA an omega-3 fatty acid from fish oils) for the treatment of cancer cachex.rm5
CD004598 v. 12.0 Local anaesthetic sympathetic blockade for complex regional pain syndrome.rm5
CD004602 v. 7.0 Single dose oral paracetamol (acetaminophen) for postoperative pain in adults.rm5
CD004604 v. 9.0 Single dose oral rofecoxib for acute postoperative pain in adults.rm5
CD004606 v. 6.0 School-based secondary prevention programmes for preventing violence.rm5
CD004607 v. 10.0 Speed cameras for the prevention of road traffic injuries and deaths.rm5
CD004609 v. 8.17 Hyperbaric oxygen therapy for the adjunctive treatment of traumatic brain injury.rm5
CD004610 v. 9.0 Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults.rm5
CD004611 v. 6.0 Probiotics for treatment of Clostridium difficile-associated colitis in adults.rm5
CD004614 v. 6.0 Unit-dose packaged drugs for treating malaria.rm5
CD004615 v. 5.2 Mannitol and other osmotic diuretics as adjuncts for treating cerebral malaria.rm5
CD004617 v. 7.0 Hyperbaric oxygen as an adjuvant treatment for malignant otitis externa.rm5
CD004618 v. 4.0 Topical antibiotics without steroids for chronically discharging ears with underlying eardrum perfor.rm5
CD004619 v. 5.8 Coblation versus other surgical techniques for tonsillectomy.rm5
CD004622 v. 7.2 Full-mouth treatment modalities (within 24 hours) for chronic periodontitis in adults.rm5
CD004624 v. 5.0 Ibuprofen andor paracetamol (acetaminophen) for pain relief after surgical removal of lower wisdom .rm5
CD004625 v. 5.0 Routine scale and polish for periodontal health in adults.rm5
CD004626 v. 10.7 First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high.rm5
CD004629 v. 9.0 Interferon-alpha for maintenance of follicular lymphoma.rm5
CD004634 v. 5.0 Follicular flushing during oocyte retrieval in assisted reproductive techniques.rm5
CD004635 v. 5.0 Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis.rm5
CD004637 v. 4.0 Antibiotic prophylaxis for elective hysterectomy.rm5
CD004638 v. 5.0 Minimally invasive surgical techniques versus open myomectomy for uterine fibroids.rm5
CD004639 v. 11.0 Calcium supplementation for the management of primary hypertension in adults.rm5
CD004640 v. 11.0 Magnesium supplementation for the management of primary hypertension in adults.rm5
CD004641 v. 10.0 Potassium supplementation for the management of primary hypertension in adults.rm5
CD004643 v. 7.0 Blood pressure lowering efficacy of alpha blockers for primary hypertension.rm5
CD004647 v. 3.0 Ileostomy or colostomy for temporary decompression of colorectal anastomosis.rm5
CD004649 v. 4.0 Laxatives for the treatment of hemorrhoids..rm5
CD004651 v. 6.0 Oral water soluble contrast for the management of adhesive small bowel obstruction.rm5
CD004654 v. 4.0 Meglitinide analogues for type 2 diabetes mellitus.rm5
CD004655 v. 5.2 Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency.rm5
CD004659 v. 5.0 Antiplatelet agents for preventing pre-eclampsia and its complications.rm5
CD004660 v. 7.0 Caesarean section for non-medical reasons at term.rm5
CD004661 v. 7.0 Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.rm5
CD004662 v. 8.0 Techniques for caesarean section.rm5
CD004663 v. 3.0 Techniques and materials for closure of the abdominal wall in caesarean section.rm5
CD004664 v. 6.0 Vibroacoustic stimulation for fetal assessment in labour in the presence of a nonreassuring fetal he.rm5
CD004665 v. 8.0 Placental cord drainage after vaginal delivery as part of the management of the third stage of labou.rm5
CD004667 v. 11.0 Midwife-led continuity models versus other models of care for childbearing women.rm5
CD004668 v. 5.0 Complex behavioural and educational interventions for nocturnal enuresis in children.rm5
CD004670 v. 7.0 Zhiling decoction for vascular dementia.rm5
CD004674 v. 4.0 Calorie controlled diet for chronic asthma.rm5
CD004676 v. 8.0 School feeding for improving the physical and psychosocial health of disadvantaged students.rm5
CD004677 v. 5.37 Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).rm5
CD004678 v. 5.14 Glatiramer acetate for multiple sclerosis.rm5
CD004679 v. 13.0 Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.rm5
CD004680 v. 11.0 Catheter type placement and insertion techniques for preventing peritonitis in peritoneal dialysis .rm5
CD004682 v. 7.0 Duration of antibacterial treatment for uncomplicated urinary tract infection in women.rm5
CD004683 v. 7.1 Interventions for lowering plasma homocysteine levels in dialysis patients.rm5
CD004684 v. 4.0 Laser and photoepilation for unwanted hair growth.rm5
CD004685 v. 7.0 Systemic antifungal therapy for tinea capitis in children.rm5
CD004687 v. 9.1 Short-term psychodynamic psychotherapies for common mental disorders.rm5
CD004688 v. 6.0 Paraprofessionals for anxiety and depressive disorders.rm5
CD004690 v. 8.7 Cognitive behavioural therapy for anxiety disorders in children and adolescents.rm5
CD004691 v. 4.0 Exercise in prevention and treatment of anxiety and depression among children and young people.rm5
CD004692 v. 9.0 Omega-3 fatty acids for depression in adults.rm5
CD004694 v. 10.11 Tiagabine for acute affective episodes in bipolar disorder.rm5
CD004695 v. 11.0 Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception.rm5
CD004696 v. 7.0 Nutrient-enriched formula versus standard formula for preterm infants following hospital discharge.rm5
CD004697 v. 6.0 Prophylactic antibiotics to reduce morbidity and mortality in neonates with umbilical artery cathete.rm5
CD004699 v. 7.0 Surgery for local and locally advanced non-small cell lung cancer.rm5
CD004700 v. 10.0 Early versus late chest radiotherapy in patients with limited-stage small cell lung cancer.rm5
CD004703 v. 6.0 Transabdominal pre-peritoneal (TAPP) vs totally extraperitoneal (TEP) laparoscopic techniques for in.rm5
CD004704 v. 10.5 Mass media interventions for smoking cessation in adults.rm5
CD004705 v. 7.2 Biomedical risk assessment as an aid for smoking cessation.rm5
CD004706 v. 10.2 Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.rm5
CD004707 v. 7.0 Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia.rm5
CD004708 v. 5.0 Interventions for psychosexual dysfunction in women treated for gynaecological malignancy.rm5
CD004711 v. 8.0 Heat and moisture exchangers versus heated humidifiers for mechanically ventilated adults and childr.rm5
CD004712 v. 5.0 Hyperbaric oxygen therapy for promoting fracture healing and treating fracture non-union.rm5
CD004713 v. 6.0 Hyperbaric oxygen therapy for delayed onset muscle soreness and closed soft tissue injury.rm5
CD004714 v. 6.0 Treatment of periodontal disease for glycaemic control in people with diabetes mellitus.rm5
CD004715 v. 6.0 Pharmacological interventions for pain in patients with temporomandibular disorders.rm5
CD004716 v. 8.0 Supportive therapy for schizophrenia.rm5
CD004717 v. 4.0 Distraction techniques for schizophrenia.rm5
CD004718 v. 7.0 Early intervention for psychosis.rm5
CD004719 v. 7.0 Estrogen for schizophrenia.rm5
CD004720 v. 8.0 Screening for prostate cancer.rm5
CD004721 v. 5.0 Palliation of metastatic bone pain single fraction versus multifraction radiotherapy.rm5
CD004722 v. 7.0 Transdermal nicotine for induction of remission in ulcerative colitis.rm5
CD004725 v. 7.0 Spinal fixation surgery for acute traumatic spinal cord injury.rm5
CD004726 v. 4.3 Education of children and adolescents for the prevention of dog bite injuries.rm5
CD004727 v. 9.0 Hyperbaric oxygen therapy for thermal burns.rm5
CD004728 v. 11.5 Street lighting for preventing road traffic injuries.rm5
CD004730 v. 10.0 Insulin and oral agents for managing cystic fibrosis-related diabetes.rm5
CD004731 v. 10.4 Protein substitute for children and adults with phenylketonuria.rm5
CD004732 v. 6.0 Surgical techniques for uterine incision and uterine closure at the time of caesarean section.rm5
CD004733 v. 6.2 Prophylactic oral betamimetics for reducing preterm birth in women with a twin pregnancy.rm5
CD004734 v. 6.0 Aspirin andor heparin for women with unexplained recurrent miscarriage with or without inherited th.rm5
CD004735 v. 4.0 Planned early birth versus expectant management for women with preterm prelabour rupture of membrane.rm5
CD004736 v. 8.0 Daily oral iron supplementation during pregnancy.rm5
CD004737 v. 3.1 Methods of delivering the placenta at caesarean section.rm5
CD004739 v. 7.2 Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus.rm5
CD004740 v. 3.0 Interventions for acute otitis externa.rm5
CD004742 v. 6.0 Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults.rm5
CD004744 v. 6.0 Rivastigmine for vascular cognitive impairment.rm5
CD004746 v. 8.0 Galantamine for vascular cognitive impairment.rm5
CD004747 v. 5.0 Cholinesterase inhibitors for Parkinson's disease dementia.rm5
CD004748 v. 6.1 Velnacrine for Alzheimer's disease.rm5
CD004749 v. 8.0 Interventions to increase the use of electronic health information by healthcare practitioners to im.rm5
CD004750 v. 11.0 Superficial heat or cold for low back pain.rm5
CD004751 v. 6.14 Laparoscopy versus laparotomy for benign ovarian tumour.rm5
CD004752 v. 5.0 Glucocorticoid supplementation during ovarian stimulation for IVF or ICSI.rm5
CD004753 v. 8.2 Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis.rm5
CD004754 v. 5.0 Pharmacological interventions for preventing complications in idiopathic hypercalciuria.rm5
CD004756 v. 9.2 Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant reci.rm5
CD004759 v. 9.0 Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.rm5
CD004760 v. 8.0 Creatine for treating muscle disorders.rm5
CD004761 v. 4.2 Treatment for Fisher syndrome Bickerstaff's brainstem encephalitis and related disorders.rm5
CD004762 v. 9.0 Drug treatment for myotonia.rm5
CD004763 v. 4.0 Laser photocoagulation for neovascular age-related macular degeneration.rm5
CD004764 v. 6.0 Patching for corneal abrasion.rm5
CD004765 v. 4.0 Laser photocoagulation for choroidal neovascularisation in pathologic myopia.rm5
CD004767 v. 11.0 Interventions for cutaneous molluscum contagiosum.rm5
CD004768 v. 12.0 Single dose oral diclofenac for acute postoperative pain in adults.rm5
CD004770 v. 11.0 Drug therapy for delirium in terminally ill adult patients.rm5
CD004771 v. 12.0 Intravenous or intramuscular parecoxib for acute postoperative pain in adults.rm5
CD004772 v. 6.0 Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age.rm5
CD004773 v. 7.0 Antifungal interventions for the primary prevention of cryptococcal disease in adults with HIV.rm5
CD004775 v. 4.0 Mass media interventions for promoting HIV testing.rm5
CD004776 v. 5.2 Treatment for anemia in people with AIDS.rm5
CD004778 v. 8.0 Laparoscopic repair for perforated peptic ulcer disease.rm5
CD004780 v. 11.0 Family therapy for anorexia nervosa.rm5
CD004782 v. 11.0 Chinese medicinal herbs for the common cold.rm5
CD004783 v. 16.0 Antibiotics for acute laryngitis in adults.rm5
CD004785 v. 10.0 Antibiotics for preventing meningococcal infections.rm5
CD004786 v. 13.0 Fluid therapy for acute bacterial meningitis.rm5
CD004787 v. 5.0 Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma.rm5
CD004788 v. 7.0 Small-incision versus open cholecystectomy for patients with symptomatic cholecystolithiasis.rm5
CD004789 v. 7.0 D-penicillamine for primary biliary cirrhosis.rm5
CD004790 v. 4.0 Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers.rm5
CD004791 v. 5.5 Antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhotic patients with ascites wit.rm5
CD004792 v. 14.0 Vitamin K for upper gastrointestinal bleeding in people with acute or chronic liver diseases.rm5
CD004794 v. 5.0 Interventions to improve water quality for preventing diarrhoea.rm5
CD004795 v. 6.0 Fluoroquinolones for treating tuberculosis (presumed drug-sensitive).rm5
CD004796 v. 6.0 Manipulative therapies for infantile colic.rm5
CD004797 v. 6.0 Multisystemic Therapy for social emotional and behavioral problems in youth aged 10-17.rm5
CD004800 v. 7.2 Sulfasalazine for ankylosing spondylitis.rm5
CD004803 v. 6.0 Retention versus sacrifice of the posterior cruciate ligament in total knee arthroplasty for treatin.rm5
CD004804 v. 6.0 Interventions for improving adherence to treatment in patients with high blood pressure in ambulator.rm5
CD004805 v. 12.0 Combined calcium magnesium and potassium supplementation for the management of primary hypertension.rm5
CD004807 v. 3.0 Consumer-providers of care for adult clients of statutory mental health services.rm5
CD004808 v. 6.2 Contracts between patients and healthcare practitioners for improving patients' adherence to treatme.rm5
CD004809 v. 4.2 Policy interventions implemented through sporting organisations for promoting healthy behaviour chan.rm5
CD004811 v. 5.2 Family-centred care for hospitalised children aged 0-12 years.rm5
CD004812 v. 5.2 Interventions implemented through sporting organisations for increasing participation in sport.rm5
CD004815 v. 7.0 Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elev.rm5
CD004816 v. 16.0 Statins for the primary prevention of cardiovascular disease.rm5
CD004818 v. 6.0 Hyperbaric oxygen therapy for acute coronary syndrome.rm5
CD004822 v. 6.0 Antibiotics for prolonged moist cough in children.rm5
CD004823 v. 11.0 Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults.rm5
CD004825 v. 5.0 Psychosocial interventions for erectile dysfunction.rm5
CD004826 v. 5.0 Probiotics for maintenance of remission in Crohn's disease.rm5
CD004827 v. 8.0 Probiotics for the prevention of pediatric antibiotic-associated diarrhea.rm5
CD004829 v. 5.2 Pain relief for women undergoing oocyte retrieval for assisted reproduction.rm5
CD004832 v. 9.0 Aspirin for in vitro fertilisation.rm5
CD004833 v. 7.0 Interventions for skin changes caused by nerve damage in leprosy.rm5
CD004834 v. 6.0 Interventions for American cutaneous and mucocutaneous leishmaniasis.rm5
CD004835 v. 5.0 Surgical excision margins for primary cutaneous melanoma.rm5
CD004837 v. 5.0 Cannabis and schizophrenia.rm5
CD004838 v. 6.0 Nicotine for schizophrenia.rm5
CD004839 v. 6.0 Oral deferiprone for iron chelation in people with thalassaemia.rm5
CD004840 v. 6.0 Surgery versus radiosurgery for patients with a solitary brain metastasis from non-small cell lung c.rm5
CD004844 v. 10.0 Antipsychotics for acute and chronic pain in adults.rm5
CD004845 v. 14.0 Homeopathic medicines for adverse effects of cancer treatments.rm5
CD004849 v. 7.0 Tai chi for treating rheumatoid arthritis.rm5
CD004851 v. 11.2 Newer generation antidepressants for depressive disorders in children and adolescents.rm5
CD004853 v. 5.0 Psychotherapeutic treatments for older depressed people.rm5
CD004854 v. 6.0 Interventions for helping people recognise early signs of recurrence in bipolar disorder.rm5
CD004856 v. 6.0 Behavioural and cognitive behavioural therapy for obsessive compulsive disorder in children and adol.rm5
CD004857 v. 12.2 Oxcarbazepine for acute affective episodes in bipolar disorder.rm5
CD004860 v. 8.0 Fertility awareness-based methods for contraception.rm5
CD004861 v. 6.0 Types of progestogens in combined oral contraception effectiveness and side-effects.rm5
CD004862 v. 3.0 Nutrient-enriched formula milk versus human breast milk for preterm infants following hospital disch.rm5
CD004863 v. 10.0 Early erythropoiesis-stimulating agents in preterm or low birth weight infants.rm5
CD004864 v. 3.0 Sodium bicarbonate infusion during resuscitation of infants at birth.rm5
CD004865 v. 5.0 Early versus late erythropoietin for preventing red blood cell transfusion in preterm andor low bir.rm5
CD004866 v. 6.0 Multinutrient fortification of human breast milk for preterm infants following hospital discharge.rm5
CD004868 v. 6.0 Late erythropoietin for preventing red blood cell transfusion in preterm andor low birth weight inf.rm5
CD004869 v. 5.0 Cysteine cystine or N-acetylcysteine supplementation in parenterally fed neonates.rm5
CD004871 v. 10.0 Massage for mechanical neck disorders.rm5
CD004872 v. 7.0 Short-term late-generation antibiotics versus longer term penicillin for acute streptococcal pharyng.rm5
CD004873 v. 14.0 Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old.rm5
CD004874 v. 10.0 Antibiotics for community-acquired pneumonia in children.rm5
CD004875 v. 9.0 Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumo.rm5
CD004876 v. 10.3 Vaccines for preventing influenza in the elderly.rm5
CD004877 v. 14.0 Chinese medicinal herbs for sore throat.rm5
CD004878 v. 10.0 Glucocorticoids for acute viral bronchiolitis in infants and young children.rm5
CD004879 v. 12.2 Vaccines for preventing influenza in healthy children.rm5
CD004882 v. 10.0 Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS).rm5
CD004884 v. 9.0 Antibiotic prophylaxis for preventing meningitis in patients with basilar skull fractures.rm5
CD004885 v. 8.0 Corticosteroids for preventing graft-versus-host disease after allogeneic myeloablative stem cell tr.rm5
CD004886 v. 3.9 Image-guided percutaneous procedure plus metronidazole versus metronidazole alone for uncomplicated .rm5
CD004887 v. 9.0 Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver di.rm5
CD004888 v. 5.0 Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus.rm5
CD004889 v. 5.2 TIPS versus paracentesis for cirrhotic patients with refractory ascites.rm5
CD004890 v. 7.0 Endoscopic balloon sphincter dilation (sphincteroplasty) versus sphincterotomy for common bile duct .rm5
CD004893 v. 7.0 Anticonvulsants for preventing seizures in patients with chronic subdural haematoma.rm5
CD004896 v. 9.2 Antifibrinolytic drugs for acute traumatic injury.rm5
CD004897 v. 6.0 Alkalinisation for organophosphorus pesticide poisoning.rm5
CD004898 v. 5.0 Monoamine oxidase B inhibitors for early Parkinson's disease.rm5
CD004899 v. 3.0 Botulinum toxin type A therapy for hemifacial spasm.rm5
CD004900 v. 4.0 Botulinum toxin type A therapy for blepharospasm.rm5
CD004901 v. 6.0 Misoprostol for induction of labour to terminate pregnancy in the second or third trimester for wome.rm5
CD004902 v. 7.0 Risk-scoring systems for predicting preterm birth with the aim of reducing associated adverse outcom.rm5
CD004903 v. 7.0 Pneumococcal vaccination during pregnancy for preventing infant infection.rm5
CD004904 v. 7.0 Prophylactic antibiotics for manual removal of retained placenta in vaginal birth.rm5
CD004905 v. 12.0 Multiple-micronutrient supplementation for women during pregnancy.rm5
CD004906 v. 8.0 Elective repeat caesarean section versus induction of labour for women with a previous caesarean bir.rm5
CD004907 v. 5.0 Package of care for active management in labour for reducing caesarean section rates in low-risk wom.rm5
CD004908 v. 6.0 Analgesia for relief of pain due to uterine crampinginvolution after birth.rm5
CD004909 v. 8.0 Fetal movement counting for assessment of fetal wellbeing.rm5
CD004910 v. 5.0 Shared care across the interface between primary and specialty care in management of long term condi.rm5
CD004912 v. 5.0 Drugs for treating uncomplicated malaria in pregnant women.rm5
CD004913 v. 4.0 Vaccines for preventing smallpox.rm5
CD004916 v. 5.4 Interventions to slow progression of myopia in children.rm5
CD004917 v. 6.0 Interventions for infantile esotropia.rm5
CD004918 v. 5.2 Aqueous shunts for glaucoma.rm5
CD004919 v. 11.0 Intra-articular lignocaine versus intravenous analgesia with or without sedation for manual reductio.rm5
CD004920 v. 10.2 Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.rm5
CD004921 v. 5.0 Chinese medicinal herbs to treat the side-effects of chemotherapy in breast cancer patients.rm5
CD004923 v. 7.0 Non-hormonal interventions for hot flushes in women with a history of breast cancer.rm5
CD004925 v. 8.0 Routine intraoperative ureteric stenting for kidney transplant recipients.rm5
CD004926 v. 9.3 Fluids and diuretics for acute ureteric colic.rm5
CD004927 v. 5.0 Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfu.rm5
CD004929 v. 5.0 Prophylactic nasogastric decompression after abdominal surgery.rm5
CD004930 v. 6.0 Systemic prokinetic pharmacologic treatment for postoperative adynamic ileus following abdominal sur.rm5
CD004931 v. 5.0 Intragastric balloon for obesity.rm5
CD004932 v. 5.0 Prevention and treatment of cryptosporidiosis in immunocompromised patients.rm5
CD004934 v. 8.0 Hydralazine for essential hypertension.rm5
CD004935 v. 9.0 Relaxation therapies for the management of primary hypertension in adults.rm5
CD004937 v. 6.12 Effect of longer-term modest salt reduction on blood pressure.rm5
CD004943 v. 6.0 Interventions at caesarean section for reducing the risk of aspiration pneumonitis.rm5
CD004944 v. 7.0 Techniques for assisting difficult delivery at caesarean section.rm5
CD004945 v. 8.0 Induction of labour for improving birth outcomes for women at or beyond term.rm5
CD004946 v. 4.0 Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) rec.rm5
CD004947 v. 11.0 Prenatal administration of progesterone for preventing preterm birth in women considered to be at ri.rm5
CD004950 v. 5.0 Breastfeeding or breast milk for procedural pain in neonates.rm5
CD004951 v. 6.0 Body positioning for spontaneously breathing preterm infants with apnoea.rm5
CD004953 v. 7.0 Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve .rm5
CD004954 v. 5.0 Hyperbaric oxygen therapy for acute ischaemic stroke.rm5
CD004955 v. 5.0 Puerarin for ischaemic stroke.rm5
CD004956 v. 9.0 Bisphosphonates for Paget's disease of bone in adults.rm5
CD004957 v. 4.0 Multidisciplinary rehabilitation programmes following joint replacement at the hip and knee in chron.rm5
CD004958 v. 8.0 Single or double-level anterior interbody fusion techniques for cervical degenerative disc disease.rm5
CD004959 v. 10.0 Opioids compared to placebo or other treatments for chronic low-back pain.rm5
CD004961 v. 6.0 Intramedullary nails for extracapsular hip fractures in adults.rm5
CD004962 v. 4.0 Conservative management following closed reduction of traumatic anterior dislocation of the shoulder.rm5
CD004963 v. 6.0 Exercise for improving balance in older people.rm5
CD004964 v. 6.0 Amphetamines for schizophrenia.rm5
CD004966 v. 4.0 Sulfadoxine-pyrimethamine plus artesunate versus sulfadoxine-pyrimethamine plus amodiaquine for trea.rm5
CD004967 v. 4.0 Drugs for treating paracoccidioidomycosis.rm5
CD004969 v. 6.2 Antibiotic use for irreversible pulpitis.rm5
CD004970 v. 10.0 Interventions for replacing missing teeth treatment of peri-implantitis.rm5
CD004971 v. 4.0 Different powered toothbrushes for plaque control and gingival health.rm5
CD004974 v. 9.0 Immunostimulants for preventing respiratory tract infection in children.rm5
CD004975 v. 10.0 Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatme.rm5
CD004976 v. 8.5 Oral antihistamine-decongestant-analgesic combinations for the common cold.rm5
CD004977 v. 6.0 Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray .rm5
CD004979 v. 8.0 Oral antibiotics versus parenteral antibiotics for severe pneumonia in children.rm5
CD004980 v. 3.0 Surgery versus sclerotherapy for the treatment of varicose veins.rm5
CD004981 v. 5.0 Treatment for femoral pseudoaneurysms.rm5
CD004982 v. 10.0 Treatment for superficial thrombophlebitis of the leg.rm5
CD004983 v. 11.2 Wound cleansing for pressure ulcers.rm5
CD004985 v. 10.0 Preoperative bathing or showering with skin antiseptics to prevent surgical site infection.rm5
CD004986 v. 7.0 Quit and Win contests for smoking cessation.rm5
CD004987 v. 6.0 Acupuncture for vascular dementia.rm5
CD004989 v. 4.0 Massage and touch for dementia.rm5
CD004990 v. 6.2 Trazodone for agitation in dementia.rm5
CD004992 v. 8.0 Excisional surgery versus ablative surgery for ovarian endometriomata.rm5
CD004993 v. 5.5 Total versus subtotal hysterectomy for benign gynaecological conditions.rm5
CD004994 v. 7.3 Bicyclol for chronic hepatitis C.rm5
CD004996 v. 7.0 Antioxidant supplements for non-alcoholic fatty liver disease andor steatohepatitis.rm5
CD004997 v. 4.0 Types of indwelling urinary catheters for long-term bladder drainage in adults.rm5
CD004998 v. 5.2 Meditation therapy for anxiety disorders.rm5
CD004999 v. 5.0 Risperidone in long-term treatment for bipolar disorder.rm5
CD005000 v. 9.0 Aripiprazole alone or in combination for acute mania.rm5
CD005001 v. 9.0 Exercise for women receiving adjuvant therapy for breast cancer.rm5
CD005002 v. 8.0 Preoperative chemotherapy for women with operable breast cancer.rm5
CD005003 v. 7.0 Rapid versus slow withdrawal of antiepileptic drugs.rm5
CD005004 v. 7.0 Green tea (Camellia sinensis) for the prevention of cancer.rm5
CD005005 v. 9.0 Hyperbaric oxygen therapy for late radiation tissue injury.rm5
CD005006 v. 11.0 Different anthracycline derivates for reducing cardiotoxicity in cancer patients.rm5
CD005007 v. 9.0 Hyperbaric oxygenation for tumour sensitisation to radiotherapy.rm5
CD005008 v. 11.0 Different dosage schedules for reducing cardiotoxicity in people with cancer receiving anthracycline.rm5
CD005009 v. 5.0 Intermittent versus continuous androgen suppression for prostatic cancer.rm5
CD005010 v. 6.0 Cryotherapy for localised prostate cancer.rm5
CD005011 v. 10.0 Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia.rm5
CD005014 v. 9.0 Home safety education and provision of safety equipment for injury prevention.rm5
CD005015 v. 11.0 Interventions for preventing bone disease in kidney transplant recipients.rm5
CD005016 v. 8.0 High-flux versus low-flux membranes for end-stage kidney disease.rm5
CD005019 v. 9.2 HMG CoA reductase inhibitors (statins) for kidney transplant recipients.rm5
CD005020 v. 7.0 Vision screening for amblyopia in childhood.rm5
CD005022 v. 5.0 Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-r.rm5
CD005023 v. 7.3 Vision screening for correctable visual acuity deficits in school-age children and adolescents.rm5
CD005024 v. 7.0 Surgery for traumatic optic neuropathy.rm5
CD005025 v. 6.0 Reminder packaging for improving adherence to self-administered long-term medications.rm5
CD005028 v. 7.0 Topical treatments for chronic plaque psoriasis.rm5
CD005029 v. 5.0 Treatment for ataxia in multiple sclerosis.rm5
CD005030 v. 9.0 Interventions for prevention of drug use by young people delivered in non-school settings.rm5
CD005031 v. 13.0 Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxificat.rm5
CD005032 v. 8.0 Alcoholics Anonymous and other 12-step programmes for alcohol dependence.rm5
CD005033 v. 6.0 Perioperative blood transfusions and recurrence of colorectal cancer.rm5
CD005034 v. 6.0 Rubber band ligation versus excisional haemorrhoidectomy for haemorrhoids.rm5
CD005037 v. 15.0 Selenium for alleviating the side effects of chemotherapy radiotherapy and surgery in cancer patien.rm5
CD005038 v. 5.0 Massage for promoting mental and physical health in typically developing infants under the age of si.rm5
CD005039 v. 11.0 Community-based supplementary feeding for promoting the growth of children under five years of age i.rm5
CD005040 v. 5.0 Risperidone for autism spectrum disorder.rm5
CD005042 v. 7.0 Family therapy for attention-deficit disorder or attention-deficithyperactivity disorder in childre.rm5
CD005043 v. 7.0 Advocacy interventions to reduce or eliminate violence and promote the physical and psychosocial wel.rm5
CD005044 v. 5.0 Quinine for muscle cramps.rm5
CD005045 v. 4.0 Treatment for periodic paralysis.rm5
CD005046 v. 10.0 Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasi.rm5
CD005048 v. 8.0 Interventions for dysphagia in oesophageal cancer.rm5
CD005049 v. 7.2 Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.rm5
CD005050 v. 4.0 Influenza vaccines for preventing cardiovascular disease.rm5
CD005051 v. 4.3 Whole grain cereals for the primary or secondary prevention of cardiovascular disease.rm5
CD005053 v. 7.0 Adjuvant antiviral therapy for recurrent respiratory papillomatosis.rm5
CD005055 v. 11.0 Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and child.rm5
CD005056 v. 6.0 Paracervical local anaesthesia for cervical dilatation and uterine intervention.rm5
CD005059 v. 11.0 Epidural pain relief versus systemic opioid-based pain relief for abdominal aortic surgery.rm5
CD005060 v. 6.0 Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin.rm5
CD005061 v. 3.0 Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood gl.rm5
CD005062 v. 10.0 Acupuncture for epilepsy.rm5
CD005063 v. 8.3 Benzodiazepines for alcohol withdrawal.rm5
CD005064 v. 9.0 Anticonvulsants for alcohol withdrawal.rm5
CD005066 v. 6.0 Stroke liaison workers for stroke patients and carers an individual patient data meta-analysis.rm5
CD005067 v. 9.0 Interventions for Old World cutaneous leishmaniasis.rm5
CD005068 v. 6.0 Interventions for pityriasis rosea.rm5
CD005070 v. 6.0 Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovaria.rm5
CD005071 v. 5.0 Gonadotrophins for idiopathic male factor subfertility.rm5
CD005072 v. 6.0 Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surge.rm5
CD005073 v. 7.0 Uterine artery embolization for symptomatic uterine fibroids.rm5
CD005074 v. 5.0 Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease.rm5
CD005075 v. 4.0 Indoor air modification interventions for prolonged non-specific cough in children.rm5
CD005076 v. 6.0 Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults a.rm5
CD005077 v. 4.0 Surgical interventions for anterior shoulder instability in adults.rm5
CD005078 v. 3.0 Surgical versus conservative management for odontoid fractures.rm5
CD005079 v. 4.0 Surgical versus non-surgical treatment for thoracolumbar burst fractures without neurological defici.rm5
CD005080 v. 3.0 Intra-peritoneal prophylactic agents for preventing adhesions and adhesive intestinal obstruction af.rm5
CD005081 v. 7.0 Medical and surgical treatment for ocular myasthenia.rm5
CD005082 v. 11.0 Silver based wound dressings and topical agents for treating diabetic foot ulcers.rm5
CD005083 v. 11.0 Honey as a topical treatment for wounds.rm5
CD005084 v. 6.0 Interventions for tobacco cessation in the dental setting.rm5
CD005085 v. 4.0 Oximes for acute organophosphate pesticide poisoning.rm5
CD005086 v. 9.0 Plugs for containing faecal incontinence.rm5
CD005087 v. 8.0 Sodium channel blockers for cystic fibrosis.rm5
CD005088 v. 8.0 Bisphosphonate therapy for osteogenesis imperfecta.rm5
CD005089 v. 4.2 Partial exchange transfusion to prevent neurodevelopmental disability in infants with polycythemia.rm5
CD005090 v. 4.0 The effect of inotropes on morbidity and mortality in preterm infants with low systemic or organ blo.rm5
CD005091 v. 6.0 One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or prov.rm5
CD005092 v. 5.0 Cup feeding versus other forms of supplemental enteral feeding for newborn infants unable to fully b.rm5
CD005093 v. 8.0 Increased energy intake for preterm infants with (or developing) bronchopulmonary dysplasiachronic .rm5
CD005095 v. 5.0 Enteral iron supplementation in preterm and low birth weight infants.rm5
CD005096 v. 8.2 Chinese herbal medicines for induction of remission in advanced or late gastric cancer.rm5
CD005098 v. 4.0 Reinforcement of anchorage during orthodontic brace treatment with implants or other surgical method.rm5
CD005101 v. 7.0 Slow-release fluoride devices for the control of dental decay.rm5
CD005103 v. 4.0 Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabet.rm5
CD005105 v. 3.0 Low glycaemic index or low glycaemic load diets for overweight and obesity.rm5
CD005106 v. 9.0 Patient education for neck pain.rm5
CD005107 v. 9.0 Low level laser therapy for nonspecific low-back pain.rm5
CD005108 v. 4.0 Self-management education programmes by lay leaders for people with chronic conditions.rm5
CD005109 v. 9.0 Recombinant human interleukin 10 for induction of remission in Crohn's disease.rm5
CD005110 v. 4.0 Hypnotherapy for treatment of irritable bowel syndrome.rm5
CD005111 v. 5.0 Acupuncture for treatment of irritable bowel syndrome.rm5
CD005112 v. 5.0 Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis.rm5
CD005113 v. 5.0 Adalimumab for treating rheumatoid arthritis.rm5
CD005114 v. 5.0 Dehydroepiandrosterone for systemic lupus erythematosus.rm5
CD005115 v. 4.0 Rofecoxib for osteoarthritis.rm5
CD005117 v. 6.8 Diacerein for osteoarthritis.rm5
CD005118 v. 4.0 Arthroscopic debridement for knee osteoarthritis.rm5
CD005119 v. 8.0 Calcium supplementation for improving bone mineral density in children.rm5
CD005121 v. 3.0 Anakinra for rheumatoid arthritis.rm5
CD005122 v. 11.0 Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for ass.rm5
CD005123 v. 7.0 Antenatal perineal massage for reducing perineal trauma.rm5
CD005124 v. 4.0 Antenatal psychosocial assessment for reducing perinatal mental health morbidity.rm5
CD005125 v. 7.0 Antibiotic prophylaxis for third- and fourth-degree perineal tear during vaginal birth.rm5
CD005126 v. 5.1 Chinese herbal medicines for treating pre-eclampsia.rm5
CD005128 v. 8.3 Interventions for preventing and treating kidney disease in Henoch-Schnlein Purpura (HSP).rm5
CD005129 v. 8.0 Immunoglobulins vaccines or interferon for preventing cytomegalovirus disease in solid organ transp.rm5
CD005131 v. 7.2 Oestrogens for preventing recurrent urinary tract infection in postmenopausal women.rm5
CD005133 v. 10.0 Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ.rm5
CD005134 v. 7.0 Pentasaccharides for the prevention of venous thromboembolism.rm5
CD005135 v. 5.2 Laser-assisted in-situ keratomileusis (LASIK) versus photorefractive keratectomy (PRK) for myopia.rm5
CD005136 v. 6.0 Occlusion for stimulus deprivation amblyopia.rm5
CD005137 v. 5.0 Interventions for unilateral and bilateral refractive amblyopia.rm5
CD005138 v. 7.0 Antiangiogenic therapy with interferon alfa for neovascular age-related macular degeneration.rm5
CD005139 v. 6.0 Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.rm5
CD005143 v. 6.0 Hyperbaric versus isobaric bupivacaine for spinal anaesthesia for caesarean section.rm5
CD005144 v. 5.0 Nutritional support for critically ill children.rm5
CD005146 v. 9.0 Haloperidol plus promethazine for psychosis-induced aggression.rm5
CD005147 v. 6.0 Training to recognise the early signs of recurrence in schizophrenia.rm5
CD005148 v. 4.0 Interventions to reduce weight gain in schizophrenia.rm5
CD005149 v. 10.0 Intranasal steroids for acute sinusitis.rm5
CD005151 v. 5.0 Nitrates for acute heart failure syndromes.rm5
CD005154 v. 7.0 Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia.rm5
CD005158 v. 6.0 Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events.rm5
CD005159 v. 4.2 Rifabutin for treating pulmonary tuberculosis.rm5
CD005160 v. 4.0 Bile acids for non-alcoholic fatty liver disease andor steatohepatitis.rm5
CD005161 v. 6.0 Cyclosporin versus tacrolimus for liver transplanted patients.rm5
CD005162 v. 7.0 Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome.rm5
CD005164 v. 5.0 Elective surgery for benign liver tumours.rm5
CD005165 v. 4.0 Probiotics for non-alcoholic fatty liver disease andor steatohepatitis.rm5
CD005167 v. 6.0 Family interventions for bipolar disorder.rm5
CD005169 v. 6.0 Omega-3 fatty acids for bipolar disorder.rm5
CD005170 v. 7.2 Pharmacotherapy for anxiety disorders in children and adolescents.rm5
CD005171 v. 9.0 Oxcarbazepine in the maintenance treatment of bipolar disorder.rm5
CD005173 v. 11.0 Tiagabine in the maintenance treatment of bipolar disorder.rm5
CD005175 v. 4.0 The medical use of cannabis for reducing morbidity and mortality in patients with HIVAIDS.rm5
CD005176 v. 9.0 Aerobic exercise training programmes for improving physical and psychosocial health in adults with D.rm5
CD005177 v. 8.0 Interventions for noisy breathing in patients near to death.rm5
CD005179 v. 8.0 Psychological interventions for needle-related procedural pain and distress in children and adolesce.rm5
CD005181 v. 8.2 Interferon beta for secondary progressive multiple sclerosis.rm5
CD005182 v. 7.0 Interventions used to improve control of blood pressure in patients with hypertension.rm5
CD005184 v. 10.5 Creatine and creatine analogues in hypertension and cardiovascular disease.rm5
CD005185 v. 6.2 Thiazide diuretics and the risk of hip fracture.rm5
CD005186 v. 7.2 Interventions to improve hand hygiene compliance in patient care.rm5
CD005187 v. 9.4 Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-ter.rm5
CD005188 v. 7.0 Interventions to increase influenza vaccination rates of those 60 years and older in the community.rm5
CD005189 v. 12.0 Antibiotics for bronchiolitis in children under two years of age.rm5
CD005190 v. 7.0 Psychotropic analgesic nitrous oxide for alcoholic withdrawal states.rm5
CD005191 v. 9.0 Brief interventions for heavy alcohol users admitted to general hospital wards.rm5
CD005192 v. 7.0 Auricular acupuncture for cocaine dependence.rm5
CD005195 v. 14.3 Selenium for preventing cancer.rm5
CD005196 v. 17.2 Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumour.rm5
CD005197 v. 9.0 Anti-pseudomonal beta-lactams for the initial empirical treatment of febrile neutropenia comparis.rm5
CD005198 v. 8.7 Therapeutic interventions for Burkitt lymphoma in children.rm5
CD005199 v. 7.0 Transverse verses midline incisions for abdominal surgery.rm5
CD005200 v. 4.0 Laparoscopic versus open total mesorectal excision for rectal cancer.rm5
CD005202 v. 4.0 Adjuvant chemotherapy for small intestine adenocarcinoma.rm5
CD005203 v. 4.0 Dietary exclusions for established atopic eczema.rm5
CD005205 v. 7.0 Dietary supplements for established atopic eczema.rm5
CD005207 v. 9.0 Colony stimulating factors (including erythropoietin granulocyte colony stimulating factor and anal.rm5
CD005208 v. 6.0 Glycoprotein IIb-IIIa inhibitors for acute ischaemic stroke.rm5
CD005211 v. 6.0 Exercise interventions for upper-limb dysfunction due to breast cancer treatment.rm5
CD005212 v. 6.0 Sequencing of chemotherapy and radiotherapy for early breast cancer.rm5
CD005213 v. 3.0 Interventions to support the decision-making process for older people facing the possibility of long.rm5
CD005214 v. 5.2 Depot medroxyprogesterone versus Norethisterone oenanthate for long-acting progestogenic contracepti.rm5
CD005215 v. 7.0 Interventions for preventing unintended pregnancies among adolescents.rm5
CD005216 v. 7.0 Medical methods for mid-trimester termination of pregnancy.rm5
CD005217 v. 5.0 Perioperative antibiotics to prevent infection after first-trimester abortion.rm5
CD005218 v. 6.0 Spermicide used alone for contraception.rm5
CD005219 v. 11.0 Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster he.rm5
CD005220 v. 6.1 Drugs for the acute treatment of migraine in children and adolescents.rm5
CD005221 v. 5.2 Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical trea.rm5
CD005222 v. 7.3 Corticosteroids including ACTH for childhood epilepsy other than epileptic spasms.rm5
CD005224 v. 4.0 Immunosuppressive agents for myasthenia gravis.rm5
CD005225 v. 6.2 Creatine for amyotrophic lateral sclerosismotor neuron disease.rm5
CD005226 v. 6.4 Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease.rm5
CD005228 v. 6.2 Interventions for preventing neuropathy caused by cisplatin and related compounds.rm5
CD005229 v. 5.2 Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease.rm5
CD005230 v. 4.8 Complementary and miscellaneous interventions for nocturnal enuresis in children.rm5
CD005231 v. 7.0 Interventions to reduce harm from continued tobacco use.rm5
CD005233 v. 5.0 Cognitive behavioural therapy for tinnitus.rm5
CD005235 v. 3.2 Inferior turbinate surgery for nasal obstruction in allergic rhinitis after failed medical treatment.rm5
CD005237 v. 7.0 Risperidone versus olanzapine for schizophrenia.rm5
CD005239 v. 6.2 Psychological treatment for anxiety in people with traumatic brain injury.rm5
CD005240 v. 5.0 Motorcycle rider training for the prevention of road traffic crashes.rm5
CD005242 v. 4.4 Increased police patrols for preventing alcohol-impaired driving.rm5
CD005244 v. 9.2 Interventions in the alcohol server setting for preventing injuries.rm5
CD005246 v. 3.0 Neo-adjuvant chemotherapy for invasive bladder cancer.rm5
CD005247 v. 4.0 Chemotherapy for hormone-refractory prostate cancer.rm5
CD005248 v. 8.0 Intravenous in-line filters for preventing morbidity and mortality in neonates.rm5
CD005249 v. 5.0 Push versus gravity for intermittent bolus gavage tube feeding of premature and low birth weight inf.rm5
CD005251 v. 5.0 Prophylactic antibiotics to reduce morbidity and mortality in neonates with umbilical venous cathete.rm5
CD005252 v. 6.0 Avoidance of bottles during the establishment of breast feeds in preterm infants.rm5
CD005253 v. 3.0 Iodine supplementation for the prevention of mortality and adverse neurodevelopmental outcomes in pr.rm5
CD005254 v. 3.0 Surfactant for pulmonary haemorrhage in neonates.rm5
CD005255 v. 6.0 Responsive versus scheduled feeding for preterm infants.rm5
CD005256 v. 2.0 Early introduction of lipids to parenterally-fed preterm infants.rm5
CD005257 v. 4.2 Interventions for non-oliguric hyperkalaemia in preterm neonates.rm5
CD005258 v. 4.2 Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of ve.rm5
CD005259 v. 6.0 Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy.rm5
CD005260 v. 8.0 Prosthetic rehabilitation for older dysvascular people following a unilateral transfemoral amputatio.rm5
CD005261 v. 7.0 Endovascular treatment for ruptured abdominal aortic aneurysm.rm5
CD005262 v. 10.0 Pentoxifylline for intermittent claudication.rm5
CD005263 v. 6.0 Supervised exercise therapy versus home-based exercise therapy versus walking advice for intermitten.rm5
CD005265 v. 3.3 Antibiotic prophylaxis for patients undergoing elective laparoscopic cholecystectomy.rm5
CD005268 v. 2.2 Individual patient education for people with type 2 diabetes mellitus.rm5
CD005270 v. 1.2 Long-term non-pharmacological weight loss interventions for adults with prediabetes.rm5
CD005272 v. 4.0 Behavioral interventions to reduce the transmission of HIV infection among sex workers and their cli.rm5
CD005274 v. 5.2 Interventions to reduce risky sexual behaviour for preventing HIV infection in workers in occupation.rm5
CD005275 v. 7.0 Insoles for prevention and treatment of back pain.rm5
CD005276 v. 7.0 Topical anaesthesia alone versus topical anaesthesia with intracameral lidocaine for phacoemulsifica.rm5
CD005277 v. 5.2 Recompression and adjunctive therapy for decompression illness.rm5
CD005278 v. 6.0 Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating.rm5
CD005279 v. 5.0 Ultrasound use for the placement of haemodialysis catheters.rm5
CD005282 v. 6.0 Fish oil for kidney transplant recipients.rm5
CD005283 v. 6.0 Biocompatible hemodialysis membranes for acute renal failure.rm5
CD005284 v. 9.2 Treatment for peritoneal dialysis-associated peritonitis.rm5
CD005285 v. 8.0 Preoperative fasting for preventing perioperative complications in children.rm5
CD005287 v. 6.0 Selective estrogen receptor modulators (SERMs) for uterine leiomyomas.rm5
CD005288 v. 6.0 Chinese herbal medicine for primary dysmenorrhoea.rm5
CD005289 v. 5.0 Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI).rm5
CD005291 v. 5.0 Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fert.rm5
CD005292 v. 5.2 Herbal preparations for uterine fibroids.rm5
CD005293 v. 3.0 Interventions for iatrogenic inferior alveolar and lingual nerve injury.rm5
CD005296 v. 4.2 Single versus multiple visits for endodontic treatment of permanent teeth.rm5
CD005297 v. 4.2 Treating periodontal disease for preventing adverse birth outcomes in pregnant women.rm5
CD005298 v. 5.2 Routine prophylactic drugs in normal labour for reducing gastric aspiration and its effects.rm5
CD005299 v. 6.0 Symphysiotomy for feto-pelvic disproportion.rm5
CD005300 v. 9.0 Specialised antenatal clinics for women with a multiple pregnancy for improving maternal and infant .rm5
CD005302 v. 6.0 Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term.rm5
CD005303 v. 7.0 Restriction of oral intake of water for aspiration lung disease in children.rm5
CD005304 v. 4.0 Interventions for primary (intrinsic) tracheomalacia in children.rm5
CD005305 v. 5.0 Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease.rm5
CD005306 v. 3.1 Written action plans for asthma in children.rm5
CD005307 v. 7.0 Addition of long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asth.rm5
CD005308 v. 9.0 Continuous positive airway pressure delivery interfaces for obstructive sleep apnoea.rm5
CD005309 v. 9.0 Fluticasone versus 'extrafine' HFA-beclomethasone dipropionate for chronic asthma in adults and chil.rm5
CD005310 v. 10.0 Methylxanthines for prolonged non-specific cough in children.rm5
CD005311 v. 6.0 Parent-initiated oral corticosteroid therapy for intermittent wheezing illnesses in children.rm5
CD005312 v. 5.3 Hawthorn extract for treating chronic heart failure.rm5
CD005313 v. 4.0 Primary stenting versus primary balloon angioplasty for treating acute myocardial infarction.rm5
CD005314 v. 4.0 Interventions for increasing the proportion of health professionals practising in rural and other un.rm5
CD005315 v. 4.0 Sensory environment on health-related outcomes of hospital patients.rm5
CD005317 v. 5.0 Cholinesterase inhibitors for delirium.rm5
CD005318 v. 6.0 Cognitive reframing for carers of people with dementia.rm5
CD005319 v. 3.0 Acupuncture for shoulder pain.rm5
CD005320 v. 3.0 Operative and non-operative treatment options for dislocation of the hip following total hip arthrop.rm5
CD005321 v. 4.0 Viscosupplementation for the treatment of osteoarthritis of the knee.rm5
CD005324 v. 4.0 Bisphosphonate therapy for children and adolescents with secondary osteoporosis.rm5
CD005326 v. 5.0 Strontium ranelate for preventing and treating postmenopausal osteoporosis.rm5
CD005328 v. 6.2 Intra-articular corticosteroid for knee osteoarthritis.rm5
CD005330 v. 6.0 Media-delivered cognitive behavioural therapy and behavioural therapy (self-help) for anxiety disord.rm5
CD005331 v. 4.0 Psychosocial interventions for conversion disorder.rm5
CD005332 v. 6.0 Pharmacotherapy and psychotherapy for body dysmorphic disorder.rm5
CD005333 v. 3.0 Psychological treatments versus treatment as usual for obsessive compulsive disorder (OCD).rm5
CD005335 v. 5.10 Combined psychotherapy plus benzodiazepines for panic disorder.rm5
CD005336 v. 6.0 Psychosocial interventions for cannabis use disorder.rm5
CD005338 v. 5.0 Therapeutic communities for substance related disorder.rm5
CD005339 v. 5.0 Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunctio.rm5
CD005340 v. 13.0 Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer.rm5
CD005341 v. 6.0 Granulocyte transfusions for preventing infections in people with neutropenia or neutrophil dysfunct.rm5
CD005342 v. 6.0 Adjuvant platinum-based chemotherapy for early stage cervical cancer.rm5
CD005343 v. 8.0 Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.rm5
CD005344 v. 13.0 Laparoscopy versus laparotomy for FIGO stage I ovarian cancer.rm5
CD005346 v. 9.3 Insulin for glycaemic control in acute ischaemic stroke.rm5
CD005347 v. 6.0 Copper containing framed intra-uterine devices for contraception.rm5
CD005351 v. 3.2 Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema.rm5
CD005353 v. 9.2 Cannabinoid type 1 receptor antagonists for smoking cessation.rm5
CD005354 v. 7.0 Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology.rm5
CD005355 v. 8.0 Interventions to reduce haemorrhage during myomectomy for fibroids.rm5
CD005356 v. 6.0 Ovarian stimulation protocols (anti-oestrogens gonadotrophins with and without GnRH agonistsantago.rm5
CD005360 v. 9.0 Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery.rm5
CD005364 v. 11.0 Topical anaesthetics for pain control during repair of dermal laceration.rm5
CD005365 v. 3.0 Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts.rm5
CD005370 v. 9.3 Antithrombin III for critically ill patients.rm5
CD005372 v. 5.0 Oxygen therapy during exercise training in chronic obstructive pulmonary disease.rm5
CD005373 v. 6.0 Inhaled beta2-agonists for non-specific chronic cough in children.rm5
CD005374 v. 3.0 Oral corticosteroids for stable chronic obstructive pulmonary disease.rm5
CD005375 v. 10.0 Surgery for scoliosis in Duchenne muscular dystrophy.rm5
CD005376 v. 5.0 Treatment for IgG and IgA paraproteinaemic neuropathy.rm5
CD005377 v. 7.0 Atypical antipsychotics for people with both schizophrenia and depression.rm5
CD005378 v. 3.0 Drama therapy for schizophrenia or schizophrenia-like illnesses.rm5
CD005379 v. 7.0 Omega 3 fatty acid for the prevention of cognitive decline and dementia.rm5
CD005380 v. 9.1 Metal protein attenuating compounds for the treatment of Alzheimer's dementia.rm5
CD005381 v. 5.1 Aerobic exercise to improve cognitive function in older people without known cognitive impairment.rm5
CD005382 v. 5.0 Yizhi capsule for vascular dementia.rm5
CD005383 v. 5.3 Antithrombin for respiratory distress syndrome in preterm infants.rm5
CD005384 v. 4.0 Early nasal intermittent positive pressure ventilation (NIPPV) versus early nasal continuous positiv.rm5
CD005385 v. 5.0 Recombinant human activated protein C for severe sepsis in neonates.rm5
CD005386 v. 3.0 Pre-discharge car seat challenge for preventing morbidity and mortality in preterm infants.rm5
CD005387 v. 7.0 Physical activity programs for promoting bone mineralization and growth in preterm infants.rm5
CD005389 v. 4.0 Fluid restriction for treatment of preterm infants with chronic lung disease.rm5
CD005390 v. 4.0 Adjuvant Therapy for completely resected Stage II Colon Cancer.rm5
CD005391 v. 4.6 Workload and surgeons specialty for outcome after colorectal cancer surgery.rm5
CD005392 v. 4.0 Anti-angiogenic therapies for metastatic colorectal cancer.rm5
CD005393 v. 6.2 Stapled versus conventional surgery for hemorrhoids.rm5
CD005395 v. 4.2 Surgery for Mnire's disease.rm5
CD005397 v. 6.0 Vestibular rehabilitation for unilateral peripheral vestibular dysfunction.rm5
CD005398 v. 10.0 Antiepileptic drugs for the primary and secondary prevention of seizures after stroke.rm5
CD005399 v. 10.0 Pharmacological interventions for epilepsy in people with intellectual disabilities.rm5
CD005400 v. 4.2 Magnesium for acute traumatic brain injury.rm5
CD005401 v. 8.0 Bicycle helmet legislation for the uptake of helmet use and prevention of head injuries.rm5
CD005405 v. 9.0 Oral anti-pseudomonal antibiotics for cystic fibrosis.rm5
CD005406 v. 9.0 Fluid replacement therapy for acute episodes of pain in people with sickle cell disease.rm5
CD005411 v. 3.2 Systemic interventions for recurrent aphthous stomatitis (mouth ulcers).rm5
CD005414 v. 5.0 Interventions for preventing non-melanoma skin cancers in high-risk groups.rm5
CD005415 v. 9.0 Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bl.rm5
CD005417 v. 3.0 Home-based care for reducing morbidity and mortality in people infected with HIVAIDS.rm5
CD005419 v. 4.0 Interventions for previously untreated patients with AIDS-associated Non-Hodgkins Lymphoma.rm5
CD005420 v. 5.0 Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor set.rm5
CD005421 v. 3.2 Abstinence-only programs for HIV infection prevention in high-income countries.rm5
CD005425 v. 7.0 Lipid-lowering agents for nephrotic syndrome.rm5
CD005426 v. 9.0 Nutritional support for acute kidney injury.rm5
CD005427 v. 6.0 Combined chiropractic interventions for low-back pain.rm5
CD005428 v. 6.0 Antibiotic prophylaxis for short-term catheter bladder drainage in adults.rm5
CD005429 v. 5.0 Which anticholinergic drug for overactive bladder symptoms in adults.rm5
CD005430 v. 5.0 Topical corticosteroids as adjunctive therapy for bacterial keratitis.rm5
CD005431 v. 5.2 Medical interventions for traumatic hyphema.rm5
CD005433 v. 5.2 Lactose avoidance for young children with acute diarrhoea.rm5
CD005434 v. 6.0 Electronic mosquito repellents for preventing mosquito bites and malaria infection.rm5
CD005435 v. 6.0 Drugs for preventing tuberculosis in people at risk of multiple-drug-resistant pulmonary tuberculosi.rm5
CD005436 v. 7.0 Oral zinc for treating diarrhoea in children.rm5
CD005437 v. 8.0 Pre-admission antibiotics for suspected cases of meningococcal disease.rm5
CD005440 v. 9.0 Early versus delayed laparoscopic cholecystectomy for people with acute cholecystitis.rm5
CD005441 v. 6.0 Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C.rm5
CD005442 v. 7.0 Bile acids for liver-transplanted patients.rm5
CD005443 v. 7.0 Antacids for preventing oesophagogastric variceal bleeding and rebleeding in cirrhotic patients.rm5
CD005444 v. 6.4 Pre-operative biliary drainage for obstructive jaundice.rm5
CD005445 v. 6.4 Ribavirin plus interferon versus interferon for chronic hepatitis C.rm5
CD005449 v. 3.0 Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in typ.rm5
CD005450 v. 3.0 Chinese herbal medicines for hyperthyroidism.rm5
CD005451 v. 17.0 Carbamazepine for chronic neuropathic pain and fibromyalgia in adults.rm5
CD005454 v. 12.0 Antidepressants for neuropathic pain.rm5
CD005455 v. 4.0 Choice of instruments for assisted vaginal delivery.rm5
CD005456 v. 4.0 Prophylactic use of ergot alkaloids in the third stage of labour.rm5
CD005457 v. 7.0 Carbetocin for preventing postpartum haemorrhage.rm5
CD005458 v. 6.0 Antibiotics for mastitis in breastfeeding women.rm5
CD005459 v. 6.0 Laparoscopic surgery for presumed benign ovarian tumor during pregnancy.rm5
CD005460 v. 6.0 Traditional birth attendant training for improving health behaviours and pregnancy outcomes.rm5
CD005461 v. 8.0 Effect of partogram use on outcomes for women in spontaneous labour at term.rm5
CD005462 v. 5.0 Fundal pressure versus controlled cord traction as part of the active management of the third stage .rm5
CD005463 v. 3.2 Individual and group-based parenting programmes for the treatment of physical child abuse and neglec.rm5
CD005465 v. 8.0 Interventions for preventing falls in older people in care facilities and hospitals.rm5
CD005467 v. 3.0 Chinese herbal medicines for treating osteoporosis.rm5
CD005468 v. 3.0 TNF-alpha inhibitors for ankylosing spondylitis.rm5
CD005470 v. 6.1 Tailored interventions to address determinants of practice.rm5
CD005471 v. 5.0 Interventions to improve outpatient referrals from primary care to secondary care.rm5
CD005472 v. 6.2 Acupuncture for insomnia.rm5
CD005473 v. 3.0 Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders.rm5
CD005474 v. 6.0 Zuclopenthixol dihydrochloride for schizophrenia.rm5
CD005475 v. 8.2 Acupuncture for schizophrenia.rm5
CD005476 v. 7.0 Laetrile treatment for cancer.rm5
CD005477 v. 5.0 Single layer versus double layer suture anastomosis of the gastrointestinal tract.rm5
CD005478 v. 3.0 Naftidrofuryl for acute stroke.rm5
CD005479 v. 3.0 Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1.rm5
CD005481 v. 7.0 Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS.rm5
CD005482 v. 4.0 Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults.rm5
CD005483 v. 3.0 Anabolic steroids for the treatment of weight loss in HIV-infected individuals.rm5
CD005485 v. 7.0 Pressure-relieving devices for treating heel pressure ulcers.rm5
CD005486 v. 8.0 Topical silver for treating infected wounds.rm5
CD005487 v. 6.1 Infraclavicular brachial plexus block for regional anaesthesia of the lower arm.rm5
CD005488 v. 3.0 Urinary alkalinisation for acute chlorophenoxy herbicide poisoning.rm5
CD005489 v. 3.9 Early versus delayed enteral nutrition support for burn injuries.rm5
CD005490 v. 3.0 Antidotes for acute cardenolide (cardiac glycoside) poisoning.rm5
CD005491 v. 10.0 Corticosteroids for treating nerve damage in leprosy.rm5
CD005493 v. 7.10 Botulinum toxin injections for adults with overactive bladder syndrome.rm5
CD005494 v. 5.0 Sildenafil for pulmonary hypertension in neonates.rm5
CD005495 v. 6.0 Early developmental intervention programmes provided post hospital discharge to prevent motor and co.rm5
CD005496 v. 7.0 Probiotics for prevention of necrotizing enterocolitis in preterm infants.rm5
CD005497 v. 8.2 Advance provision of emergency contraception for pregnancy prevention.rm5
CD005500 v. 4.0 Topical pimecrolimus for eczema.rm5
CD005501 v. 9.0 Antiepileptic drugs for the primary and secondary prevention of seizures after intracranial venous t.rm5
CD005502 v. 9.0 Non-pharmacological interventions for people with epilepsy and intellectual disabilities.rm5
CD005504 v. 4.0 Levodopa for the treatment of restless legs syndrome.rm5
CD005506 v. 7.8 Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents.rm5
CD005507 v. 5.0 Cryoplasty for peripheral arterial disease.rm5
CD005508 v. 4.0 Beta blockers for peripheral arterial disease.rm5
CD005509 v. 6.0 Interventions for preventing venous thromboembolism following abdominal aortic surgery.rm5
CD005511 v. 5.0 Endodontic procedures for retreatment of periapical lesions.rm5
CD005512 v. 4.3 Preformed crowns for decayed primary molar teeth.rm5
CD005514 v. 3.0 Occlusal splints for treating sleep bruxism (tooth grinding).rm5
CD005515 v. 8.0 Orthodontic and orthopaedic treatment for anterior open bite in children.rm5
CD005516 v. 4.0 Enamel etching for bonding fixed orthodontic braces.rm5
CD005517 v. 3.2 Materials for retrograde filling in root canal therapy.rm5
CD005520 v. 6.0 Oral appliances and functional orthopaedic appliances for obstructive sleep apnoea in children.rm5
CD005521 v. 3.0 Systemic corticosteroids for acute gout.rm5
CD005522 v. 5.0 Tramadol for osteoarthritis.rm5
CD005523 v. 5.0 Aquatic exercise for the treatment of knee and hip osteoarthritis.rm5
CD005525 v. 4.0 Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistanc.rm5
CD005526 v. 3.0 Cyclosporin A for primary biliary cirrhosis.rm5
CD005527 v. 5.4 Ribavirin monotherapy for chronic hepatitis C.rm5
CD005528 v. 4.0 Non-clinical interventions for reducing unnecessary caesarean section.rm5
CD005529 v. 6.0 Outreach and Early Warning Systems (EWS) for the prevention of Intensive Care admission and death of.rm5
CD005530 v. 9.0 Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary pre.rm5
CD005531 v. 12.0 Chinese medicinal herbs for measles.rm5
CD005532 v. 8.4 Vitamin C for preventing and treating pneumonia.rm5
CD005533 v. 3.0 Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in ad.rm5
CD005534 v. 3.3 Oxygen therapy in the pre-hospital setting for acute exacerbations of chronic obstructive pulmonary .rm5
CD005535 v. 3.0 Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticost.rm5
CD005536 v. 6.0 Commercial versus home-made spacers in delivering bronchodilator therapy for acute therapy in childr.rm5
CD005537 v. 9.0 Psychotherapy for depression among incurable cancer patients.rm5
CD005539 v. 7.0 Nutritional screening for improving professional practice for patient outcomes in hospital and prima.rm5
CD005540 v. 14.0 Interventions for sexual dysfunction following treatments for cancer in women.rm5
CD005541 v. 4.0 Antenatal phenobarbital for reducing neonatal jaundice after red cell isoimmunization.rm5
CD005542 v. 8.0 Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant wo.rm5
CD005543 v. 4.0 Intrapartum interventions for preventing shoulder dystocia.rm5
CD005544 v. 3.0 Medications for increasing milk supply in mothers expressing breastmilk for their preterm hospitalis.rm5
CD005545 v. 3.0 Trial of instrumental delivery in theatre versus immediate caesarean section for anticipated difficu.rm5
CD005546 v. 8.0 Caesarean section versus vaginal delivery for preventing mother to infant hepatitis C virus transmis.rm5
CD005547 v. 7.0 Effect of administration of antihelminthics for soil-transmitted helminths during pregnancy.rm5
CD005548 v. 6.0 Altered dietary salt for preventing pre-eclampsia and its complications.rm5
CD005549 v. 8.0 Interventions for waterpipe smoking cessation.rm5
CD005552 v. 5.0 Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism acne and risk o.rm5
CD005555 v. 3.0 Lens extraction for chronic angle-closure glaucoma.rm5
CD005556 v. 3.3 Interventions for chronic blepharitis.rm5
CD005558 v. 3.0 Independent living programmes for improving outcomes for young people leaving the care system.rm5
CD005562 v. 5.0 Cognitive stimulation to improve cognitive functioning in people with dementia.rm5
CD005563 v. 5.0 Interventions for preventing delirium in hospitalised non-ICU patients.rm5
CD005564 v. 6.0 Artemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malaria.rm5
CD005565 v. 5.3 Corticosteroid regimens for treatment of acute and chronic graft versus host disease (GvHD) after al.rm5
CD005566 v. 4.0 Prophylactic corticosteroids for cardiopulmonary bypass in adults.rm5
CD005568 v. 3.0 Dengzhanhua preparations for acute cerebral infarction.rm5
CD005569 v. 3.0 Chuanxiong-type preparations for acute ischemic stroke.rm5
CD005570 v. 11.2 Wound drains after incisional hernia repair.rm5
CD005571 v. 8.0 Systemic antimicrobial prophylaxis for percutaneous endoscopic gastrostomy.rm5
CD005573 v. 4.0 Probiotics for induction of remission in ulcerative colitis.rm5
CD005574 v. 4.0 Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care f.rm5
CD005575 v. 6.2 Organisational travel plans for improving health.rm5
CD005576 v. 8.0 Hypertonic salt solution for peri-operative fluid management.rm5
CD005578 v. 3.0 Pharmacotherapy for sleep bruxism.rm5
CD005579 v. 6.0 Pharmacological interventions for clozapine-induced hypersalivation.rm5
CD005580 v. 3.0 Antipsychotic medication for elderly people with schizophrenia.rm5
CD005581 v. 4.0 Antidepressants for the negative symptoms of schizophrenia.rm5
CD005582 v. 7.0 Corticosteroids for preventing postherpetic neuralgia.rm5
CD005583 v. 4.22 Helicobacter pylori eradication for the prevention of gastric neoplasia.rm5
CD005584 v. 6.0 Epinephrine injection versus epinephrine injection and a second endoscopic method in high-risk bleed.rm5
CD005586 v. 5.0 Instruments for assessing readiness to commence suck feeds in preterm infants effects on time to es.rm5
CD005588 v. 4.0 Magnesium sulfate for persistent pulmonary hypertension of the newborn.rm5
CD005589 v. 6.0 Topotecan for ovarian cancer.rm5
CD005590 v. 8.0 Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.rm5
CD005592 v. 4.0 Huperzine A for Alzheimer's disease.rm5
CD005593 v. 11.0 Cholinesterase inhibitors for Alzheimer's disease.rm5
CD005594 v. 5.0 Antipsychotics for delirium.rm5
CD005595 v. 3.0 Rehabilitation for ankle fractures in adults.rm5
CD005598 v. 11.0 Antibiotics for treating community-acquired pneumonia in people with sickle cell disease.rm5
CD005599 v. 12.0 Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-rel.rm5
CD005601 v. 3.0 Psychosocial interventions for prevention of psychological disorders in law enforcement officers.rm5
CD005602 v. 11.0 Leukotriene receptor antagonist for prolonged non-specific cough in children.rm5
CD005603 v. 7.0 Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children a.rm5
CD005604 v. 8.0 Anti-histamines for prolonged non-specific cough in children.rm5
CD005606 v. 3.0 Topical anaesthetic or vasoconstrictor preparations for flexible fibre-optic nasal pharyngoscopy and.rm5
CD005607 v. 5.0 Antibiotics to reduce post-tonsillectomy morbidity.rm5
CD005608 v. 2.0 Systemic antibiotics versus topical treatments for chronically discharging ears with underlying eard.rm5
CD005609 v. 3.4 Interventions to increase clinical incident reporting in health care.rm5
CD005610 v. 5.0 Interventions to reduce waiting times for elective procedures.rm5
CD005612 v. 9.0 Pregabalin add-on for drug-resistant partial epilepsy.rm5
CD005613 v. 6.0 Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellit.rm5
CD005614 v. 6.0 Chondroitin for osteoarthritis.rm5
CD005616 v. 3.0 Corticosteroid injection for de Quervain's tenosynovitis.rm5
CD005617 v. 2.0 Corticosteroid injection for trigger finger in adults.rm5
CD005619 v. 3.0 Surgery for rotator cuff disease.rm5
CD005620 v. 4.0 Direct composite resin fillings versus amalgam fillings for permanent or adult posterior teeth.rm5
CD005622 v. 9.0 Intravenous lidocaine for the treatment of background or procedural burn pain.rm5
CD005624 v. 4.0 Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus open surgery for great .rm5
CD005625 v. 4.0 Rutosides for treatment of post-thrombotic syndrome.rm5
CD005626 v. 4.2 Rutosides for prevention of post-thrombotic syndrome.rm5
CD005627 v. 7.3 Diet or exercise or both for weight reduction in women after childbirth.rm5
CD005631 v. 5.0 Heparin and related substances for preventing diabetic kidney disease.rm5
CD005632 v. 4.0 Steroid avoidance or withdrawal for kidney transplant recipients.rm5
CD005633 v. 5.2 Vitamin D compounds for people with chronic kidney disease requiring dialysis.rm5
CD005634 v. 7.2 Specialist breast care nurses for supportive care of women with breast cancer.rm5
CD005637 v. 6.0 Prophylactic antibiotics for transcervical intrauterine procedures.rm5
CD005638 v. 6.0 Hysterectomy versus hysterectomy plus oophorectomy for premenopausal women.rm5
CD005640 v. 6.5 T-tube drainage versus primary closure after open common bile duct exploration.rm5
CD005641 v. 6.5 T-tube drainage versus primary closure after laparoscopic common bile duct exploration.rm5
CD005642 v. 6.0 Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C.rm5
CD005643 v. 5.0 Interventions for squamous cell carcinoma of the conjunctiva in HIV-infected individuals.rm5
CD005644 v. 2.1 Antimotility agents for chronic diarrhoea in people with HIVAIDS.rm5
CD005645 v. 3.0 Interventions for the treatment of decreased bone mineral density associated with HIV infection.rm5
CD005646 v. 3.0 Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIVAIDS in patients with .rm5
CD005647 v. 3.0 Treatment of acute cryptococcal meningitis in HIV infected adults with an emphasis on resource-limi.rm5
CD005648 v. 4.0 Homeopathy for attention deficithyperactivity disorder or hyperkinetic disorder.rm5
CD005649 v. 3.3 Treatment Foster Care for improving outcomes in children and young people.rm5
CD005650 v. 5.0 Cognitive-behavioral treatment for antisocial behavior in youth in residential treatment.rm5
CD005652 v. 6.0 Psychological therapies for people with borderline personality disorder.rm5
CD005653 v. 4.0 Pharmacological interventions for borderline personality disorder.rm5
CD005654 v. 5.0 Pelvic floor muscle training versus no treatment or inactive control treatments for urinary incont.rm5
CD005655 v. 4.0 Peripheral iridotomy for pigmentary glaucoma.rm5
CD005656 v. 4.0 Intravitreal steroids for macular edema in diabetes.rm5
CD005657 v. 8.0 Topical analgesia for acute otitis media.rm5
CD005660 v. 5.0 Analgesia in patients with acute abdominal pain.rm5
CD005661 v. 3.0 Closure methods for laparotomy incisions for preventing incisional hernias and other wound complicat.rm5
CD005937 v. 4.0 Treatments for suppression of lactation.rm5
CD005938 v. 4.0 Maintenance therapy with oxytocin antagonists for inhibiting preterm birth after threatened preterm .rm5
CD005939 v. 3.0 Rest during pregnancy for preventing pre-eclampsia and its complications in women with normal blood .rm5
CD005940 v. 5.0 Repeat digital cervical assessment in pregnancy for identifying women at risk of preterm labour.rm5
CD005941 v. 7.3 Probiotics for preventing preterm labour.rm5
CD005942 v. 3.0 Exercise or other physical activity for preventing pre-eclampsia and its complications.rm5
CD005943 v. 8.0 Progestogen for treating threatened miscarriage.rm5
CD005944 v. 6.0 Vitamin A supplementation for postpartum women.rm5
CD005945 v. 3.0 Postnatal thyroid hormones for preterm infants with transient hypothyroxinaemia.rm5
CD005946 v. 3.0 Postnatal thyroid hormones for respiratory distress syndrome in preterm infants.rm5
CD005947 v. 6.0 Glutamine supplementation for young infants with severe gastrointestinal disease.rm5
CD005948 v. 4.0 Prophylactic postnatal thyroid hormones for prevention of morbidity and mortality in preterm infants.rm5
CD005949 v. 4.0 Higher versus lower amino acid intake in parenteral nutrition for newborn infants.rm5
CD005950 v. 8.0 Mental practice for treating upper extremity deficits in individuals with hemiparesis after stroke.rm5
CD005951 v. 5.0 Haemostatic therapies for acute spontaneous intracerebral haemorrhage.rm5
CD005952 v. 3.0 Therapy-based rehabilitation services for patients living at home more than one year after stroke.rm5
CD005953 v. 3.0 Extracranial-intracranial arterial bypass surgery for occlusive carotid artery disease.rm5
CD005954 v. 3.0 Exercise therapy in juvenile idiopathic arthritis.rm5
CD005955 v. 3.0 Exercise for acutely hospitalised older medical patients.rm5
CD005956 v. 3.0 Interventions to improve adherence to exercise for chronic musculoskeletal pain in adults.rm5
CD005958 v. 6.6 Manual material handling advice and assistive devices for preventing and treating back pain in worke.rm5
CD005959 v. 3.0 Dynamic compression plating versus locked intramedullary nailing for humeral shaft fractures in adul.rm5
CD005960 v. 3.0 Patellar tendon versus hamstring tendon autograft for anterior cruciate ligament rupture in adults.rm5
CD005962 v. 3.0 Lamotrigine for schizophrenia.rm5
CD005963 v. 8.0 Advance treatment directives for people with severe mental illness.rm5
CD005965 v. 3.0 Artemether-lumefantrine (four-dose regimen) for treating uncomplicated falciparum malaria.rm5
CD005966 v. 4.2 Vaccines for preventing malaria (SPf66).rm5
CD005967 v. 9.3 Artesunate versus quinine for treating severe malaria.rm5
CD005968 v. 7.0 Interventions for replacing missing teeth dental implants in fresh extraction sockets (immediate i.rm5
CD005969 v. 6.0 Magnification devices for endodontic therapy.rm5
CD005970 v. 5.0 Replacement versus repair of defective restorations in adults amalgam.rm5
CD005971 v. 5.0 Replacement versus repair of defective restorations in adults resin composite.rm5
CD005972 v. 8.0 Orthodontic treatment for deep bite and retroclined upper front teeth in children.rm5
CD005974 v. 8.0 Homeopathic medicinal products for preventing and treating acute respiratory tract infections in chi.rm5
CD005975 v. 5.4 Oxygen therapy for lower respiratory tract infections in children between 3 months and 15 years of a.rm5
CD005976 v. 9.2 Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in ch.rm5
CD005978 v. 11.0 Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months.rm5
CD005979 v. 6.0 Pharmaceutical policies effects of reference pricing other pricing and purchasing policies.rm5
CD005981 v. 6.0 Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevent.rm5
CD005982 v. 4.0 Low molecular weight heparin for prevention of central venous catheterization-related thrombosis in .rm5
CD005983 v. 5.0 Heparin-bonded catheters for prolonging the patency of central venous catheters in children.rm5
CD005984 v. 5.0 Enteral nutrition for maintenance of remission in Crohn's disease.rm5
CD005986 v. 4.0 Fish oil for induction of remission in ulcerative colitis.rm5
CD005987 v. 6.0 Scalpel versus electrosurgery for major abdominal incisions.rm5
CD005989 v. 4.0 Herbal interventions for chronic asthma in adults and children.rm5
CD005990 v. 4.0 Nicobrevin for smoking cessation.rm5
CD005992 v. 5.21 Legislative smoking bans for reducing harms from secondhand smoke exposure smoking prevalence and t.rm5
CD005993 v. 5.0 Procaine treatments for cognition and dementia.rm5
CD005994 v. 7.0 -Non-pharmacological interventions for wandering of people with dementia in the domestic setting.rm5
CD005996 v. 5.0 Peri-implantation glucocorticoid administration for assisted reproductive technology cycles.rm5
CD005997 v. 3.0 Hormone therapy for endometriosis and surgical menopause.rm5
CD005998 v. 6.79 Preoperative ripening of the cervix before operative hysteroscopy.rm5
CD005999 v. 5.0 Ovarian cyst aspiration prior to in vitro fertilization treatment for subfertility.rm5
CD006000 v. 3.0 Azathioprine for primary biliary cirrhosis.rm5
CD006001 v. 3.0 Endoscopic retrograde cholangiopancreaticography with or without stenting in patients with pancreati.rm5
CD006002 v. 3.0 Interferon alpha for chronic hepatitis D.rm5
CD006003 v. 6.2 Routine abdominal drainage for uncomplicated open cholecystectomy.rm5
CD006004 v. 7.2 Routine abdominal drainage versus no abdominal drainage for uncomplicated laparoscopic cholecystecto.rm5
CD006005 v. 3.0 Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B re.rm5
CD006006 v. 4.0 Prostaglandins for adult liver transplanted patients.rm5
CD006007 v. 11.2 Antifibrinolytic amino acids for upper gastrointestinal bleeding in people with acute or chronic liv.rm5
CD006009 v. 4.0 Dopamine agonists for the treatment of restless legs syndrome.rm5
CD006011 v. 7.0 Methods of communicating a primary diagnosis of breast cancer to patients.rm5
CD006013 v. 7.0 Interventions for reducing anxiety in women undergoing colposcopy.rm5
CD006014 v. 9.5 Interval debulking surgery for advanced epithelial ovarian cancer.rm5
CD006015 v. 8.0 Finasteride for benign prostatic hyperplasia.rm5
CD006017 v. 4.4 Targeted therapy for advanced renal cell carcinoma.rm5
CD006018 v. 4.0 Adjuvant chemotherapy for invasive bladder cancer (individual patient data).rm5
CD006019 v. 5.0 Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer.rm5
CD006020 v. 6.0 Parenting interventions for the prevention of unintentional injuries in childhood.rm5
CD006022 v. 6.0 Dietary interventions for preventing complications in idiopathic hypercalciuria.rm5
CD006023 v. 6.0 Phosphate binders for preventing and treating bone disease in chronic kidney disease patients.rm5
CD006027 v. 4.0 Nonsteroidal anti-inflammatory drugs (NSAIDs) and non-opioids for acute renal colic.rm5
CD006028 v. 5.0 Atrial natriuretic peptide for preventing and treating acute kidney injury.rm5
CD006029 v. 11.0 Extracorporeal shock wave lithotripsy (ESWL) versus ureteroscopic management for ureteric calculi.rm5
CD006030 v. 5.8 Acupuncture for glaucoma.rm5
CD006032 v. 5.0 Steroids for traumatic optic neuropathy.rm5
CD006033 v. 6.2 Steroidal contraceptives effect on bone fractures in women.rm5
CD006034 v. 5.0 Non-steroidal anti-inflammatory drugs for heavy bleeding or pain associated with intrauterine-device.rm5
CD006036 v. 5.0 Multidisciplinary rehabilitation for adults with multiple sclerosis.rm5
CD006037 v. 6.0 Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared.rm5
CD006039 v. 6.0 Resection versus no intervention or other surgical interventions for colorectal cancer liver metasta.rm5
CD006040 v. 3.0 Reconstructive Techniques After Rectal Resection for Rectal Cancer.rm5
CD006041 v. 4.0 Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer.rm5
CD006043 v. 10.0 Pain relief for the removal of femoral sheath after percutaneous coronary intervention.rm5
CD006044 v. 11.0 Lamotrigine for chronic neuropathic pain and fibromyalgia in adults.rm5
CD006045 v. 4.0 Behavioral interventions to reduce the transmission of HIV infection among sex workers and their cli.rm5
CD006046 v. 3.0 Family support for reducing morbidity and mortality in people with HIVAIDS.rm5
CD006047 v. 8.0 Household interventions for preventing domestic lead exposure in children.rm5
CD006048 v. 7.0 Cognitive behavioural therapy for men who physically abuse their female partner.rm5
CD006049 v. 3.0 Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosismotor neuron disease.rm5
CD006050 v. 6.0 Immunosuppressive treatment for non-systemic vasculitic neuropathy.rm5
CD006052 v. 3.0 Treatment for Charcot-Marie-Tooth disease.rm5
CD006053 v. 11.0 Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whip.rm5
CD006055 v. 4.0 The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women.rm5
CD006056 v. 3.0 Pressure support versus T-tube for weaning from mechanical ventilation in adults.rm5
CD006058 v. 10.0 Incentive spirometry for prevention of postoperative pulmonary complications in upper abdominal surg.rm5
CD006060 v. 4.0 Pioglitazone for type 2 diabetes mellitus.rm5
CD006061 v. 3.0 Whole grain foods for the prevention of type 2 diabetes mellitus.rm5
CD006062 v. 3.0 Weight reduction for primary prevention of stroke in adults with overweight or obesity.rm5
CD006063 v. 4.0 Rosiglitazone for type 2 diabetes mellitus.rm5
CD006064 v. 2.12 Antenatal breast examination for promoting breastfeeding.rm5
CD006065 v. 5.0 Garlic for preventing pre-eclampsia and its complications.rm5
CD006066 v. 7.0 Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessmen.rm5
CD006067 v. 5.0 Fundal pressure during the second stage of labour.rm5
CD006068 v. 5.0 Patient isolation measures for infants with candida colonization or infection for preventing or redu.rm5
CD006069 v. 5.0 Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention .rm5
CD006071 v. 5.2 Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus clo.rm5
CD006072 v. 4.0 Effect of taurine supplementation on growth and development in preterm or low birth weight infants.rm5
CD006073 v. 5.0 Repetitive task training for improving functional ability after stroke.rm5
CD006074 v. 3.0 Carotid endarterectomy for carotid stenosis in patients selected for coronary artery bypass graft su.rm5
CD006075 v. 3.0 Overground physical therapy gait training for chronic stroke patients with mobility deficits.rm5
CD006076 v. 3.3 Acupuncture for dysphagia in acute stroke.rm5
CD006077 v. 5.0 Allopurinol for chronic gout.rm5
CD006080 v. 5.0 Percutaneous pinning for treating distal radial fractures in adults.rm5
CD006081 v. 3.0 Transcranial magnetic stimulation (TMS) for schizophrenia.rm5
CD006085 v. 4.0 Antiamoebic drugs for treating amoebic colitis.rm5
CD006086 v. 5.2 Nutritional supplements for people being treated for active tuberculosis.rm5
CD006087 v. 4.0 Interventions for the management of mandibular fractures.rm5
CD006088 v. 8.0 Over-the-counter (OTC) medications to reduce cough as an adjunct to antibiotics for acute pneumonia .rm5
CD006089 v. 8.1 Antibiotics for clinically diagnosed acute rhinosinusitis in adults.rm5
CD006090 v. 8.0 Vitamin A for preventing acute lower respiratory tract infections in children up to seven years of a.rm5
CD006093 v. 5.0 Interventions for promoting information and communication technologies adoption in healthcare profes.rm5
CD006094 v. 3.0 Interventions for improving the appropriate use of imaging in people with musculoskeletal conditions.rm5
CD006095 v. 4.0 Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.rm5
CD006096 v. 6.0 Interventions for treating lymphocytic colitis.rm5
CD006097 v. 3.0 Natalizumab for induction of remission in Crohn's disease.rm5
CD006099 v. 6.0 Wound drains following thyroid surgery.rm5
CD006100 v. 3.5 Leukotriene receptor antagonists in addition to usual care for acute asthma in adults and children.rm5
CD006101 v. 3.0 Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary dise.rm5
CD006102 v. 3.0 Smoking cessation interventions for smokers with current or past depression.rm5
CD006103 v. 13.12 Nicotine receptor partial agonists for smoking cessation.rm5
CD006104 v. 7.0 Donepezil for mild cognitive impairment.rm5
CD006105 v. 6.0 Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.rm5
CD006106 v. 5.0 Pain relief in hysterosalpingography.rm5
CD006107 v. 5.0 Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women.rm5
CD006108 v. 10.0 Exercise for vasomotor menopausal symptoms.rm5
CD006109 v. 8.0 Oral contraceptive pill progestogen or oestrogen pretreatment for ovarian stimulation protocols for.rm5
CD006110 v. 10.0 Antibiotics for treating acute chest syndrome in people with sickle cell disease.rm5
CD006111 v. 7.0 Piracetam for reducing the incidence of painful sickle cell disease crises.rm5
CD006112 v. 5.0 Inspiratory muscle training for cystic fibrosis.rm5
CD006113 v. 4.0 Intravesical treatments for painful bladder syndrome interstitial cystitis.rm5
CD006114 v. 7.0 Fluvoxamine versus other anti-depressive agents for depression.rm5
CD006115 v. 4.0 Azapirones for generalized anxiety disorder.rm5
CD006116 v. 4.0 Psychosocial and psychological interventions for treating postpartum depression.rm5
CD006117 v. 10.0 Sertraline versus other antidepressive agents for depression.rm5
CD006118 v. 10.0 Interventions for psychotic symptoms concomitant with epilepsy.rm5
CD006119 v. 7.0 Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion .rm5
CD006120 v. 9.0 Pain relief for women with cervical intraepithelial neoplasia undergoing colposcopy treatment.rm5
CD006121 v. 10.0 Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain m.rm5
CD006122 v. 7.0 High-carbohydrate high-protein low-fat versus low-carbohydrate high-protein high-fat enteral fee.rm5
CD006123 v. 8.0 Fitness training for cardiorespiratory conditioning after traumatic brain injury.rm5
CD006124 v. 4.1 Laparoscopic versus open nephrectomy for live kidney donors.rm5
CD006126 v. 5.0 Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy.rm5
CD006127 v. 4.0 Blood pressure control for diabetic retinopathy.rm5
CD006129 v. 4.0 Screening for prevention of optic nerve damage due to chronic open angle glaucoma.rm5
CD006131 v. 4.0 Interventions for Mooren's ulcer.rm5
CD006132 v. 5.2 Interventions for improving adherence to ocular hypotensive therapy.rm5
CD006133 v. 6.0 Steroidal contraceptives effect on carbohydrate metabolism in women without diabetes mellitus.rm5
CD006134 v. 6.0 Oral contraceptives for functional ovarian cysts.rm5
CD006135 v. 3.0 Probiotics for treating eczema.rm5
CD006136 v. 4.2 Oral potassium iodide for the treatment of sporotrichosis.rm5
CD006137 v. 6.0 H1-antihistamines for chronic spontaneous urticaria.rm5
CD006140 v. 5.0 Sustained-Release Naltrexone For Opioid Dependence.rm5
CD006142 v. 10.0 Transcutaneous electrical nerve stimulation for acute pain.rm5
CD006145 v. 7.0 Exercise for the management of cancer-related fatigue in adults.rm5
CD006146 v. 8.0 Opioids for neuropathic pain.rm5
CD006148 v. 3.0 Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.rm5
CD006149 v. 4.0 Interventions for treating AIDS-associated Hodgkins lymphoma in treatment-naive adults.rm5
CD006150 v. 3.9 Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection.rm5
CD006151 v. 6.0 Fundoplication versus postoperative medication for gastro-oesophageal reflux in children with neurol.rm5
CD006152 v. 3.0 Decompressive surgery of lower limbs for symmetrical diabetic peripheral neuropathy.rm5
CD006153 v. 4.0 Treatment for familial amyotrophic lateral sclerosismotor neuron disease.rm5
CD006154 v. 5.0 Interventions for the prevention and treatment of pes cavus.rm5
CD006157 v. 3.0 Chemotherapy and surgery versus surgery alone in non-small cell lung cancer.rm5
CD006158 v. 3.0 Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer.rm5
CD006160 v. 11.0 H1-antihistamines for the treatment of anaphylaxis with and without shock.rm5
CD006161 v. 5.5 Supplemental oxygen for caesarean section during regional anaesthesia.rm5
CD006162 v. 4.0 Rimonabant for overweight or obesity.rm5
CD006163 v. 3.0 Parenteral calcium for intensive care unit patients.rm5
CD006164 v. 3.0 Interventions for the prevention of nutritional rickets in term born children.rm5
CD006165 v. 5.0 Interventions for latent autoimmune diabetes (LADA) in adults.rm5
CD006167 v. 8.0 Amniotomy for shortening spontaneous labour.rm5
CD006168 v. 3.0 Biofeedback for pain management during labour.rm5
CD006169 v. 3.0 Combination of tocolytic agents for inhibiting preterm labour.rm5
CD006170 v. 6.2 Methods of milk expression for lactating women.rm5
CD006171 v. 4.0 Prenatal education for congenital toxoplasmosis.rm5
CD006172 v. 5.0 Home uterine monitoring for detecting preterm labour.rm5
CD006173 v. 4.0 Timing of prophylactic uterotonics for the third stage of labour after vaginal birth.rm5
CD006174 v. 6.0 Intrapartum fetal scalp lactate sampling for fetal assessment in the presence of a non-reassuring fe.rm5
CD006175 v. 4.0 Progesterone for preventing pre-eclampsia and its complications.rm5
CD006176 v. 3.0 Umbilical vein injection for the routine management of third stage of labour.rm5
CD006177 v. 4.1 Interventions in the workplace to support breastfeeding for women in employment.rm5
CD006178 v. 7.0 Antenatal lower genital tract infection screening and treatment programs for preventing preterm deli.rm5
CD006179 v. 4.0 Prophylactic systemic antibiotics to reduce morbidity and mortality in neonates with central venous .rm5
CD006180 v. 3.0 Protein-containing synthetic surfactant versus protein-free synthetic surfactant for the prevention .rm5
CD006181 v. 5.0 Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity.rm5
CD006182 v. 3.0 Peritoneal drainage versus laparotomy as initial surgical treatment for perforated necrotizing enter.rm5
CD006183 v. 3.2 Antibiotics for neonates born through meconium-stained amniotic fluid.rm5
CD006184 v. 3.0 Antiplatelet therapy for aneurysmal subarachnoid haemorrhage.rm5
CD006185 v. 7.0 Electromechanical-assisted training for walking after stroke.rm5
CD006186 v. 4.0 Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular .rm5
CD006187 v. 3.2 Very early versus delayed mobilisation after stroke.rm5
CD006188 v. 3.0 Surgical interventions for the rheumatoid shoulder.rm5
CD006189 v. 2.0 Oral steroids for adhesive capsulitis.rm5
CD006190 v. 5.0 Colchicine for acute gout.rm5
CD006193 v. 4.0 Cemented cementless or hybrid fixation options in total knee arthroplasty for osteoarthritis and ot.rm5
CD006194 v. 4.0 External fixation versus conservative treatment for distal radial fractures in adults.rm5
CD006196 v. 3.6 Intermittent drug techniques for schizophrenia.rm5
CD006197 v. 5.0 Testosterone for schizophrenia.rm5
CD006198 v. 3.0 Vaccines for preventing malaria (pre-erythrocytic).rm5
CD006199 v. 3.0 Vaccines for preventing malaria (blood-stage).rm5
CD006201 v. 5.0 Chemotherapy for second-stage Human African trypanosomiasis.rm5
CD006202 v. 3.0 Home-based chemically-induced whitening of teeth in adults.rm5
CD006203 v. 4.0 Interventions for treating traumatised permanent front teeth luxated (dislodged) teeth.rm5
CD006204 v. 5.0 Resorbable versus titanium plates for orthognathic surgery.rm5
CD006205 v. 5.0 Interventions for the treatment of oral and oropharyngeal cancers surgical treatment.rm5
CD006206 v. 8.0 Garlic for the common cold.rm5
CD006207 v. 9.1 Physical interventions to interrupt or reduce the spread of respiratory viruses.rm5
CD006208 v. 5.0 Interventions for reducing medication errors in children in hospital.rm5
CD006210 v. 5.0 The psychological effects of the physical healthcare environment on healthcare personnel.rm5
CD006211 v. 4.19 Comprehensive geriatric assessment for older adults admitted to hospital.rm5
CD006212 v. 6.0 Vena caval filters for the prevention of pulmonary embolism.rm5
CD006213 v. 9.0 Healing by primary versus secondary intention after surgical treatment for pilonidal sinus.rm5
CD006214 v. 7.0 Debridement for surgical wounds.rm5
CD006215 v. 7.0 Negative pressure wound therapy for partial-thickness burns.rm5
CD006216 v. 5.0 Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers.rm5
CD006217 v. 3.0 Ciclesonide versus placebo for chronic asthma in adults and children.rm5
CD006218 v. 5.0 Influenza vaccine for children and adults with bronchiectasis.rm5
CD006219 v. 5.25 Interventions for preventing weight gain after smoking cessation.rm5
CD006220 v. 4.0 Cognition-based interventions for healthy older people and people with mild cognitive impairment.rm5
CD006221 v. 4.0 Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people.rm5
CD006222 v. 8.0 Driving assessment for maintaining mobility and safety in drivers with dementia.rm5
CD006224 v. 6.13 Chinese herbal medicine in the treatment of ectopic pregnancy.rm5
CD006225 v. 4.6 Soft versus firm catheters for intrauterine insemination.rm5
CD006226 v. 6.0 Long versus short course treatment with metformin and clomiphene citrate for ovulation induction in .rm5
CD006227 v. 7.5 Microwave therapy for cervical ectropion.rm5
CD006229 v. 2.2 Laparoscopic versus small-incision cholecystectomy for patients with symptomatic cholecystolithiasis.rm5
CD006230 v. 3.5 Cholecystectomy for patients with silent gallstones.rm5
CD006231 v. 2.0 Laparoscopic versus open cholecystectomy for patients with symptomatic cholecystolithiasis.rm5
CD006232 v. 5.2 Routine abdominal drainage for uncomplicated liver resection.rm5
CD006233 v. 4.0 Cholecystectomy deferral in patients with endoscopic sphincterotomy.rm5
CD006237 v. 5.0 Interventions to improve return to work in depressed people.rm5
CD006239 v. 3.0 Pharmacological interventions for preventing post-traumatic stress disorder (PTSD).rm5
CD006240 v. 3.0 Therapeutic touch for anxiety disorders.rm5
CD006242 v. 5.12 Trastuzumab-containing regimens for metastatic breast cancer.rm5
CD006243 v. 4.0 Trastuzumab containing regimens for early breast cancer.rm5
CD006244 v. 7.0 Care delivery and self management strategies for adults with epilepsy.rm5
CD006245 v. 9.0 Care delivery and self-management strategies for children with epilepsy.rm5
CD006246 v. 5.0 Chemotherapy andor radiotherapy in combination with surgery for ovarian carcinosarcoma .rm5
CD006247 v. 5.0 Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemothe.rm5
CD006248 v. 5.3 Primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of.rm5
CD006250 v. 5.0 Bisphosphonates for advanced prostate cancer.rm5
CD006251 v. 8.2 Interventions to prevent injuries in construction workers.rm5
CD006252 v. 4.21 Vision screening of older drivers for preventing road traffic injuries and fatalities.rm5
CD006254 v. 8.2 Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients.rm5
CD006257 v. 7.0 Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the .rm5
CD006258 v. 7.0 Haemodiafiltration haemofiltration and haemodialysis for end-stage kidney disease.rm5
CD006259 v. 4.7 Mitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgery.rm5
CD006260 v. 5.0 Immediate start of hormonal contraceptives for contraception.rm5
CD006261 v. 5.0 Steroid hormones for contraception in women with sickle cell disease.rm5
CD006263 v. 3.0 Interventions for pemphigus vulgaris and pemphigus foliaceus.rm5
CD006264 v. 3.0 Corticosteroids for the long-term treatment in multiple sclerosis.rm5
CD006266 v. 6.0 Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses.rm5
CD006267 v. 3.3 Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial .rm5
CD006268 v. 3.0 Propofol for sedation during colonoscopy.rm5
CD006269 v. 3.0 Concomitant hyperthermia and radiation therapy for treating locally advanced rectal cancer.rm5
CD006271 v. 9.0 Haloperidol for the treatment of nausea and vomiting in palliative care patients.rm5
CD006273 v. 8.0 Medically assisted hydration for adult palliative care patients.rm5
CD006274 v. 8.0 Medically assisted nutrition for adult palliative care patients.rm5
CD006275 v. 13.0 Non-pharmacological management of infant and young child procedural pain.rm5
CD006276 v. 7.0 Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults.rm5
CD006277 v. 2.2 Personal assistance for children and adolescents (0-18) with physical impairments.rm5
CD006278 v. 3.3 Intervention for childhood apraxia of speech.rm5
CD006279 v. 2.0 Intervention for dysarthria associated with acquired brain injury in children and adolescents.rm5
CD006281 v. 4.0 Drug treatment for spinal muscular atrophy type I.rm5
CD006282 v. 4.0 Drug treatment for spinal muscular atrophy types II and III.rm5